Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3027953	s-aldol	U/l (u/l)	2228	3250	0.03%
3027953	s-aldol	— (—)	517	605	100.00%	Distribution not available
3027953	s-aldol	U/l_______ (u/l)	69	78	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Myalgia

377

404

9.58

317.38

1.4

4.97

5.89

u/l

1.59

321

347

ILD medications: prednisolone, methylprednisolone, prednisone

983

1252

4.41

312.44

1.8

1.1

5.88

6.46

u/l

0.43

840

1060

Diseases of the myoneural junction and muscle

322

257

13.24

307.65

1.9

1.4

8.82

6.13

u/l

1.62

269

222

Systemic connective tissue disorders

786

708

11.56

307.65

2.2

1.2

6.15

5.76

u/l

0.43

699

591

Other systemic involvement of connective tissue (FG)

545

387

14.36

307.65

1.8

1.3

5.63

6.20

u/l

0.43

477

323

Other soft tissue disorders, not elsewhere classified

893

1016

5.06

307.65

1.4

6.23

6.08

u/l

0.06

762

862

Symptoms and signs involving the nervous and musculoskeletal systems

785

1369

5.85

307.65

1.4

1.5

5.39

6.00

u/l

1.02

660

1191

Other systemic involvement of connective tissue

555

560

10.28

307.65

1.8

1.2

5.62

5.90

u/l

0.26

487

470

ILD medications: immunosuppressive drugs

787

1171

6.19

307.65

2.1

1.1

6.10

6.54

u/l

0.28

700

999

Oral corticosteroids

1036

1375

4.47

307.65

1.9

1.2

5.98

6.31

u/l

0.24

885

1173

Inflammatory bowel disease treatment related agents

1038

1404

4.14

306.24

1.8

1.2

6.00

6.29

u/l

0.21

888

1202

ILD medications

1000

1265

4.30

304.94

1.8

1.1

5.82

6.45

u/l

0.48

865

1073

Myositis

175

55.17

304.16

3.3

1.3

9.50

5.45

u/l

3.88

167

Other symptoms and signs involving the nervous and musculoskeletal systems

553

970

5.82

299.13

1.4

1.5

4.99

5.83

u/l

2.91

468

842

Disorders of muscles

244

147

17.40

294.36

2.8

1.5

8.47

5.81

u/l

2.67

221

127

Reimbursement for rheumatic diseases

663

1382

4.85

292.28

2.2

1.2

5.82

5.71

u/l

0.15

591

1169

Autoimmune diseases related-to ILD

829

1717

4.08

279.01

1.9

1.2

6.09

6.08

u/l

0.01

717

1450

Second line medication for Crohn's disease

657

1478

4.51

265.79

2.2

1.2

6.04

5.78

u/l

0.35

583

1253

L04AX Other immunosuppressants

647

1445

4.55

264.39

2.2

1.2

6.06

5.79

u/l

0.36

573

1228

Pain in limb

717

998

4.61

254.21

1.5

1.4

6.56

6.11

u/l

0.18

617

844

Other and unspecified myopathies

226

162

14.76

248.94

2.0

1.4

9.42

6.80

u/l

0.96

194

139

First line medication for Crohn's disease

903

1269

3.86

241.41

1.8

1.2

5.86

6.42

u/l

0.41

776

1086

Finngen Rheumatological endpoints

800

1111

4.12

237.48

1.7

1.2

5.82

6.66

u/l

0.59

710

927

Pain in joint

542

588

5.73

236.94

1.4

1.5

5.12

6.68

u/l

3.39

462

511

Other specified/unspecified systemic involvement of connective tissue

177

105

18.14

215.97

2.1

1.2

6.20

5.64

u/l

0.33

162

Polymyalgia rheumatica

222

207

11.10

206.90

1.5

1.1

5.41

6.13

u/l

0.38

189

175

Polymyositis

104

130.56

204.26

4.2

1.2

9.72

5.41

u/l

2.12

Other specific joint derangements/joint disorders

650

1012

4.04

195.43

1.4

1.5

5.16

7.17

u/l

2.01

555

848

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

148

36.66

178.55

2.1

1.0

6.08

5.20

u/l

0.60

138

Soft tissue disorders

716

1021

3.62

172.60

1.6

1.4

5.77

6.08

u/l

0.29

615

866

Autoimmune diseases excluding thyroid diseases

786

1345

3.19

161.52

1.9

1.2

7.07

5.64

u/l

0.95

691

1140

Autoimmune diseases excluding thyroid diseases, strict definition

761

1295

3.22

158.83

1.9

1.2

7.12

5.65

u/l

0.94

669

1099

Spondylopathies

605

996

3.62

154.52

1.4

5.83

6.93

u/l

0.74

520

856

Abnormalities of gait and mobility

192

220

9.01

153.92

1.4

6.51

6.28

u/l

0.07

156

187

Other arthritis (FG)

294

543

5.49

150.57

1.5

1.3

5.44

6.15

u/l

0.78

257

462

Dorsalgia

704

1169

3.21

145.18

1.5

1.4

5.62

6.78

u/l

1.00

610

1000

Low back pain

580

1152

3.42

143.38

1.4

5.35

6.81

u/l

1.37

498

984

Malaise and fatigue

438

882

3.95

139.12

1.6

1.4

5.57

5.87

u/l

0.30

366

760

Neurological diseases

562

768

3.70

138.70

1.5

1.4

5.92

5.55

u/l

0.39

489

649

Other and unspecified polyneuropathies, also in other diseases

247

422

5.99

137.84

1.4

1.5

5.27

6.35

u/l

1.40

213

360

Neurological diseases, wide definition

192

15.19

137.71

1.5

1.0

5.88

5.07

u/l

0.64

163

Polyneuropathies and other disorders of the peripheral nervous system

267

492

5.55

137.44

1.4

1.5

5.37

6.31

u/l

1.29

232

421

Other dorsopathies, not elsewhere classified

699

1172

3.12

136.69

1.5

1.4

5.78

6.77

u/l

0.78

598

1002

Diseases of the musculoskeletal system and connective tissue

316

252

6.33

136.58

1.6

1.1

6.70

7.02

u/l

0.09

273

206

Fibromyalgia

152

151

10.39

135.56

1.3

1.5

4.80

5.68

u/l

1.77

130

131

Spondylosis

436

899

3.83

132.47

1.4

5.34

6.44

u/l

1.97

384

776

Polyarthropathies

511

926

3.57

132.14

1.6

1.5

5.55

7.35

u/l

1.47

443

777

Other intervertebral disc disorders

579

1087

3.20

123.82

1.5

1.4

5.54

6.88

u/l

1.13

497

933

General symptoms and signs

717

1243

2.91

123.61

1.5

1.4

5.78

5.80

u/l

0.02

624

1066

Other specified/unspecified arthritis

266

540

5.00

122.54

1.5

1.6

5.47

6.31

u/l

1.14

231

459

ILD medications: azathioprine

176

244

7.37

120.05

2.9

1.1

6.61

5.99

u/l

0.44

152

214

Fever of other and unknown origin

426

1053

3.53

119.30

1.7

1.4

6.00

5.85

u/l

0.18

359

908

Lower back pain or/and sciatica

775

1871

2.59

116.18

1.5

1.4

5.29

6.43

u/l

1.75

669

1587

Sicca syndrome [Sjögren]

138

149

9.59

115.93

2.0

1.2

5.46

5.63

u/l

0.10

119

128

Dorsopathies

668

1179

2.89

114.28

1.5

1.4

5.72

6.78

u/l

0.86

582

1008

Autoimmune diseases

725

1349

2.74

113.61

1.8

1.2

6.24

5.64

u/l

0.78

634

1142

Abnormalities of breathing

627

1255

2.88

111.16

1.5

6.28

6.11

u/l

0.08

537

1077

Azathioprine

176

270

6.66

109.34

2.9

1.2

6.61

5.74

u/l

0.77

152

236

Headache

472

1163

3.16

107.44

1.4

7.45

5.80

u/l

0.56

409

1000

Tramadol

564

1155

2.96

106.54

1.5

1.4

7.71

5.78

u/l

0.85

481

988

Used for control exclusion in common control thyroid runs

668

1225

2.76

106.00

1.8

1.2

6.08

5.70

u/l

0.42

586

1044

Sciatica+with lumbago

385

995

3.45

104.93

1.5

1.4

5.08

7.00

u/l

1.97

338

861

Pain, not elsewhere classified

253

572

4.48

102.24

1.6

1.5

4.97

5.90

u/l

2.59

216

495

Nerve, nerve root and plexus disorders

736

1790

2.48

100.55

1.6

1.4

5.72

6.30

u/l

0.58

628

1531

Dermatitis

482

1650

2.88

99.27

1.5

5.28

5.93

u/l

1.85

420

1394

Other joint disorders

568

1030

2.89

98.71

1.4

1.5

5.28

7.15

u/l

1.78

498

861

Pain (limb, back, neck, head abdominally)

417

591

3.56

97.85

1.5

5.85

6.69

u/l

0.75

366

512

Examination and observation for other reasons

406

658

3.51

97.77

1.5

1.4

5.77

5.93

u/l

0.14

343

570

Asthma, excluding more controls

507

854

3.07

96.47

1.5

1.3

5.24

5.67

u/l

0.92

430

741

Asthma

520

895

3.02

96.43

1.5

1.3

5.27

5.70

u/l

0.95

442

776

Care involving use of rehabilitation procedures

498

1607

2.81

96.06

1.7

1.4

5.45

5.94

u/l

0.96

424

1388

Other and unspecified dermatitis

421

1397

3.04

96.04

1.5

5.30

5.94

u/l

1.71

370

1186

Asthma (mode)

512

903

3.00

94.66

1.5

1.3

5.35

5.70

u/l

0.68

436

784

Disorders of thyroid, IBD co-morbidities

105

15.42

94.61

1.5

1.0

6.04

4.96

u/l

0.82

Spinal stenosis

350

731

3.56

94.45

1.4

6.05

6.28

u/l

0.13

301

622

Infections, IBD-co-morbidities

15.97

92.20

1.7

1.0

6.48

4.92

u/l

0.98

Shoulder lesions

436

860

3.06

87.18

1.4

1.3

5.48

6.17

u/l

0.87

386

735

Medical observation and evaluation for suspected diseases and conditions

417

659

3.25

86.92

1.4

6.45

5.93

u/l

0.38

360

571

Arthropathies

556

1034

2.73

86.60

1.5

5.62

7.14

u/l

1.19

486

865

Pain in throat and chest

549

1235

2.65

84.86

1.5

1.4

6.02

6.11

u/l

0.05

481

1060

Asthma (only as main-diagnosis), excluding more controls

455

854

2.96

84.18

1.5

1.3

5.45

5.67

u/l

0.33

385

741

L04AA Selective immunosuppressants

241

622

3.94

81.92

2.5

1.4

6.38

5.97

u/l

0.36

218

536

Other and unspecified primary disorders of muscles

43.36

81.40

1.5

1.6

7.48

8.24

u/l

0.09

Asthma (only as main-diagnosis)

458

895

2.88

80.95

1.5

1.3

5.45

5.70

u/l

0.41

385

776

Opioids

601

1250

2.50

79.44

1.5

5.86

5.72

u/l

0.14

514

1067

Lumbar disc prolapse

406

1051

2.88

78.28

1.5

1.4

5.77

6.93

u/l

0.79

348

903

Abnormal involuntary movements

148

268

5.63

77.82

1.3

1.5

4.97

6.08

u/l

1.72

121

235

Other respiratory diseases principally affecting the interstitium

177

378

4.76

77.03

2.0

1.6

5.94

6.67

u/l

0.60

160

323

ILD, hospital admissions 1, main diag only

153

289

5.41

76.87

2.1

1.5

5.97

6.62

u/l

0.41

139

246

ILD, hospital admissions

165

334

5.04

76.61

2.0

1.5

5.96

6.49

u/l

0.36

150

283

354

1201

2.95

76.55

1.6

1.4

5.33

6.00

u/l

1.68

301

1045

Other interstitial pulmonary diseases

165

335

5.02

76.33

2.0

1.5

5.96

6.51

u/l

0.38

150

284

Interstitial lung disease endpoints

165

336

5.01

76.07

2.0

1.5

5.96

6.48

u/l

0.36

150

284

Interstitial lung disease

165

336

5.01

76.07

2.0

1.5

5.96

6.48

u/l

0.36

150

284

Asthma, unspecified (mode), excluding more controls

351

816

3.10

76.00

1.5

1.3

5.23

5.69

u/l

0.91

292

709

Other necrotizing vasculopathies (FG)

11.28

75.66

1.4

1.2

5.81

7.24

u/l

0.28

Asthma-related infections

423

1557

2.67

75.48

1.6

1.5

5.44

6.05

u/l

1.39

359

1342

Asthma, hospital admission 2, infections

423

1557

2.67

75.48

1.6

1.5

5.44

6.05

u/l

1.39

359

1342

Dyspnoea

598

1861

2.33

75.12

1.5

1.4

6.02

5.86

u/l

0.14

518

1582

Dermatitis and eczema

707

1903

2.21

74.60

1.5

5.36

6.38

u/l

1.55

616

1609

Other necrotizing vasculopathies

112

8.73

74.53

1.5

1.2

5.74

7.00

u/l

0.37

Codeine

564

1240

2.47

74.15

1.6

1.5

5.62

5.72

u/l

0.13

497

1057

Symptoms and signs involving the skin and subcutaneous tissue

506

1978

2.43

73.96

1.4

1.5

5.59

5.90

u/l

0.35

437

1677

Asthma, unspecified (mode)

354

854

3.01

73.29

1.5

1.3

5.25

5.72

u/l

1.00

294

742

Rotator cuff syndrome

352

809

3.01

72.04

1.4

1.3

5.38

6.24

u/l

1.06

303

689

Dermatopolymyositis, unspecified

160.89

71.70

4.0

1.1

6.32

5.10

u/l

—

Other/unspecified dorsalgia

253

733

3.44

70.70

1.5

1.4

5.50

5.81

u/l

0.20

214

630

SLE (Finngen)

12.89

70.52

2.0

1.1

5.72

5.61

u/l

0.03

Migraine

365

1016

2.82

68.52

1.5

4.79

5.80

u/l

3.63

309

868

Rheumatism, unspecified

124

216

5.84

67.92

1.4

1.5

4.70

6.29

u/l

1.56

101

182

Symptoms and signs involving the circulatory and respiratory systems

587

1258

2.35

67.90

1.6

1.5

6.13

6.10

u/l

0.01

503

1080

ILD, hospital admission 2, with pulmonary infections

110

175

6.42

66.13

2.2

1.5

6.17

6.28

u/l

0.05

101

153

General examination and investigation of persons without complaint and reported diagnosis

369

658

2.93

65.66

1.4

5.79

5.93

u/l

0.07

322

570

Dysphagia

205

558

3.72

64.55

1.7

1.4

5.50

6.41

u/l

0.94

179

482

Diseases of oesophagus, stomach and duodenum

659

1826

2.14

64.42

1.5

1.4

7.00

5.79

u/l

0.57

556

1577

Episodal and paroxysmal disorders

637

1470

2.21

64.34

1.5

5.47

5.88

u/l

0.62

548

1241

Persons encountering health services for specific procedures and health care

662

1839

2.13

64.23

1.6

1.4

5.77

6.19

u/l

0.37

563

1579

Disorders of synovium and tendon

301

862

2.98

64.10

1.4

1.3

5.40

6.20

u/l

0.88

263

735

Anaemias

155

191

5.25

63.95

1.4

5.10

5.07

u/l

0.03

136

176

Systemic lupus erythematosus

10.93

63.39

2.0

1.2

5.72

6.23

u/l

0.22

Other pulmonary diagnosis

459

903

2.56

63.35

1.5

1.3

6.11

5.70

u/l

0.34

392

783

Systemic atrophies primarily affecting the central nervous system

10.54

62.91

1.1

1.5

5.49

8.40

u/l

0.60

Excluding asthma or asthma-COPD overlap

456

903

2.54

62.15

1.5

1.3

6.13

5.70

u/l

0.36

389

783

Asthma (diagnoses ohter than nonallergic)

555

2056

2.19

61.93

1.5

5.33

6.00

u/l

2.09

466

1762

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

184

195

4.76

61.49

1.5

1.3

6.45

6.24

u/l

0.09

157

175

ILD differential diagnosis

453

903

2.53

60.96

1.5

1.3

6.12

5.70

u/l

0.34

386

784

COPD differential diagnosis

452

904

2.52

60.44

1.5

1.3

6.12

5.71

u/l

0.34

385

785

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

609

1942

2.12

60.36

1.7

1.4

5.73

6.25

u/l

0.55

514

1670

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

532

1381

2.26

59.29

1.8

1.4

6.40

5.87

u/l

0.55

450

1176

532

1381

2.26

59.29

1.8

1.4

6.40

5.87

u/l

0.55

450

1176

Hypothyroidism (congenital or acquired)

166

195

4.80

58.89

1.7

1.5

5.18

5.00

u/l

0.19

140

179

Abnormal findings on examination of blood, without diagnosis

329

1117

2.69

58.69

1.8

1.4

5.91

6.19

u/l

0.34

281

964

Disturbances of skin sensation

236

751

3.18

58.23

1.2

1.5

5.00

5.60

u/l

0.93

203

650

Anxiety disorders, excluding more controls

517

1476

2.25

58.20

1.5

5.58

6.20

u/l

0.46

447

1268

Other antidepressants

599

1419

2.16

57.90

1.4

1.5

5.60

6.05

u/l

0.61

518

1208

Hypothyroidism, levothyroxine purchases

164

194

4.77

57.85

1.6

1.4

5.23

5.00

u/l

0.25

135

178

Hypothyroidism and >3 levothyroxin purchases

164

194

4.77

57.85

1.6

1.4

5.23

5.00

u/l

0.25

135

178

Codeine or tramadol medication

663

1766

2.05

56.72

1.5

1.4

6.62

5.87

u/l

0.34

578

1494

Mood disorders, excluding more controls

565

1544

2.16

56.56

1.5

5.86

6.23

u/l

0.23

468

1325

Symptoms and signs concerning food and fluid intake

105

188

5.67

55.78

1.4

6.23

6.77

u/l

0.15

167

Neurotic, stress-related and somatoform disorders

558

1831

2.11

54.72

1.4

1.5

5.54

6.19

u/l

0.59

481

1574

Anxiety disorders

561

1842

2.10

54.30

1.4

1.5

5.55

6.19

u/l

0.59

484

1581

Cardiovascular diseases

367

749

2.61

53.87

1.5

5.89

5.23

u/l

0.92

319

651

Metabolic disorders

571

1637

2.10

53.69

1.5

1.4

7.18

5.77

u/l

0.61

487

1410

Somatoform disorder

160

418

3.89

53.63

1.5

1.4

5.02

6.25

u/l

1.57

140

356

Any reimbursement code in KELA

332

602

2.78

53.49

1.6

1.2

5.69

5.61

u/l

0.07

294

520

Other enthesopathies

186

540

3.47

53.15

1.2

1.4

4.91

5.79

u/l

1.86

161

472

Influenza and pneumonia

631

1951

2.00

52.66

1.7

1.4

6.24

5.96

u/l

0.23

540

1674

GASTRO-related operations

439

930

2.38

52.38

1.6

1.4

6.19

5.55

u/l

0.63

376

815

Any gastric operation

439

930

2.38

52.38

1.6

1.4

6.19

5.55

u/l

0.63

376

815

Diseases of the skin and subcutaneous tissue

543

1264

2.16

52.34

1.5

1.4

5.70

6.72

u/l

0.86

476

1069

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

419

1610

2.28

52.21

1.6

1.4

6.30

5.81

u/l

0.44

368

1379

Mood [affective] disorders

610

1948

2.01

52.12

1.5

5.84

6.19

u/l

0.26

502

1687

Cervicobrachial syndrome

159

423

3.80

51.85

1.3

1.4

5.45

5.88

u/l

0.34

137

370

Mood disorders

610

1949

2.01

51.78

1.5

5.84

6.19

u/l

0.26

502

1688

Asthma, including avohilmo

683

1933

1.95

51.63

1.5

5.46

6.32

u/l

1.10

579

1660

Non-invasive ventilation

172

408

3.67

51.28

1.7

1.3

6.73

5.22

u/l

0.88

149

356

Rheumatoid arthritis

200

541

3.30

51.12

1.8

1.6

5.50

6.26

u/l

1.10

174

459

Parasetamol

390

805

2.46

50.08

1.6

1.5

6.12

5.99

u/l

0.08

334

698

Cervical disc disorders

219

729

3.03

50.02

1.3

1.4

5.11

6.13

u/l

2.29

183

633

Other headache syndromes

276

1038

2.67

49.82

1.4

4.90

5.84

u/l

3.26

242

881

Depression

572

1904

2.02

49.60

1.4

1.5

5.74

6.19

u/l

0.34

471

1651

Giant cell arteritis

9.51

48.54

1.1

1.0

6.08

7.57

u/l

0.23

Chronic lower respiratory diseases

688

1903

1.91

48.33

1.5

5.94

6.16

u/l

0.16

577

1641

Abdominal and pelvic pain

547

1321

2.09

48.29

1.4

1.5

6.67

6.15

u/l

0.17

463

1149

Depression medications

167

203

4.16

48.25

1.6

1.5

5.98

5.02

u/l

0.82

149

186

Small fibre neuropathy

9.92

48.05

1.6

1.5

5.42

6.20

u/l

0.36

Other special examinations and investigations of persons without complaint or reported diagnosis

335

659

2.59

47.59

1.5

1.4

5.69

5.93

u/l

0.22

295

571

Cervicalgia

142

371

3.86

47.55

1.4

1.5

5.87

5.92

u/l

0.02

119

315

Soft tissue disorders related to use, overuse and pressure

165

478

3.48

47.40

1.6

1.3

5.05

6.05

u/l

1.82

141

404

Other disorders of adrenal gland

7.47

46.78

1.7

1.3

6.92

6.49

u/l

0.07

Deforming dorsopathies

175

533

3.31

46.42

1.7

1.5

4.92

5.85

u/l

2.74

153

459

Gastro-oesophageal reflux disease

419

1637

2.17

46.26

1.4

7.01

5.89

u/l

0.31

351

1424

Symptoms and signs involving the digestive system and abdomen

541

1321

2.06

46.18

1.6

1.5

5.64

6.15

u/l

0.74

462

1149

SLE, strict definition

7.95

46.17

1.8

1.4

5.49

6.63

u/l

0.62

SLE, ICD10

7.95

46.17

1.8

1.4

5.49

6.63

u/l

0.62

Adrenocortical insufficiency

8.33

45.90

1.4

6.96

6.15

u/l

0.13

All pneumoniae

594

1999

1.94

45.79

1.7

1.4

6.29

5.94

u/l

0.29

501

1718

Polyarthrosis

139

324

3.90

45.76

1.3

1.7

5.25

6.49

u/l

1.30

124

270

Methotrexate

107

234

4.63

45.38

1.9

1.2

6.07

5.56

u/l

0.29

208

Hypothyroidism, strict autoimmune

377

1079

2.30

45.36

1.4

1.2

6.01

5.57

u/l

0.39

312

908

Symptoms and signs involving cognition, perception, emotional state and behaviour

565

1933

1.96

45.35

1.4

1.5

6.59

5.99

u/l

0.41

488

1652

COPD/asthma/ILD related infections

556

1381

2.02

45.33

1.6

1.4

5.99

5.87

u/l

0.10

480

1176

COPD/asthma related infections

556

1381

2.02

45.33

1.6

1.4

5.99

5.87

u/l

0.10

480

1176

Raynaud syndrome

106

231

4.69

45.29

1.4

1.6

5.38

6.32

u/l

0.51

200

Pneumonias (Asthma/COPD co-morbidities)

590

2000

1.93

45.28

1.7

1.4

6.28

5.95

u/l

0.28

499

1716

Disorders of other endocrine glands

296

1191

2.46

45.19

1.5

7.65

5.91

u/l

0.35

252

1018

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

151

5.68

44.69

1.5

1.4

6.01

6.93

u/l

0.35

131

Oedema, not elsewhere classified

197

644

3.01

44.36

1.7

1.4

6.32

5.85

u/l

0.24

168

553

Cramp and spasm

106

6.81

44.33

1.3

1.5

5.28

8.04

u/l

1.00

Persons encountering health services for other counselling and medical advice, not elsewhere classified

614

1703

1.92

44.09

1.4

1.5

6.16

5.94

u/l

0.08

545

1443

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

577

2008

1.92

43.62

1.8

1.4

6.32

5.94

u/l

0.32

488

1723

Antihypertensive medication - note that there are other indications

348

764

2.39

42.68

1.6

1.4

6.26

5.47

u/l

0.81

302

658

Other disorders of lacrimal gland

255

1002

2.57

42.59

1.5

1.4

5.14

6.01

u/l

1.96

212

862

Disorders of eyelid, lacrimal system and orbit

509

1897

1.97

42.55

1.5

1.4

5.17

6.00

u/l

3.20

417

1630

Temporal arteritis

9.41

42.34

1.2

1.1

6.32

7.90

u/l

0.22

Carpal tunnel syndrome

364

1441

2.20

41.90

1.6

1.4

5.69

5.77

u/l

0.09

316

1236

Abnormal findings on diagnostic imaging of lung

297

1190

2.38

41.78

1.6

1.4

6.00

6.03

u/l

0.02

266

1006

Intracranial trauma

254

652

2.64

41.16

1.7

1.4

7.03

5.62

u/l

0.71

220

558

Asthma, hospital admissions , main diagnosis only

475

2104

1.97

40.95

1.5

5.43

6.26

u/l

1.38

400

1803

Disorders of lacrimal system

287

1192

2.38

40.87

1.6

1.4

5.15

5.86

u/l

1.68

241

1031

L04AD Calcineurin inhibitors

114

285

4.07

40.80

3.0

1.4

6.14

6.77

u/l

0.31

247

Obesity related asthma

241

942

2.58

40.72

1.5

1.4

5.43

6.16

u/l

1.44

213

825

Other peripheral vascular diseases

191

4.86

40.71

1.3

1.6

5.57

5.70

u/l

0.07

169

Migraine with aura

173

568

3.07

40.57

1.5

1.4

5.00

6.05

u/l

1.76

145

486

Irritable bowel syndrome

199

707

2.84

40.56

1.4

4.89

5.96

u/l

2.17

162

605

ILD, hospital admissions 3, with pneumonia sepsis

162

5.22

40.36

2.2

1.6

6.38

6.30

u/l

0.03

144

Vocal cord dysfunction

163

4.96

40.25

1.6

1.1

6.35

5.15

u/l

0.67

140

Persons encountering health services in other circumstances, wide

616

1704

1.86

40.13

1.5

6.88

5.94

u/l

0.39

545

1443

Gonarthrosis [arthrosis of knee](FG)

340

850

2.31

39.90

1.4

1.2

5.68

6.28

u/l

0.57

291

712

Cardiovascular diseases (excluding rheumatic etc)

366

940

2.24

39.82

1.5

1.4

5.65

5.31

u/l

0.46

320

815

Pneumonia, organism unspecified

520

1861

1.92

39.80

1.7

1.4

6.09

6.00

u/l

0.07

438

1602

Recurrent or chronic depression

249

665

2.61

39.73

1.3

1.6

6.41

5.90

u/l

0.18

205

574

Other arthrosis

279

758

2.48

39.68

1.5

6.06

6.93

u/l

0.56

238

637

Trochanteric bursitis

101

236

4.33

39.44

1.2

1.5

4.83

6.42

u/l

1.65

197

Cardiac arrhythmias

362

1055

2.21

39.42

1.4

6.34

5.27

u/l

1.27

312

913

Asthma/COPD (KELA code 203)

538

1901

1.90

39.39

1.5

5.21

6.16

u/l

1.67

450

1639

Persons encountering health services for examination and investigation

316

659

2.41

39.16

1.5

1.4

6.21

5.93

u/l

0.17

281

571

Implicit Sepsis

437

1601

2.02

39.02

1.5

1.4

7.07

5.98

u/l

0.63

375

1382

608

1667

1.85

38.88

1.5

1.4

5.29

6.12

u/l

2.23

516

1420

Systemic lupus erythematosus, unspecified

7.75

38.87

1.9

1.4

5.43

6.66

u/l

0.61

Migraine without aura

147

453

3.27

38.41

1.5

1.4

4.50

5.85

u/l

3.12

127

393

Other specified disorders of muscle

10.33

38.20

1.8

1.4

8.90

5.33

u/l

0.93

Pain in thoracic spine

109

277

3.98

38.06

1.3

1.5

5.22

6.00

u/l

1.02

241

Arthrosis

354

871

2.24

38.05

1.4

6.29

7.47

u/l

0.59

311

735

Certain infectious and parasitic diseases

503

1289

1.96

37.79

1.5

6.19

5.64

u/l

0.54

435

1113

Sleep apnoea

533

1793

1.88

37.51

1.4

6.89

5.99

u/l

0.32

465

1533

Dizziness and giddiness

433

1701

1.99

37.47

1.4

1.5

6.28

5.68

u/l

0.52

373

1450

Visual disturbances

306

1381

2.23

37.47

1.4

1.5

5.70

5.98

u/l

0.16

252

1192

Concussion

221

649

2.65

37.45

1.8

1.4

6.62

5.63

u/l

0.46

194

555

Cough

238

892

2.50

37.43

1.6

1.5

5.05

5.58

u/l

1.22

193

769

Other diseases of intestines

576

1741

1.85

37.40

1.5

5.51

6.49

u/l

1.17

496

1500

Hypothyroidism, drug reimbursement

137

4.83

37.06

1.5

1.4

6.26

4.99

u/l

1.04

127

Coxarthrosis [arthrosis of hip](FG)

245

666

2.54

37.04

1.3

5.26

6.28

u/l

1.37

218

559

Hypertensive diseases (excluding secondary)

306

768

2.33

36.71

1.6

1.4

8.17

5.31

u/l

0.71

263

673

Implicit Sepsis, including avohilmo

466

1727

1.93

36.70

1.5

1.4

7.18

5.84

u/l

0.90

400

1488

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

505

1809

1.89

36.70

1.5

7.00

5.74

u/l

1.00

434

1560

Giant cell arteritis with polymyalgia rheumatica

7.86

36.70

1.2

6.32

8.59

u/l

0.38

Other arrhythmias

384

1397

2.06

36.42

1.4

6.44

5.55

u/l

0.72

335

1210

Acute upper respiratory infections

560

1836

1.83

36.08

1.5

1.4

5.21

6.09

u/l

2.82

471

1568

Osteopathies and chondropathies

339

1469

2.12

36.01

1.5

1.4

7.27

5.81

u/l

0.34

287

1263

Diseases of the respiratory system

331

738

2.26

35.46

1.5

1.4

6.34

5.81

u/l

0.35

287

634

Depression or dysthymia

351

885

2.17

35.35

1.5

5.74

6.24

u/l

0.45

303

754

Other heart diseases

275

759

2.37

35.25

1.5

1.4

6.54

5.33

u/l

1.03

233

664

Undetermined asthma, excluding more controls

232

4.13

35.00

1.7

1.4

5.05

6.05

u/l

1.34

203

Other bacterial diseases, including avohilmo

559

1934

1.81

34.89

1.5

1.4

7.99

5.59

u/l

1.17

476

1664

Other neurological diseases

400

1564

1.99

34.83

1.4

1.5

5.68

5.92

u/l

0.18

341

1344

Sleep apnoea, including avohilmo

549

1828

1.82

34.75

1.4

1.5

5.60

6.00

u/l

0.52

476

1557

Other heart diseases, wide

512

1671

1.86

34.62

1.5

1.4

6.27

6.00

u/l

0.18

440

1441

Visual disturbances and blindness

314

1477

2.14

34.58

1.4

1.5

5.69

5.98

u/l

0.17

257

1271

Hypertension, essential

436

1253

1.97

34.51

1.5

1.4

7.40

5.90

u/l

0.47

381

1082

Diseases of the eye and adnexa

420

1044

2.02

34.41

1.4

1.5

5.11

6.40

u/l

3.23

358

920

Other functional intestinal disorders

266

1058

2.30

34.38

1.4

1.5

4.97

6.19

u/l

3.15

226

913

Any mental disorder

565

1562

1.82

33.90

1.5

6.07

6.24

u/l

0.11

497

1339

Undetermined asthma

238

4.03

33.83

1.7

1.4

5.05

6.18

u/l

1.63

210

Extrapyramidal and movement disorders

240

1022

2.36

33.79

1.3

1.5

5.18

6.18

u/l

2.07

206

868

Condition for Implicit Sepsis (Organ dysfunction codes)

473

1758

1.87

33.51

1.5

1.4

7.33

5.80

u/l

1.06

406

1516

Abnormalities of heart beat

200

760

2.57

33.46

1.3

1.5

5.88

5.64

u/l

0.11

163

652

Diarrhoea and gastroenteritis of presumed infectious origin

399

1839

1.94

33.37

1.4

1.5

5.49

6.23

u/l

0.94

336

1579

Seropositive rheumatoid arthritis

124

376

3.30

32.97

1.7

1.3

5.19

6.25

u/l

0.99

106

314

Asthma-related pneumonia

215

879

2.45

32.86

1.6

1.5

5.58

6.34

u/l

1.08

178

751

Bacterial infection, other or unspecified, including avohilmo

333

1323

2.07

32.70

1.7

1.4

8.76

5.86

u/l

0.75

281

1136

Asthma-related pneumonia or sepsis

215

882

2.44

32.61

1.6

1.5

5.58

6.33

u/l

1.06

178

754

Asthma, hospital admissions 3, pneumonia

215

882

2.44

32.61

1.6

1.5

5.58

6.33

u/l

1.06

178

754

Intestinal infectious diseases

514

2134

1.80

32.51

1.4

1.5

5.58

6.21

u/l

0.86

436

1830

Weight loss

233

4.01

32.42

1.4

1.5

4.94

7.04

u/l

1.86

206

Complications of surgical and medical care, not elsewhere classified

538

2023

1.78

32.28

1.4

7.37

5.79

u/l

0.61

454

1725

Enthesopathies of lower limb, excluding foot

134

437

3.09

31.94

1.5

1.4

4.96

5.81

u/l

1.81

114

381

Bronchitis

580

2001

1.74

31.74

1.5

1.4

5.47

5.98

u/l

1.13

489

1709

Urticaria and erythema

238

1041

2.30

31.52

1.6

1.5

5.41

5.94

u/l

0.67

205

895

Sleep disorders (combined)

560

1653

1.77

31.51

1.5

5.94

5.97

u/l

0.02

491

1397

Rheumatoid arthritis, including avohilmo

236

1029

2.31

31.51

1.7

1.4

5.54

5.95

u/l

0.61

204

877

Endocrine, nutritional and metabolic diseases

404

1037

1.97

31.09

1.5

5.87

5.85

u/l

0.01

349

900

Bacterial infection, other or unspecified

305

1235

2.09

31.00

1.7

1.4

9.17

5.93

u/l

0.78

256

1063

Anxiety (asthma-related co-morbidities)

351

1340

2.00

30.87

1.4

1.5

5.88

6.09

u/l

0.10

299

1172

Acute sinusitis

308

1360

2.07

30.76

1.4

5.06

6.08

u/l

2.93

265

1183

Spondylopathies (FG)

233

3.90

30.71

1.4

1.2

5.02

6.27

u/l

0.85

200

All anxiety disorders

357

1405

1.98

30.68

1.4

1.5

5.86

6.31

u/l

0.23

303

1218

Spondylolisthesis/Spondylolysis

110

327

3.39

30.57

1.5

4.92

6.02

u/l

2.22

281

Abnormal weight loss

217

4.03

30.49

1.4

1.6

4.98

7.14

u/l

1.77

193

Other anxiety disorders

277

1098

2.16

30.47

1.5

6.21

6.51

u/l

0.11

233

945

Immunodeficiency with predominantly antibody defects

7.92

30.35

1.7

1.4

4.72

7.52

u/l

1.28

Constipation

484

1829

1.80

30.23

1.5

5.82

5.90

u/l

0.06

408

1576

Complications of procedures, not elsewhere classified

446

1977

1.82

30.13

1.4

7.51

5.81

u/l

0.54

382

1688

Implicit viral Sepsis, including avohilmo

192

779

2.48

29.99

1.6

1.4

6.23

5.44

u/l

0.37

161

663

Acute upper respiratory infections of multiple and unspecified sites

416

1630

1.87

29.77

1.5

5.50

6.02

u/l

0.99

351

1403

Other and unspecified nerve root and plexus disorders, also in other diseases

143

504

2.86

29.76

1.8

1.5

5.81

6.07

u/l

0.15

116

436

Other bacterial diseases

505

1897

1.77

29.68

1.6

1.4

8.34

5.63

u/l

1.20

430

1636

Other reaction to severe stress, and adjustment disorders

223

973

2.30

29.67

1.4

1.5

6.28

6.59

u/l

0.09

192

836

Certain infectious and parasitic diseases, including avohilmo

354

874

2.04

29.62

1.4

1.5

6.29

5.64

u/l

0.55

301

755

Intestinal infectious diseases, including avohilmo, including avohilmo

597

1962

1.70

29.39

1.4

1.5

5.73

6.21

u/l

0.43

505

1680

Immunodeficiencies

100

5.63

29.04

1.7

1.4

4.66

6.54

u/l

1.62

Other disorders of urethra and urinary system

377

1372

1.92

28.99

1.4

1.5

5.87

5.85

u/l

0.01

321

1159

Osteoporosis

164

574

2.64

28.85

1.6

1.5

5.64

6.30

u/l

0.47

144

481

Follow-up examination after treatment for conditions other than malignant neoplasms

210

580

2.42

28.62

1.6

1.4

5.64

5.99

u/l

0.36

181

503

Oxycodone

200

714

2.41

28.54

1.4

6.40

6.09

u/l

0.14

171

611

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

531

1981

1.72

28.42

1.4

1.5

5.67

6.17

u/l

0.45

445

1698

Hypermobility syndrome

102

5.50

28.40

1.3

1.2

4.71

5.52

u/l

0.66

Gastrointestinal diseases

297

698

2.14

28.25

1.6

1.4

6.23

5.86

u/l

0.21

251

599

Disorders of conjunctiva

457

2002

1.77

28.05

1.4

1.5

5.14

6.16

u/l

1.99

388

1715

Biological medication for rheuma

137

490

2.82

27.80

1.4

1.5

5.69

6.30

u/l

0.47

121

427

Dental caries

153

543

2.68

27.76

1.8

1.4

6.05

6.75

u/l

0.34

134

447

Disorders of the thyroid gland

490

1823

1.75

27.65

1.5

6.20

5.72

u/l

0.44

410

1566

Hypertensive diseases

421

1290

1.85

27.54

1.5

1.4

7.54

5.88

u/l

0.52

367

1117

Hypertension

421

1290

1.85

27.53

1.5

1.4

7.54

5.88

u/l

0.52

367

1117

Heart failure, not strict

394

1427

1.86

27.52

1.6

1.4

6.36

5.77

u/l

0.56

332

1227

Implicit viral Sepsis

138

500

2.78

27.31

1.6

1.5

6.66

5.81

u/l

0.27

116

428

Coxibs

132

219

3.18

27.29

1.4

1.5

6.85

7.23

u/l

0.09

116

183

Disorders of lipoprotein metabolism and other lipidaemias

424

1416

1.83

27.26

1.5

1.4

6.09

5.86

u/l

0.19

376

1217

Viral Sepsis

138

502

2.77

27.11

1.6

1.5

6.66

5.81

u/l

0.27

116

430

Hypothyroidism, other/unspecified

461

1720

1.77

27.07

1.4

1.5

5.89

5.71

u/l

0.17

383

1478

Other localized connective tissue disorders

8.34

27.07

2.3

1.4

5.50

7.32

u/l

0.56

Brachial plexus disorders

218

3.81

27.06

1.4

1.5

4.82

6.76

u/l

1.69

192

Caries of dentine

139

488

2.77

27.01

1.8

1.4

6.04

6.46

u/l

0.18

120

401

Hypothyreosis and Thyroxine purchase for inclusion criteria

479

1802

1.75

26.98

1.4

1.5

5.84

5.77

u/l

0.06

396

1542

Migraine with aura and triptan purchases

118

397

3.00

26.77

1.4

1.5

4.91

5.75

u/l

1.34

348

Non-selective monoamine reuptake inhibitors

206

871

2.28

26.68

1.4

4.86

5.87

u/l

3.05

177

750

Complications of medical and surgical care

397

1981

1.81

26.63

1.3

1.5

7.52

5.87

u/l

0.44

329

1695

Other extrapyramidal and movement disorders in other diseases

164

657

2.52

26.57

1.3

1.5

5.02

6.22

u/l

2.42

141

560

Implicit fungal Sepsis, including avohilmo

156

4.37

26.48

1.2

1.4

7.42

5.64

u/l

0.34

134

Oxicams

117

202

3.31

26.47

1.3

1.5

4.96

7.05

u/l

1.95

100

169

Conjunctivitis

416

1882

1.79

26.31

1.4

1.5

5.21

6.17

u/l

1.63

350

1613

Pure hypercholesterolaemia

383

1313

1.86

26.29

1.5

1.4

6.22

5.89

u/l

0.27

337

1126

Symptoms and signs involving speech and voice

206

920

2.25

26.10

1.3

1.5

5.13

6.07

u/l

1.32

172

797

Certain disorders involving the immune mechanism

138

513

2.72

26.06

1.7

1.5

5.01

6.17

u/l

1.85

114

447

Other general symptoms and signs

5.75

25.99

1.4

1.3

5.42

6.74

u/l

0.72

Chronic rhinitis, nasopharyngitis and pharyngitis

200

884

2.28

25.95

1.4

5.48

6.05

u/l

0.72

159

781

Radiculopathy

275

3.37

25.43

1.3

1.5

5.79

6.30

u/l

0.24

234

Other disorders of skin and subcutaneous tissue

386

1817

1.80

25.29

1.7

1.4

5.77

5.83

u/l

0.05

324

1560

Percutaneous Coronary Intervention

406

1371

1.81

25.28

1.5

1.4

6.83

6.12

u/l

0.42

363

1180

Emergency coronary revascularization (for ACS)

430

1467

1.78

25.22

1.5

1.4

6.80

6.12

u/l

0.43

383

1253

Subjective visual disturbances

168

698

2.43

25.18

1.3

1.5

4.83

6.25

u/l

3.06

140

606

Enlarged lymph nodes

100

317

3.18

25.13

1.6

1.5

7.44

5.98

u/l

0.38

271

Temporomandibular joint disorders, including avohilmo

271

1319

2.00

25.08

1.3

1.5

4.95

5.79

u/l

2.56

232

1132

Thyroiditis, ILD-related definition

244

3.52

25.06

1.4

1.2

4.73

5.64

u/l

0.70

212

Voice disturbances

172

724

2.39

25.05

1.4

1.5

5.23

6.11

u/l

0.95

145

625

Chronic sinusitis

244

1184

2.07

24.93

1.7

1.4

5.03

5.81

u/l

2.48

211

1037

Seronegative rheumatoid arthritis

172

4.05

24.88

1.5

1.3

5.63

6.79

u/l

0.56

149

Coronary revascularization (ANGIO or CABG)

405

1372

1.80

24.86

1.5

1.4

6.83

6.12

u/l

0.42

363

1181

Hallux valgus (acquired)

162

459

2.54

24.84

1.4

1.6

5.40

6.09

u/l

0.57

142

388

Spondyloarthritis

107

356

3.03

24.76

1.3

4.98

5.59

u/l

0.61

308

Exclusions for E4_PCOS_BROAD

129

477

2.73

24.59

1.6

1.5

6.35

5.89

u/l

0.15

116

415

Gonarthrosis

285

798

2.02

24.40

1.4

1.5

5.80

7.54

u/l

1.06

246

673

Major coronary heart disease event

424

1444

1.76

24.23

1.5

1.4

6.53

6.10

u/l

0.25

376

1242

Psychiatric diseases

473

1378

1.72

24.06

1.5

6.20

6.35

u/l

0.08

417

1177

Bacterial pneumonia (organism specified)

236

1037

2.07

23.78

1.7

1.5

6.47

6.07

u/l

0.32

193

887

Hard cardiovascular diseases

427

1448

1.75

23.69

1.5

1.4

7.01

5.89

u/l

0.70

368

1249

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

282

1415

1.93

23.57

1.5

1.4

6.38

6.49

u/l

0.04

228

1225

Paroxysmal tachycardia

127

388

2.74

23.45

1.4

1.3

5.98

5.55

u/l

0.26

103

338

Bacterial pneumonia, not elsewhere classified

209

854

2.16

23.36

1.8

1.4

6.65

5.92

u/l

0.65

170

736

Other disorders of fluid, electrolyte and acid-base balance

170

689

2.34

23.27

1.4

1.5

6.02

5.94

u/l

0.05

135

581

Non-allergic asthma (mode), excluding more controls

101

334

3.02

23.21

1.7

1.4

5.40

6.23

u/l

0.61

295

Urticaria

189

856

2.22

23.20

1.6

1.5

5.48

5.92

u/l

0.41

160

734

Other specified/unspecified soft tissue disorders

6.43

23.11

1.4

4.90

5.63

u/l

0.76

Candidiasis, including avohilmo

190

865

2.21

23.05

1.3

1.5

6.31

5.72

u/l

0.30

154

741

Budesonide

253

3.35

22.99

1.6

1.2

5.42

5.76

u/l

0.19

222

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

468

2196

1.66

22.95

1.6

1.4

5.75

6.16

u/l

0.34

400

1877

Diseases of arteries, arterioles and capillaries

332

1330

1.84

22.75

1.5

6.56

5.95

u/l

0.42

282

1135

Non-allergic asthma (mode)

101

338

2.98

22.74

1.7

1.4

5.40

6.16

u/l

0.57

301

Other diseases of upper respiratory tract

530

1690

1.64

22.58

1.6

1.4

5.84

6.29

u/l

0.40

439

1455

Cerebral palsy and other paralytic syndromes

257

3.31

22.46

1.3

1.5

4.84

6.85

u/l

1.96

227

Benzodiazepine use

509

2115

1.63

22.39

1.4

1.5

7.42

5.80

u/l

0.56

413

1829

Coxarthrosis

220

668

2.13

22.35

1.3

1.5

5.29

6.85

u/l

2.52

197

563

Other diseases of pleura

232

994

2.04

22.27

1.9

1.5

7.68

6.00

u/l

0.90

206

842

Bacterial pneumoniae

218

923

2.08

22.25

1.8

1.4

6.60

5.88

u/l

0.68

178

796

Pain and other conditions associated with female genital organs and menstrual cycle

132

427

2.60

22.15

1.4

1.5

5.12

5.76

u/l

0.44

107

359

Other diseases of urinary system

484

1640

1.66

22.14

1.4

1.5

6.11

5.89

u/l

0.15

418

1397

Rash and other nonspecific skin eruption

211

3.55

22.10

1.6

1.5

7.31

5.95

u/l

0.27

182

Haemorrhage from respiratory passages

166

641

2.30

21.77

1.4

6.15

5.87

u/l

0.18

140

547

Ganglion

102

357

2.87

21.62

1.3

1.4

5.34

5.93

u/l

0.35

308

Cerebral cysts

122

4.42

21.32

1.6

1.5

5.88

7.66

u/l

0.50

105

Other enthesopathy of foot (+metatarsalgia)

165

3.85

21.28

1.1

1.5

4.56

5.55

u/l

1.91

141

Infections of the skin and subcutaneous tissue

311

1709

1.80

20.94

1.7

1.4

5.58

6.51

u/l

1.14

260

1484

Codes for special purposes

280

1503

1.85

20.90

1.4

1.5

5.75

5.84

u/l

0.08

240

1280

Ischemic heart diseases

409

1434

1.70

20.83

1.6

1.4

6.57

6.08

u/l

0.28

360

1231

Hypothyroidism, strict autoimmune, 3 medication purchases required

415

1663

1.68

20.69

1.4

1.5

5.71

5.76

u/l

0.04

345

1420

Sulfasalazine

134

551

2.44

20.62

1.3

1.2

4.95

5.91

u/l

1.83

115

477

Provisional assignment of new diseases of uncertain etiology

279

1503

1.85

20.60

1.4

1.5

5.75

5.84

u/l

0.08

240

1279

Cutaneous lupus erythematosus

6.23

20.42

1.9

1.3

4.79

6.95

u/l

0.92

All kidney diseases

491

2055

1.60

20.39

1.6

1.4

6.67

5.88

u/l

0.68

412

1766

Migraine without aura and triptan purchases

111

420

2.66

20.34

1.4

1.5

4.50

5.78

u/l

3.09

365

Factors influencing health status and contact with health services

126

232

2.74

20.21

1.5

1.4

8.33

6.52

u/l

0.54

108

195

Mycoses, including avohilmo

465

2204

1.61

20.06

1.5

7.38

5.82

u/l

0.52

385

1896

Other bursopathies

196

3.50

19.98

1.6

1.5

6.97

5.82

u/l

0.22

168

Other specified/unspecified inflammatory spondylopathies

5.42

19.98

1.3

1.6

5.31

6.35

u/l

0.70

Neuralgia and neuritis, unspecified

5.42

19.97

1.6

5.65

5.95

u/l

0.20

Muscular dystrophy

21.23

19.94

1.7

1.3

8.60

7.69

u/l

0.09

Cystitis

407

1442

1.68

19.90

1.4

1.5

5.31

5.89

u/l

1.04

343

1220

Bacterial Sepsis

243

1046

1.93

19.85

1.5

7.94

5.70

u/l

1.18

207

894

Diseases of salivary glands

193

939

2.07

19.81

1.6

1.5

5.53

5.96

u/l

0.56

170

811

Disorders of skin appendages

273

1485

1.84

19.80

1.5

5.73

u/l

0.00

228

1287

All influenza

148

649

2.29

19.72

1.9

1.5

6.55

5.55

u/l

0.36

125

562

Syncope and collapse

195

786

2.08

19.70

1.5

1.4

5.14

5.92

u/l

2.40

170

677

Selective serotonin reuptake inhibitors

450

1424

1.65

19.67

1.5

5.79

6.05

u/l

0.19

382

1212

Tumor necrosis factor alpha inhibitors

114

447

2.57

19.48

1.2

1.5

4.93

6.39

u/l

2.28

391

Diaphragmatic hernia

192

939

2.06

19.44

1.5

5.83

6.18

u/l

0.30

156

799

Adhesive capsulitis of shoulder

267

3.05

19.16

1.2

1.4

5.25

6.26

u/l

0.88

228

Allergic asthma (mode)

115

444

2.54

19.15

1.4

5.37

5.83

u/l

0.52

394

Allergic asthma (mode), excluding more controls

115

444

2.54

19.14

1.4

5.37

5.81

u/l

0.48

394

Lateral epicondylitis

227

3.24

19.05

1.3

1.5

5.05

5.83

u/l

1.28

197

Other shoulder lesions

151

3.81

18.99

1.3

1.5

4.81

5.97

u/l

1.58

130

Other/unspecified enthesopathies of lower limb, excluding foot

112

4.33

18.97

1.2

1.7

4.60

5.87

u/l

1.84

Psoriatic and enteropathic arthropathies

198

3.41

18.97

1.3

1.2

4.95

6.13

u/l

0.73

168

Implicit bacterial Sepsis, including avohilmo

234

1018

1.92

18.91

1.5

1.4

7.85

5.73

u/l

1.03

198

870

Internal derangement of knee

165

762

2.15

18.87

1.2

1.5

5.33

6.90

u/l

2.29

135

645

Implicit bacterial Sepsis

213

928

1.98

18.84

1.5

8.11

5.77

u/l

1.03

181

789

Disorders of parathyroid gland

119

478

2.48

18.80

1.4

1.6

10.57

6.17

u/l

0.35

405

Nonorganic sleeping disorders, excluding more controls

118

480

2.47

18.65

1.2

1.4

7.20

5.68

u/l

0.55

102

418

Benign neoplasms

472

1609

1.60

18.64

1.4

1.5

5.68

6.20

u/l

0.42

408

1387

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

484

1942

1.58

18.62

1.5

6.86

5.88

u/l

0.32

411

1665

Covid-19 confirmed case

192

953

2.02

18.60

1.5

5.67

6.07

u/l

0.40

168

808

Functional dyspepsia

154

706

2.19

18.48

1.3

1.4

4.87

5.72

u/l

2.20

131

611

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

306

1731

1.74

18.48

1.3

1.5

8.08

6.00

u/l

0.44

258

1483

Metatarsalgia

154

3.74

18.47

1.1

1.5

4.59

5.57

u/l

1.69

132

Exposure to unspecified factor

499

2188

1.55

18.24

1.4

1.5

7.33

5.80

u/l

0.55

423

1872

Artrosis, including avohilmo

401

1331

1.65

18.08

1.4

1.5

6.14

6.74

u/l

0.38

349

1135

Viral infections characterized by skin and mucous membrane lesions

228

1213

1.89

18.07

1.6

1.5

5.41

6.15

u/l

1.60

191

1056

Abnormal serum enzyme levels

155

692

2.17

18.06

1.9

1.4

6.14

6.60

u/l

0.39

137

602

Other diseases of the respiratory system

111

447

2.50

17.96

1.5

1.6

7.61

6.03

u/l

0.53

381

Other respiratory disorders and diseases

111

447

2.50

17.96

1.5

1.6

7.61

6.03

u/l

0.53

381

Neuromuscular dysfunction of bladder

202

3.30

17.74

1.2

1.7

4.89

6.15

u/l

1.58

177

Other (seronegative) rheumatoid arthritis, wide

117

486

2.43

17.73

1.9

1.5

5.91

6.05

u/l

0.11

107

417

Respiratory insufficiency

105

4.31

17.71

1.4

1.5

8.97

6.87

u/l

0.25

Nausea and vomiting

133

569

2.29

17.67

1.5

5.24

6.29

u/l

1.48

109

495

Renal tubulo-interstitial diseases

421

1934

1.60

17.62

1.6

1.4

7.25

5.51

u/l

1.68

353

1658

Triptan medication for migraine, min. 3 purchases

305

1324

1.73

17.23

1.4

1.5

4.69

5.74

u/l

4.14

252

1141

Propionic acid derivatives

118

230

2.59

17.21

1.6

1.5

7.15

7.19

u/l

0.01

102

192

Trigger finger

242

3.04

17.15

1.2

1.5

4.85

6.37

u/l

1.57

207

Persons encountering health services in other circumstances

206

1069

1.91

17.09

1.7

1.5

10.47

6.02

u/l

0.72

179

912

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

273

2.90

17.07

1.4

1.6

5.56

6.02

u/l

0.36

233

Asthma and allergy

214

3.16

17.00

1.4

1.5

5.33

5.54

u/l

0.19

190

STROKE

267

1004

1.80

16.91

1.4

5.96

5.59

u/l

0.18

224

862

Dentofacial anomalies [including malocclusion]

365

1753

1.63

16.89

1.3

1.5

5.00

6.25

u/l

2.18

313

1512

Asthma and allergy, excluding more controls

215

3.14

16.89

1.4

1.5

5.33

5.56

u/l

0.22

191

Chronic gastritis

136

616

2.22

16.86

1.6

1.5

5.13

5.99

u/l

2.20

114

527

Atopic dermatitis

291

1341

1.73

16.86

1.4

1.5

5.15

5.93

u/l

2.03

251

1151

Restless leg syndrome

384

2.58

16.85

1.4

1.5

4.96

6.12

u/l

1.45

340

Zoster [herpes zoster]

110

456

2.43

16.76

1.6

5.36

6.25

u/l

1.01

390

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

286

1600

1.72

16.54

1.4

1.5

5.20

5.71

u/l

1.36

238

1362

Cervicocranial syndrome

176

3.38

16.51

1.2

1.7

4.89

6.18

u/l

1.70

153

Other and unspecified anaemias

204

1013

1.90

16.37

1.4

1.5

6.25

6.32

u/l

0.03

161

862

Other and unspecified urticaria

119

518

2.31

16.26

1.5

5.18

6.00

u/l

1.00

101

443

Other anaemias

205

1021

1.89

16.15

1.4

1.5

6.24

6.30

u/l

0.03

162

870

Mycoses

162

800

2.04

16.09

1.4

1.5

5.99

5.94

u/l

0.03

137

691

Symptoms and signs involving the urinary system

362

1693

1.62

16.01

1.5

1.4

6.07

6.00

u/l

0.03

299

1465

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

284

1671

1.70

15.98

1.3

1.5

8.21

5.98

u/l

0.44

242

1435

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

4.25

15.79

1.5

1.4

5.31

6.78

u/l

0.74

Hypo-osmolality and hyponatraemia

348

2.58

15.62

1.6

4.86

5.89

u/l

1.87

289

Fibroblastic disorders

369

2.53

15.57

1.4

1.3

5.35

6.25

u/l

0.99

312

Other acute lower respiratory infections

259

1429

1.73

15.46

1.7

1.4

7.86

6.07

u/l

0.33

230

1221

Procreative management

185

793

1.93

15.28

1.4

1.6

5.62

6.82

u/l

0.73

157

684

338

2.59

15.25

1.7

1.4

12.71

5.84

u/l

0.44

283

Cerebrovascular diseases (FINNGEN)

147

488

2.12

15.19

1.4

1.3

7.04

5.47

u/l

0.49

122

424

Continuous positive airway pressure

286

2.61

15.18

1.2

1.4

5.23

5.56

u/l

0.41

248

Other symptoms and signs involving the digestive system and abdomen

374

2.50

15.17

1.9

1.4

5.19

6.65

u/l

1.10

325

Meniscus derangement

220

795

1.84

15.13

1.2

1.5

5.48

7.72

u/l

1.54

186

673

Diverticular disease of intestine

327

1238

1.65

15.11

1.6

1.4

5.46

6.25

u/l

0.93

284

1071

Zoster [herpes zoster], including avohilmo

253

1417

1.73

15.06

1.7

1.4

6.06

5.97

u/l

0.04

222

1207

Behavioural syndromes associated with physiological disturbances and physical factors

455

2033

1.52

15.03

1.5

6.00

6.06

u/l

0.04

398

1732

Other/unspecified enthesopathies, not elsewhere classified

115

3.86

15.00

1.2

1.5

5.02

6.05

u/l

0.98

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

214

3.02

14.90

1.3

1.5

5.21

6.93

u/l

1.14

186

Faecal incontinence

189

3.15

14.78

1.5

1.3

5.03

6.64

u/l

0.79

156

Migraine, single triptan purchase ok & required. ICD-code if available is included

380

1641

1.57

14.73

1.4

1.5

4.91

6.28

u/l

2.22

325

1423

Triptan medication for migraine, single purchase ok

380

1641

1.57

14.73

1.4

1.5

4.91

6.28

u/l

2.22

325

1423

Allergic conjunctivitis

295

1726

1.65

14.73

1.4

1.5

5.21

5.64

u/l

1.16

246

1473

Use of hypnotics and sedatives

504

1939

1.49

14.72

1.4

5.89

6.25

u/l

0.24

427

1669

Aplastic and other anaemias

215

1096

1.80

14.63

1.5

6.16

6.28

u/l

0.05

170

936

Other disorders of patella

322

2.59

14.60

1.4

1.5

4.91

6.44

u/l

1.78

284

Reactive arthropathies, FINNGEN

113

3.84

14.57

1.3

5.40

7.16

u/l

0.63

Implicit fungal Sepsis

4.41

14.54

1.1

1.5

5.14

6.41

u/l

0.58

Other symptoms and signs involving cognitive functions and awareness

221

1101

1.79

14.53

1.4

1.5

7.14

5.85

u/l

0.50

185

936

Reactive arthropathies

137

3.53

14.43

1.3

1.6

5.51

6.29

u/l

0.56

121

Fenamates

158

2.99

14.35

1.2

1.6

5.93

6.88

u/l

0.32

134

Polyuria

120

555

2.17

14.23

1.5

1.4

5.29

6.08

u/l

0.72

476

Other and unspecified effects of external causes

153

775

1.98

14.21

1.2

1.5

5.48

5.94

u/l

0.51

130

669

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

203

691

1.86

14.21

1.5

1.3

5.80

5.32

u/l

0.28

174

605

Other gastritis (incl. Duodenitis)

114

517

2.22

14.19

1.6

1.5

7.81

5.89

u/l

0.68

451

Use of pramipexole

121

563

2.16

14.14

1.4

1.5

5.36

5.92

u/l

0.49

105

482

Lesion of ulnar nerve

316

2.58

14.12

1.7

1.4

4.86

6.57

u/l

1.95

278

Adverse effects, not elsewhere classified

116

531

2.20

14.12

1.3

1.5

4.89

6.03

u/l

1.70

102

458

Noninfective enteritis and colitis

229

1318

1.74

14.10

1.7

1.5

5.85

5.88

u/l

0.02

192

1138

Diseases of arteries, arterioles and capillaries (FINNGEN)

112

337

2.30

14.10

1.3

1.4

8.25

5.48

u/l

0.82

296

Psoriatic arthropathies

174

3.19

14.07

1.3

1.6

5.02

6.13

u/l

1.16

150

Fungal Sepsis

4.18

13.96

1.1

1.5

5.14

6.40

u/l

0.63

Personality disorders, excluding more controls

127

604

2.11

13.92

1.2

1.5

6.21

6.74

u/l

0.13

104

521

Congenital malformations and deformations of the musculoskeletal system

212

2.94

13.75

1.5

1.6

5.62

6.17

u/l

0.34

181

Conjunctivitis (acute, non atopic)

152

774

1.96

13.74

1.5

1.6

5.14

6.02

u/l

1.82

129

673

Parkinson's disease, excluding more controls

151

3.25

13.73

1.2

1.3

5.61

6.13

u/l

0.19

121

Parkinson's disease, strict definition, excluding more controls

140

3.35

13.66

1.2

1.3

5.55

6.16

u/l

0.22

113

Benign neoplasm of colon, rectum, anus and anal canal

293

1527

1.63

13.64

1.5

1.4

5.92

5.97

u/l

0.03

244

1312

Hyperkinetic disorders, excluding more controls

224

2.81

13.56

1.4

1.7

4.94

5.71

u/l

0.85

189

Injuries to the knee and lower leg

550

2066

1.44

13.55

1.6

1.4

5.32

6.15

u/l

1.45

487

1748

KRA_PSY_EATING, excluding more controls

137

3.42

13.47

1.4

1.5

5.57

5.44

u/l

0.07

118

Diseases of the ear and mastoid process

535

1851

1.45

13.44

1.5

5.83

6.24

u/l

0.35

456

1586

Etanercept

169

3.18

13.43

1.3

1.6

4.68

6.20

u/l

2.34

144

Fall on same level

533

1967

1.45

13.37

1.5

1.4

7.58

5.74

u/l

0.77

460

1682

Urinary track infection

281

840

1.68

13.36

1.4

1.5

5.34

5.36

u/l

0.02

246

708

Other external causes of accidental injury

373

1199

1.56

13.28

1.5

1.4

5.71

5.72

u/l

0.01

323

1020

Genitourinary diseases

252

733

1.73

13.27

1.4

1.5

7.19

5.89

u/l

0.90

228

643

Disorders of mineral metabolism

176

3.10

13.18

1.1

1.4

17.97

5.81

u/l

0.45

155

Renal failure

211

1029

1.75

13.00

1.6

1.5

8.65

5.91

u/l

1.19

168

878

Oter anti-inflammatory and antirheumatic agents, non-steroids

190

2.55

12.98

1.3

1.5

5.61

6.77

u/l

0.87

158

Other sleep disorders

221

2.83

12.91

1.2

1.5

6.22

6.72

u/l

0.17

195

Other and unspecified drugs and medicaments

205

2.91

12.90

1.3

1.6

5.11

7.05

u/l

1.31

179

Impingement syndrome of shoulder

404

2.31

12.86

1.2

1.4

5.18

6.11

u/l

1.18

352

Other disorders of eye and adnexa

381

2.35

12.76

1.4

1.5

5.43

6.36

u/l

0.85

332

Hyperparathyroidism

407

2.30

12.75

1.2

1.6

12.13

5.98

u/l

0.40

344

Nutritional anaemias

230

1304

1.69

12.60

1.7

1.4

5.61

5.92

u/l

0.20

199

1106

Other hammer toe(s) (acquired)

258

2.59

12.59

1.5

1.7

5.43

7.08

u/l

1.39

212

Diseases of pulp and periapical tissues, including avohilmo

471

1666

1.46

12.55

1.7

1.4

5.99

6.35

u/l

0.28

414

1415

Other disorders of the musculoskeletal system and connective tissue

373

2.35

12.44

1.8

1.5

5.42

6.36

u/l

0.70

323

Ankylosing spondylitis

151

3.20

12.44

1.6

4.50

6.25

u/l

2.69

135

Gout

107

424

2.17

12.42

1.4

1.5

5.72

6.75

u/l

0.95

350

Acetic acid derivatives and related substances

216

2.38

12.41

1.4

1.5

6.94

7.28

u/l

0.07

180

Accidents

368

1199

1.54

12.39

1.4

6.00

5.72

u/l

0.19

318

1020

Speech therapy

139

717

1.95

12.34

1.8

1.5

5.45

6.23

u/l

0.84

117

612

Pain associated with micturition

290

2.54

12.33

1.2

1.6

4.69

6.54

u/l

2.12

253

Papulosquamous disorders

197

1135

1.74

12.25

1.3

1.5

5.27

6.16

u/l

2.26

173

982

Disease of hard tissues of teeth, NOS

235

720

1.71

12.17

1.6

1.5

5.53

6.45

u/l

1.10

212

594

Postprocedural disorders of nervous system

169

3.05

12.14

1.5

1.4

5.09

6.00

u/l

0.71

143

Conjunctivitis (acute, non atopic), including avohilmo

458

1907

1.45

12.09

1.5

6.03

6.22

u/l

0.12

391

1632

Ischaemic heart disease, wide definition

342

1368

1.54

12.09

1.5

1.4

7.27

5.62

u/l

1.48

300

1179

Pruritus

252

2.64

12.08

1.3

1.5

7.25

6.24

u/l

0.17

219

Diseases of liver

175

979

1.80

12.05

1.9

1.4

11.34

5.95

u/l

0.83

157

848

Neoplasms

353

1204

1.54

12.04

1.4

1.5

5.70

6.42

u/l

0.46

307

1030

Inflammatory diseases of female pelvic organs

301

1311

1.58

11.92

1.4

1.5

4.89

5.36

u/l

1.59

258

1100

Other nutritional deficiencies

326

1950

1.53

11.90

1.6

1.4

5.85

6.15

u/l

0.20

288

1662

Sleep disorders

424

2001

1.46

11.86

1.5

6.06

6.04

u/l

0.01

369

1708

Angina pectoris

240

959

1.66

11.80

1.4

1.5

5.88

5.57

u/l

0.43

210

818

Paracetamol or NSAID medication

105

2.99

11.79

1.6

1.4

6.90

7.05

u/l

0.04

Injuries to the abdomen, lower back, lumbar spine and pelvis

191

1088

1.74

11.72

1.5

6.25

6.13

u/l

0.04

165

930

Hernia

424

1935

1.46

11.66

1.5

7.03

5.96

u/l

0.31

369

1660

Acute bronchitis

190

1080

1.73

11.55

1.7

1.5

8.88

6.07

u/l

0.40

169

924

Coagulation defects, purpura and other haemorrhagic conditions

108

522

2.08

11.53

1.8

1.5

5.29

6.02

u/l

0.80

448

Algoneurodystrophy

4.02

11.51

1.5

1.4

5.26

6.51

u/l

0.61

Other diseases of hard tissues of teeth

235

724

1.69

11.48

1.6

1.5

6.01

6.44

u/l

0.27

204

598

Disorders of vestibular function (Vertigo)

221

1303

1.66

11.41

1.3

1.5

5.85

5.88

u/l

0.02

184

1117

Endometriosis

156

483

1.88

11.32

1.3

1.5

4.72

5.80

u/l

2.03

128

400

Psoriasis

146

791

1.85

11.21

1.3

1.5

5.30

6.13

u/l

1.38

130

682

Anti-inflammatory and antirheumatic products, non-steroids

102

230

2.24

11.17

1.6

1.5

7.50

7.19

u/l

0.06

192

Nonorganic sleeping disorders

118

598

1.98

11.08

1.2

1.5

7.20

5.63

u/l

0.58

102

521

Localized swelling, mass and lump of skin and subcutaneous tissue

151

830

1.83

11.07

1.5

5.76

5.96

u/l

0.20

133

712

Other diseases of liver

105

511

2.07

11.04

2.0

1.5

6.01

5.98

u/l

0.02

441

Other and unspecified visual disturbances

247

2.57

10.98

1.5

1.6

7.86

7.00

u/l

0.11

216

Unspecified privation

247

2.57

10.98

2.2

1.4

5.36

6.91

u/l

1.20

217

Falls/tendency to fall

480

1693

1.42

10.98

1.5

1.4

5.89

5.76

u/l

0.12

422

1442

Pneumocystosis, including avohilmo

5.52

10.93

1.3

1.2

5.62

6.76

u/l

0.35

Pneumocystosis

5.52

10.93

1.3

1.2

5.62

6.76

u/l

0.35

Dental operations

249

784

1.64

10.92

1.6

1.4

6.54

6.35

u/l

0.09

225

644

Postprocedural musculoskeletal disorders, not elsewhere classified

153

3.04

10.92

1.6

4.38

6.57

u/l

1.30

131

Coronary atherosclerosis

270

1076

1.59

10.90

1.6

1.4

7.70

5.78

u/l

1.29

235

923

L04AC Interleukin inhibitors

175

2.89

10.86

1.4

1.5

6.88

6.47

u/l

0.13

151

All chronic kidney diseases

242

1201

1.61

10.85

1.5

7.49

5.66

u/l

0.96

195

1040

Other and unspecified coagulation defects

113

3.41

10.83

1.3

1.5

4.95

6.27

u/l

0.95

External causes of morbidity and mortality

290

926

1.57

10.77

1.5

6.32

5.81

u/l

0.30

255

791

Scoliosis

129

3.20

10.66

2.0

1.6

4.36

5.80

u/l

2.10

107

Other disorders of eyelid

191

1070

1.69

10.61

1.4

1.5

4.97

6.08

u/l

3.31

155

914

Other degenerative diseases of the nervous system

307

2.19

10.60

1.3

1.4

5.34

5.81

u/l

0.55

259

Disorders of calcium metabolism

125

3.23

10.54

1.2

1.3

22.60

6.12

u/l

0.45

110

5-aminosalicylic acid

408

2.17

10.49

1.4

1.2

5.48

5.72

u/l

0.21

361

Benign neoplasm: Colon

240

1421

1.59

10.47

1.5

6.22

5.96

u/l

0.13

197

1221

Rosacea

339

2.29

10.44

1.5

1.6

4.79

5.95

u/l

1.97

294

Gingivitis and periodontal diseases

433

1563

1.43

10.41

1.6

1.4

5.97

6.24

u/l

0.19

383

1321

Persistent mood disorders

100

489

2.06

10.40

1.8

1.5

5.29

5.93

u/l

0.69

423

Ocular pain

219

2.63

10.38

1.3

1.6

5.29

6.58

u/l

0.84

190

Diseases of oral cavity, salivary glands and jaws

231

725

1.65

10.37

1.6

1.5

6.13

6.44

u/l

0.18

210

598

Other and unspecified rosacea

225

2.60

10.36

1.5

1.7

4.84

5.73

u/l

1.21

199

Atrial fibrillation and flutter with reimbursement

107

327

2.07

10.33

1.5

1.4

7.23

5.29

u/l

0.76

286

Generalized anxiety disorder

391

2.18

10.31

1.2

1.5

4.63

6.28

u/l

2.17

334

Insomnia

412

2010

1.43

10.30

1.5

5.93

6.02

u/l

0.06

357

1717

Diplopia

310

2.34

10.28

1.3

1.5

5.26

6.85

u/l

1.23

271

Other disorders of white blood cells

112

3.34

10.27

2.2

1.5

5.82

7.66

u/l

0.60

Panic disorder

354

2.24

10.27

1.5

1.4

5.03

5.76

u/l

0.96

304

Myasthenia gravis

7.65

10.26

1.1

1.3

5.38

6.52

u/l

0.31

Iron deficiency anaemia

194

1147

1.66

10.26

1.7

1.4

5.82

5.94

u/l

0.06

166

968

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

124

649

1.89

10.20

1.3

1.5

6.29

5.64

u/l

0.33

562

Primary hyperparathyroidism

269

2.44

10.15

1.2

1.7

14.89

6.16

u/l

0.40

231

Chronic kidney disease

132

688

1.85

10.11

1.4

1.5

8.84

6.07

u/l

0.69

578

Other viral diseases, including avohilmo

188

1121

1.67

10.01

1.7

1.5

5.50

5.73

u/l

0.34

158

983

Injury, poisoning and certain other consequences of external causes

231

711

1.63

10.01

1.5

6.62

5.78

u/l

0.45

204

601

Post-traumatic stress disorder

189

2.72

9.97

1.4

6.00

6.05

u/l

0.01

161

Postprocedural endocrine and metabolic disorders, not elsewhere classified

302

2.33

9.96

1.5

5.34

5.42

u/l

0.04

259

Ovarian cyst

155

492

1.81

9.93

1.4

1.5

4.68

5.79

u/l

2.13

131

407

Other disorders of nervous system

151

2.94

9.92

1.4

1.6

5.18

7.67

u/l

1.29

131

Adalimumab

272

2.41

9.92

1.2

1.5

5.13

6.87

u/l

1.51

235

Achilles tendinitis

190

2.70

9.87

1.7

1.6

5.47

5.97

u/l

0.40

166

Trigeminal neuralgia

120

3.20

9.87

1.7

1.4

5.02

6.37

u/l

1.13

104

Other noninfective gastroenteritis and colitis

121

644

1.89

9.86

1.8

1.4

5.43

5.76

u/l

0.38

104

550

Other inflammation of eyelid

367

2.19

9.85

1.4

1.5

5.32

6.66

u/l

1.33

320

Diagnoses used for exclusion with ILD

121

645

1.88

9.84

1.9

1.5

5.42

6.14

u/l

0.78

101

559

Other viral diseases

145

815

1.78

9.81

1.8

1.5

5.58

5.84

u/l

0.30

123

715

Other coagulation defects

174

2.78

9.80

2.1

1.4

4.93

6.77

u/l

1.08

151

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

299

1829

1.49

9.80

1.5

5.08

6.28

u/l

2.13

253

1580

Injuries to the wrist and hand

458

2187

1.39

9.77

1.4

1.5

6.08

5.81

u/l

0.29

392

1867

Hypoparathyroidism

3.72

9.73

1.9

1.4

4.54

6.79

u/l

1.56

Other skin changes

495

2.01

9.72

1.6

1.5

5.52

5.94

u/l

0.39

414

Injuries to the thorax

205

1274

1.61

9.64

1.5

1.4

9.81

6.18

u/l

0.58

183

1096

Vasomotor and allergic rhinitis

175

1021

1.68

9.63

1.5

5.25

5.84

u/l

0.64

151

897

Dental caries, including avohilmo

305

1036

1.51

9.57

1.6

1.5

5.95

6.15

u/l

0.14

274

868

Unspecified/other endometriosis

189

2.66

9.55

1.4

1.6

4.51

5.62

u/l

1.69

164

Heart failure and antihypertensive medication

103

332

2.02

9.47

1.9

1.3

7.10

5.94

u/l

0.33

289

Bleeding

360

1756

1.44

9.46

1.4

7.16

5.80

u/l

0.86

303

1520

Early onset COPD, excluding more controls

366

2.16

9.46

1.4

6.00

6.25

u/l

0.12

327

Cutaneous abscess, furuncle and carbuncle

130

720

1.81

9.38

1.7

1.5

5.33

6.02

u/l

1.13

111

627

Acute renal failure

502

1.98

9.36

1.8

1.4

8.24

5.93

u/l

0.76

426

Disorders of ocular muscles, binocular movement, accommodation and refraction

228

1452

1.56

9.34

1.4

1.5

5.10

5.87

u/l

2.09

184

1264

Atopic dermatitis, strict definition with reimbursement

135

726

1.79

9.33

1.5

5.54

5.90

u/l

0.42

122

624

Other metabolic disorders

324

2.24

9.31

1.5

5.34

5.35

u/l

0.01

279

Explicit Sepsis

190

1062

1.63

9.31

1.4

7.32

5.68

u/l

1.12

152

903

Venous thromboembolism

231

1433

1.56

9.30

1.7

1.4

5.94

6.05

u/l

0.07

203

1221

Diseases of inner ear

242

1507

1.54

9.29

1.3

1.5

5.85

5.97

u/l

0.10

202

1298

Autoimmune hepatitis, wide definition

3.66

9.27

1.7

1.2

7.17

5.74

u/l

0.45

Disorders of sclera, cornea, iris and ciliary body

253

1667

1.52

9.26

1.5

5.85

6.40

u/l

0.29

217

1441

Hypokalaemia

256

2.40

9.26

1.2

1.6

7.64

5.58

u/l

0.80

219

Candidiasis

370

2.15

9.26

1.3

1.6

5.23

6.20

u/l

0.91

324

Childhood asthma (age<16), excluding more controls

154

2.65

9.20

1.6

1.5

5.14

5.48

u/l

0.25

130

Diseases of pulp and periapical tissues and dental caries

270

903

1.54

9.19

1.6

1.5

6.12

6.29

u/l

0.10

244

749

All influenza (not pneumonia)

358

2.16

9.19

1.8

1.5

5.21

5.64

u/l

0.45

313

Atrial fibrillation and flutter

127

442

1.86

9.19

1.5

1.3

7.58

5.56

u/l

0.84

109

386

Traumatic subdural haemorrhage

141

2.86

9.18

1.8

1.3

13.88

6.10

u/l

0.69

118

Explicit Sepsis, including avohilmo

194

1089

1.62

9.17

1.4

7.28

5.67

u/l

1.12

156

929

Other/unspecified rheumatoid arthritis

270

2.35

9.14

2.1

1.5

5.54

6.49

u/l

0.67

235

Other diseases of blood and blood-forming organs, wide

112

598

1.88

9.11

1.9

1.5

7.08

5.79

u/l

0.96

514

Other diseases of lip and oral mucosa

201

1263

1.60

9.10

1.3

1.5

5.14

5.94

u/l

1.73

169

1102

Erysipelas, including avohilmo

314

1594

1.46

9.06

1.4

6.36

5.67

u/l

0.58

275

1383

Caries of dentine, including avohilmo

329

1147

1.47

9.05

1.6

1.5

5.94

6.04

u/l

0.07

293

963

Childhood asthma (age<16)

156

2.61

8.99

1.6

1.5

5.14

5.47

u/l

0.24

132

Hyperlipidaemia, other/unspecified

157

832

1.70

8.97

1.6

1.5

5.73

5.93

u/l

0.14

132

708

Other symptoms and signs involving the circulatory and respiratory systems

122

3.06

8.96

1.7

1.4

6.49

6.46

u/l

0.01

110

Major coronary heart disease event excluding revascularizations

240

1024

1.55

8.96

1.5

1.4

7.89

5.64

u/l

1.54

209

872

Suggestive for eosinophilic asthma

206

2.54

8.95

1.6

1.5

5.58

7.22

u/l

1.01

181

Atypical facial pain

107

3.21

8.91

1.1

1.4

4.95

6.05

u/l

1.06

Excessive, frequent and irregular menstruation

165

513

1.72

8.90

1.5

4.77

5.75

u/l

1.64

134

425

Synovial cyst of popliteal space [Baker]

3.32

8.88

1.8

1.5

10.10

6.14

u/l

0.35

Missing teeth due to accident, extraction or parodontitis

274

1650

1.49

8.84

1.4

1.5

5.40

5.97

u/l

1.06

228

1429

Cerebrovascular diseases

308

1463

1.46

8.81

1.4

1.5

7.55

5.86

u/l

0.90

255

1259

Other inflammation of eyelid, including avohilmo

205

1305

1.58

8.79

1.5

5.25

5.86

u/l

1.40

167

1134

Specific personality disorders

119

656

1.82

8.76

1.2

1.5

6.38

5.99

u/l

0.12

572

Other and unspecified iron deficiency

154

913

1.69

8.72

1.8

1.4

5.21

5.85

u/l

1.28

135

770

Collagenous colitis

215

2.48

8.70

1.7

1.4

5.69

6.86

u/l

0.63

187

Exclusions for E4_PCOS_CONSORTIUM

330

1429

1.44

8.68

1.3

1.5

5.99

5.50

u/l

0.52

286

1208

Plantar fascial fibromatosis

163

2.72

8.65

1.2

1.6

4.94

5.66

u/l

1.17

141

Use of levodopa decarboxylase inhibitor

290

2.25

8.61

1.5

5.44

6.59

u/l

0.59

246

Heart failure,strict

216

963

1.57

8.61

1.8

1.4

7.53

6.05

u/l

0.67

181

819

Ulcer of lower limb, not elsewhere classified

316

2.20

8.58

1.9

1.4

5.33

6.17

u/l

1.10

270

Bipolar affective disorders

484

1.95

8.55

1.3

1.5

5.93

6.17

u/l

0.08

429

Other bacterial intestinal infections

437

2.00

8.50

1.6

6.21

6.23

u/l

0.01

374

Benign neoplasm of other and ill-defined parts of digestive system

445

1.99

8.44

1.4

1.6

5.59

6.12

u/l

0.41

386

Arthropathic psoriasis

287

2.25

8.40

1.3

1.6

5.10

6.56

u/l

1.34

247

Endometriosis of pelvic peritoneum

360

2.06

8.38

1.3

1.5

4.48

5.91

u/l

2.24

308

Seropositive rheumatoid arthritis, wide

124

702

1.77

8.38

1.7

1.5

5.19

6.11

u/l

1.55

106

596

Disturbance of activity and attention

293

2.21

8.32

1.4

1.5

5.02

5.86

u/l

0.80

256

Deviated nasal septum

142

838

1.70

8.24

1.4

7.33

7.29

u/l

0.01

116

735

Urethritis and urethral syndrome

4.42

8.18

2.2

1.4

4.98

5.77

u/l

0.83

Hernia of abdominal wall, postoperative

366

2.07

8.16

1.4

1.3

12.87

5.82

u/l

0.41

320

Diseases of the digestive system

192

1218

1.57

8.12

1.8

1.4

5.81

6.20

u/l

0.18

160

1044

Enterocolitis due to Clostridium difficile

229

2.37

8.07

1.6

1.5

6.83

7.01

u/l

0.04

199

Herpesviral [herpes simplex] infections, including avohilmo

126

725

1.74

8.07

1.5

5.09

5.76

u/l

1.11

101

625

Otalgia

205

2.46

8.04

1.8

1.5

5.00

6.53

u/l

1.07

179

Disorders of lens

285

1211

1.46

8.04

1.5

1.4

5.99

5.95

u/l

0.03

254

1040

Congenital malformations, deformations and chromosomal abnormalities

263

1710

1.46

7.91

1.5

5.03

6.30

u/l

2.12

223

1480

Adenomyosis (Endometriosis of uterus)

307

2.16

7.90

1.2

1.5

5.04

6.22

u/l

1.00

261

Hyperkinetic disorders

312

2.13

7.90

1.4

1.5

4.98

5.84

u/l

0.89

271

Other and unspecified tonsillitis

145

720

1.68

7.86

1.6

1.4

5.13

6.38

u/l

2.02

125

636

Protozoal diseases, including avohilmo

3.52

7.85

1.3

1.6

5.64

5.95

u/l

0.14

Viral pneumonia

289

2.19

7.84

1.4

1.6

5.21

5.78

u/l

0.59

253

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

137

814

1.69

7.82

1.4

1.5

4.97

5.63

u/l

1.37

119

712

Other/unspecified synovitis and tenosynovitis

178

2.54

7.80

1.4

1.5

5.12

5.91

u/l

0.98

151

Sequelae of external causes of morbidity and mortality

121

698

1.74

7.70

1.7

1.5

5.17

6.08

u/l

1.48

102

593

Coeliac disease

305

2.14

7.66

2.4

1.5

5.30

5.80

u/l

0.55

274

Other bacterial intestinal infections, including avohilmo

109

611

1.79

7.66

1.5

6.00

6.06

u/l

0.03

516

Disorder of lipoprotein metabolism, unspecified

260

2.24

7.64

1.6

1.5

10.28

5.75

u/l

0.86

219

Special screening examination for infectious and parasitic diseases

330

1.95

7.61

1.2

1.4

6.58

6.09

u/l

0.14

290

Injuries to the ankle and foot

328

2012

1.39

7.55

1.4

1.5

5.61

6.17

u/l

0.56

301

1710

Diabetic neuropathy

236

2.29

7.47

1.6

1.7

5.22

7.21

u/l

1.63

209

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

159

995

1.60

7.43

1.6

1.5

5.32

5.82

u/l

0.69

135

865

Bacterial intestinal infections, IBD co-morbidities

459

1.90

7.43

1.6

1.5

6.28

6.18

u/l

0.04

397

Sarcoidosis

350

2.04

7.38

1.8

1.5

5.19

6.42

u/l

1.30

304

Vasculitis limited to skin, not elsewhere classified

4.06

7.37

1.4

5.40

7.61

u/l

0.77

Benign neoplasm: Stomach

214

2.35

7.36

1.3

1.6

6.02

6.37

u/l

0.13

185

Fracture of rib(s), sternum and thoracic spine

133

798

1.67

7.35

1.5

6.78

6.03

u/l

0.20

117

690

Pulmonary heart disease, diseases of pulmonary circulation

133

798

1.67

7.34

1.7

1.5

5.90

6.28

u/l

0.22

110

681

Other cataract

186

890

1.56

7.34

1.7

1.5

6.36

6.16

u/l

0.10

160

756

Female genital prolapse

126

403

1.74

7.27

1.2

1.4

5.00

5.91

u/l

1.06

109

337

Dialysis, with operation codes

292

2.14

7.26

1.6

1.4

17.91

5.92

u/l

0.47

254

Thyroiditis

173

2.51

7.25

1.3

1.5

4.71

5.49

u/l

1.09

152

Superficial injury of lower leg

121

711

1.71

7.24

1.9

1.5

5.24

6.10

u/l

1.41

109

609

Septicaemia

174

1017

1.56

7.23

1.4

1.5

7.65

6.04

u/l

0.92

138

865

Heart failure and coronary heart disease

157

681

1.62

7.22

1.7

1.5

7.75

5.80

u/l

0.65

130

568

Nail disorders

198

2.39

7.18

1.6

5.42

6.22

u/l

0.58

174

Erysipelas

227

1328

1.48

7.17

1.4

6.56

5.92

u/l

0.36

203

1141

Chronic diseases of tonsils and adenoids

331

1504

1.39

7.16

1.5

1.4

5.49

6.16

u/l

0.63

295

1307

Statin medication

297

1178

1.42

7.16

1.4

5.99

5.64

u/l

0.23

257

1009

Disorders of adult personality and behaviour

137

836

1.64

7.11

1.2

1.5

6.12

5.88

u/l

0.08

113

728

Acute tubulo-interstitial nephritis

260

1530

1.44

7.11

1.4

6.28

5.49

u/l

0.92

216

1312

Other/unspecified reactive arthropathies

158

2.55

7.01

1.3

1.5

5.47

7.19

u/l

0.88

136

Hyperkalaemia

3.10

7.01

1.6

1.3

5.44

5.66

u/l

0.08

Pneumonia due to other infectious organisms, not elsewhere classified

3.53

7.00

1.2

1.7

6.10

5.91

u/l

0.05

Exposure to other specified factors

354

2242

1.36

6.95

1.5

5.34

6.23

u/l

1.63

307

1915

Unspecified acute lower respiratory infection

386

1.95

6.92

1.7

1.4

5.42

6.46

u/l

0.92

337

Injuries to the head

479

2175

1.31

6.90

1.6

1.4

6.46

6.00

u/l

0.30

415

1852

Other/unspecified seropositive rheumatoid arthritis

118

699

1.69

6.88

1.7

1.5

5.23

6.11

u/l

1.42

101

594

Retention of urine

136

670

1.65

6.87

1.5

6.72

6.42

u/l

0.14

108

573

Insulin, combination of fast acting with intermediate-acting or long-acting

251

1591

1.43

6.86

1.5

1.4

9.93

6.03

u/l

0.78

211

1372

Cellulitis

106

610

1.74

6.86

1.5

5.74

6.07

u/l

0.21

540

Hemiplegia

103

2.94

6.85

1.2

1.5

4.64

6.31

u/l

1.33

Other septicaemia, including avohilmo

157

936

1.58

6.85

1.4

1.5

7.76

6.06

u/l

0.89

124

794

Volume depletion

160

2.51

6.83

1.6

1.4

5.52

6.05

u/l

0.38

135

Other septicaemia

153

912

1.59

6.82

1.4

1.5

7.88

6.03

u/l

0.95

120

774

Heart failure, strict

230

1093

1.47

6.78

1.7

1.5

7.40

6.01

u/l

0.66

192

932

Eating disorder

203

2.33

6.77

1.4

5.57

5.68

u/l

0.06

172

Obesity and other hyperalimentation

285

1922

1.40

6.76

1.6

1.4

6.09

6.15

u/l

0.04

253

1639

Paraplegia, diplegia of upper limbs

3.94

6.74

1.3

5.23

6.45

u/l

0.52

Other disorders of ear

395

1915

1.33

6.67

1.5

1.4

5.62

6.35

u/l

0.72

333

1651

Transient ischemic attack

207

1113

1.48

6.67

1.3

1.5

5.83

6.20

u/l

0.15

175

948

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

117

698

1.68

6.66

1.7

1.5

5.23

6.12

u/l

1.42

100

594

All-cause Heart Failure

226

1077

1.46

6.61

1.7

1.5

7.45

6.01

u/l

0.68

189

918

Dislocation, sprain and strain of joints and ligaments at neck level

421

1.89

6.60

1.5

5.62

6.26

u/l

0.49

366

Protozoal diseases

3.29

6.58

1.4

1.6

5.63

5.95

u/l

0.13

Inflammatory bowel disease

142

894

1.59

6.53

1.5

5.95

5.76

u/l

0.10

117

782

DVT of lower extremities and pulmonary embolism

168

1095

1.53

6.50

1.7

1.5

5.78

6.11

u/l

0.25

147

927

Spontaneous rupture of synovium and tendon

123

2.70

6.49

1.9

1.5

8.86

5.90

u/l

0.59

107

Other and unspecified disorders of vitreous body

184

1202

1.50

6.46

1.5

5.33

5.94

u/l

0.93

162

1027

Gonarthrosis,primary

369

1659

1.34

6.45

1.4

1.5

5.67

6.10

u/l

0.60

319

1417

Dermatographic urticaria

165

2.44

6.43

1.6

1.4

5.18

5.80

u/l

0.34

143

Cardiomyopathy, other and unspecified

165

2.44

6.43

1.6

1.4

5.60

5.80

u/l

0.12

141

Other viral diseases, not elsewhere classified, including avohilmo

125

762

1.64

6.40

1.7

1.5

5.66

5.81

u/l

0.15

103

671

Gout, FINNGEN

107

626

1.70

6.39

1.4

5.72

6.77

u/l

1.17

530

Obesity

281

1913

1.38

6.39

1.6

1.4

6.12

6.13

u/l

0.01

249

1632

Sequelae with surgical and medical care as external cause

535

1.76

6.36

1.8

1.5

4.95

6.18

u/l

2.06

461

Paralytic strabismus

142

2.55

6.36

1.2

1.5

5.07

8.15

u/l

1.59

126

Nephropathy related operations

288

2.06

6.35

1.6

1.5

5.81

6.59

u/l

0.41

251

Other infectious diseases, including avohilmo

197

2.30

6.34

1.5

1.4

7.53

6.94

u/l

0.11

172

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

174

1139

1.51

6.34

1.4

1.5

5.57

5.61

u/l

0.02

156

981

Other and unspecified mononeuropathies, also in other diseases

3.62

6.33

1.2

1.5

4.53

6.44

u/l

1.22

Disorders of gallbladder, biliary tract and pancreas

418

1983

1.31

6.30

1.5

1.4

6.85

6.06

u/l

0.21

355

1696

Valvular heart disease excluding rheumatic fever

183

868

1.51

6.29

1.7

1.4

6.70

5.73

u/l

0.42

152

745

Purpura and other haemorrhagic conditions

323

1.99

6.29

1.5

1.6

5.73

6.68

u/l

0.64

286

Overexertion and strenuous or repetitive movements

243

2.15

6.27

1.5

5.53

7.12

u/l

1.03

212

Persons encountering health services in circumstances related to reproduction

250

1182

1.42

6.26

1.4

1.5

6.08

6.62

u/l

0.33

224

1024

Non-rheumatic valve diseases

182

863

1.51

6.25

1.7

1.4

6.70

5.73

u/l

0.42

152

740

Pulmonary embolism

121

742

1.64

6.22

1.7

1.5

6.02

6.24

u/l

0.11

100

637

Disorders of choroid and retina

333

1729

1.35

6.20

1.6

1.4

8.03

6.05

u/l

0.46

278

1492

Disorders of vitreous body and globe

218

1435

1.44

6.19

1.5

1.4

5.35

6.10

u/l

1.35

190

1224

Pulmonary heart disease

121

745

1.63

6.12

1.7

1.5

6.02

6.24

u/l

0.11

100

638

Familial hypercholesterolemia

272

2.07

6.11

1.4

10.92

6.16

u/l

0.59

230

Other diseases of anus and rectum

115

697

1.65

6.10

1.5

5.72

6.51

u/l

0.65

594

Menorrhagia

136

469

1.62

6.10

1.4

1.5

4.69

5.83

u/l

1.73

114

391

Personality disorders

127

793

1.61

6.09

1.2

1.5

6.21

5.95

u/l

0.09

104

688

Other menopausal disorders

120

401

1.67

6.06

1.4

4.18

5.91

u/l

3.53

100

334

Atopic dermatitis, strict definition

133

821

1.59

6.06

1.5

5.53

5.69

u/l

0.18

121

711

Blepharochalasis

118

725

1.63

6.04

1.5

5.10

6.32

u/l

2.20

619

Amenorrhoea

128

2.59

6.03

1.6

1.7

6.24

6.15

u/l

0.04

113

Disorders of vitreous body

213

1412

1.44

6.03

1.5

5.37

6.12

u/l

1.34

187

1202

Strabismus

120

739

1.62

6.02

1.3

1.6

5.05

5.73

u/l

1.24

645

Liquid cancers

124

729

1.61

6.01

1.5

1.4

7.84

5.96

u/l

0.68

100

621

Dental pulpitis, including avohilmo

400

1957

1.31

6.00

1.4

1.5

5.23

6.31

u/l

1.76

344

1681

Dermatophytosis

350

1.92

5.99

1.5

5.80

6.57

u/l

0.48

301

Coxarthrosis, primary

235

1382

1.41

5.96

1.3

1.5

5.18

6.11

u/l

2.40

208

1174

Psoriatic arthropathies, ICD10

275

2.05

5.96

1.3

1.6

5.00

6.73

u/l

1.65

240

Myocardial infarction

181

848

1.49

5.96

1.6

1.5

8.80

5.62

u/l

1.72

157

719

Other disorders of bone

531

1.74

5.96

1.4

1.5

5.11

6.16

u/l

1.50

460

Hallux rigidus

235

2.14

5.95

1.1

1.8

4.64

6.91

u/l

2.14

196

Acute pancreatitis

487

1.77

5.95

1.5

12.11

6.35

u/l

0.38

422

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

473

1.74

5.94

1.5

1.6

5.20

5.77

u/l

0.68

400

Haemorrhoids and perianal venous thrombosis

130

815

1.59

5.94

1.7

1.5

5.56

6.19

u/l

0.53

106

698

Misadventures to patients during surgical and medical care

351

1.92

5.94

1.3

1.6

6.14

6.42

u/l

0.15

305

Heartburn

242

2.12

5.93

1.2

1.3

4.60

6.51

u/l

1.69

211

Seborrhoeic dermatitis

216

2.19

5.93

1.6

5.24

7.06

u/l

1.25

188

Spirochaetal infections, other/unspecified

223

2.17

5.90

1.1

1.7

4.73

7.02

u/l

1.93

195

Transplanted organ and tissue status

243

2.11

5.88

1.9

1.5

5.61

6.79

u/l

0.68

208

Insulin medication

251

1497

1.39

5.86

1.5

1.4

9.93

5.94

u/l

0.81

211

1294

Irregular menses

216

1133

1.43

5.86

1.4

4.97

5.38

u/l

0.95

173

969

COPD (mode)

452

1.71

5.84

1.3

9.56

6.14

u/l

0.73

401

Ankylosing spondylitis, ICD10

224

2.16

5.84

1.6

1.5

4.50

7.61

u/l

2.69

192

Convulsions, not elsewhere classified

433

1.81

5.83

1.5

8.71

6.11

u/l

0.45

382

Disorders of orbit

102

2.77

5.80

1.9

1.5

5.31

6.55

u/l

0.82

Fracture of lumbar spine and pelvis

534

1.72

5.79

1.6

1.5

4.76

6.34

u/l

2.79

447

Infective dermatitis

245

2.09

5.76

1.3

1.5

4.75

6.77

u/l

1.76

211

Artificial joint operation, meniscal resection

372

1811

1.32

5.75

1.4

5.27

6.52

u/l

2.16

322

1553

Superficial injury of wrist and hand

567

1.70

5.74

1.6

1.5

6.75

5.85

u/l

0.36

494

Chronic pancreatitis

301

1.97

5.67

1.3

1.5

16.68

6.68

u/l

0.41

261

Psoriasis vulgaris

502

1.74

5.67

1.3

1.5

5.43

6.19

u/l

0.80

438

Nummular dermatitis

169

2.32

5.66

1.2

1.6

6.27

7.58

u/l

0.44

146

Mouth breathing

170

1150

1.48

5.66

1.5

6.30

6.17

u/l

0.03

147

1007

Benign paroxysmal vertigo

128

816

1.57

5.66

1.4

1.5

6.39

6.11

u/l

0.13

105

696

Chronic periodontitis, including avohilmo

418

2070

1.29

5.60

1.5

1.4

5.58

6.28

u/l

0.87

369

1764

Abnormal results of function studies

215

2.15

5.59

2.0

1.5

5.55

6.72

u/l

0.96

194

Allergic rhinitis

136

870

1.55

5.58

1.5

1.6

5.31

5.85

u/l

0.43

115

754

Speech disturbances, not elsewhere classified

183

2.25

5.57

1.1

1.4

4.48

7.52

u/l

2.19

157

Periodontitis

418

2070

1.29

5.56

1.5

1.4

5.60

6.28

u/l

0.85

369

1763

Other viral diseases, not elsewhere classified

482

1.74

5.52

1.9

1.5

5.84

6.13

u/l

0.23

426

Inflammatory disease of uterus

368

1.86

5.49

1.2

1.5

4.84

5.28

u/l

0.61

314

Injuries to the shoulder and upper arm

355

2095

1.31

5.48

1.6

1.4

5.57

6.27

u/l

0.94

306

1793

Other spirochaetal diseases, including avohilmo

151

1006

1.51

5.48

1.5

5.63

6.04

u/l

0.52

129

871

Other retinal disorders

254

1405

1.38

5.45

1.5

1.4

8.25

6.07

u/l

0.38

211

1200

Iridocyclitis

103

629

1.64

5.45

1.3

1.5

6.88

5.94

u/l

0.21

545

Phobic anxiety disorders

312

1.93

5.42

1.5

1.4

8.94

6.26

u/l

0.30

263

Primary_lymphoid and hematopoietic malignant neoplasms

584

1.67

5.42

1.5

6.71

6.13

u/l

0.29

503

Complications of internal orthopaedic prosthetic devices, implants and grafts

524

1.70

5.41

1.4

1.6

5.56

5.99

u/l

0.43

441

Atherosclerosis, excluding cerebral and coronary sclerosis

142

730

1.53

5.39

1.5

7.48

6.25

u/l

0.37

116

609

Biomechanical lesions, not elsewhere classified

112

2.61

5.39

2.3

1.5

5.38

6.26

u/l

0.49

Chronic laryngitis and laryngotracheitis

321

1.91

5.37

1.3

1.5

7.66

6.08

u/l

0.51

278

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

466

1.74

5.34

1.2

1.5

5.13

6.18

u/l

1.35

405

Ulcerative colitis

108

671

1.61

5.34

1.4

5.55

5.85

u/l

0.32

581

Hyperplasia of prostate

131

469

1.58

5.32

1.6

1.3

6.83

6.81

u/l

0.01

122

406

Dislocation, sprain and strain of joints and ligaments of knee

261

1740

1.36

5.32

1.5

1.4

5.67

6.15

u/l

0.38

236

1491

Presence of other functional implants

231

1137

1.39

5.28

1.4

1.5

6.46

6.00

u/l

0.21

193

977

Personal history of other diseases and conditions

273

1.98

5.27

1.3

1.5

6.71

5.61

u/l

0.38

232

Secondary hypertension

135

2.42

5.26

1.5

1.4

5.81

6.35

u/l

0.26

118

Disorders of continuity of bone

261

2.00

5.26

1.5

1.6

16.90

7.06

u/l

0.37

227

Abnormal findings on diagnostic imaging of other body structures

381

1.82

5.25

1.4

1.5

5.78

5.72

u/l

0.03

334

Emotionally unstable personality disorder

338

1.87

5.25

1.3

1.4

7.60

5.68

u/l

0.39

286

Superficial injury of head

104

643

1.62

5.23

1.3

1.5

5.51

6.08

u/l

0.70

554

Tinnitus

105

652

1.62

5.22

1.5

4.85

6.31

u/l

3.01

567

Insulin, intermediate and long-acting

215

1492

1.39

5.17

1.5

1.4

10.82

6.05

u/l

0.82

178

1286

Other disorders of conjunctiva

333

1.87

5.15

1.5

1.6

4.99

6.47

u/l

1.57

287

Acute pancreatitis (for exclusion)

509

1.70

5.15

1.5

12.11

6.32

u/l

0.38

443

Senile cataract

244

1081

1.37

5.07

1.4

5.56

5.93

u/l

0.57

215

922

Dermatophytosis, including avohilmo

272

1997

1.34

5.06

1.5

1.4

8.37

5.92

u/l

0.48

227

1725

Inflammatory diseases of prostate (prostatitis)

265

1.97

5.05

1.7

1.3

6.49

6.11

u/l

0.14

228

Ménière disease

211

2.10

5.04

1.2

1.6

5.08

7.01

u/l

1.33

184

Viral warts

252

1.99

5.02

1.7

1.5

6.27

6.90

u/l

0.27

220

Chronic apical periodontitis

458

2041

1.26

5.01

1.7

1.4

5.81

6.23

u/l

0.40

402

1730

Intracranial injury

233

1590

1.37

5.01

1.7

1.4

7.16

6.31

u/l

0.31

205

1358

Adjustment and management of implanted device

365

1.81

5.00

1.6

1.5

5.79

6.28

u/l

0.49

313

Other spirochaetal diseases

147

994

1.48

5.00

1.4

1.5

5.64

6.00

u/l

0.42

125

862

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

118

753

1.55

4.97

1.6

1.5

4.95

5.77

u/l

1.52

102

652

Eating disorders

239

2.01

4.96

1.4

1.5

5.53

5.57

u/l

0.02

202

150

916

1.48

4.92

1.6

1.5

5.46

6.44

u/l

1.39

123

770

Hypertensive heart and/or renal disease

388

1.68

4.91

1.6

1.5

6.00

6.34

u/l

0.22

329

Bitten or struck by other mammals

310

1.88

4.91

1.5

5.08

6.12

u/l

1.20

270

Noninflammatory disorders of female genital tract

153

513

1.50

4.89

1.4

1.5

4.67

5.75

u/l

2.22

132

425

Myocardial infarction, strict

161

780

1.46

4.89

1.5

7.62

5.66

u/l

1.10

139

660

Ptosis of eyelid

248

1.99

4.87

1.3

1.6

4.70

6.65

u/l

1.86

216

Elevated blood glucose level

181

2.17

4.87

2.3

1.4

6.00

7.68

u/l

0.72

160

Spirochaetal infections, other/unspecified, including avohilmo

145

986

1.47

4.82

1.4

1.5

5.57

6.02

u/l

0.56

123

854

Injury of muscle and tendon at lower leg level

385

1.77

4.79

1.4

1.5

4.93

6.58

u/l

2.14

344

Noninfectious colitis NAS

349

1.81

4.78

1.8

1.4

5.34

6.10

u/l

0.67

303

Unspecified fall

205

1460

1.38

4.73

1.6

1.5

6.76

5.92

u/l

0.35

175

1252

Cluster headache, strict

2.97

4.72

1.1

1.5

4.40

8.41

u/l

1.74

Other psoriatic arthropathies

265

1.94

4.72

1.3

1.6

5.01

6.63

u/l

1.45

231

Polycystic ovarian syndrome, consortium definition

298

1299

1.32

4.68

1.5

4.87

5.37

u/l

1.60

239

1104

Benign neoplasm of other and unspecified endocrine glands

337

1.82

4.68

1.3

1.6

10.88

6.01

u/l

0.69

297

Type 2 diabetes, wide definition

323

1569

1.30

4.67

1.5

1.4

6.54

5.62

u/l

0.83

275

1347

Emphysema

133

2.34

4.66

1.3

1.4

5.20

6.04

u/l

0.66

115

Benign neoplasm: Colon, unspecified

100

633

1.58

4.64

1.7

1.5

5.84

6.14

u/l

0.19

543

Other diseases of oesophagus

198

2.08

4.64

2.1

1.6

4.68

6.51

u/l

2.00

172

Other and unspecified vasculitis limited to skin

3.37

4.62

1.3

1.4

5.46

7.69

u/l

0.72

Heart failure and bmi 25plus

125

548

1.52

4.59

1.5

6.99

5.80

u/l

0.41

100

466

Disorders of tooth development and eruption

303

1.78

4.56

1.6

1.5

5.25

6.25

u/l

0.65

250

Other abnormal findings of blood chemistry

104

2.52

4.55

2.4

1.5

6.60

6.55

u/l

0.01

Other local infections of skin and subcutaneous tissue

255

1.93

4.52

1.3

1.5

4.96

6.87

u/l

1.74

227

Nail dystrophy

6.90

4.51

1.0

1.3

6.08

7.95

u/l

—

Cluster headache, wide

2.88

4.50

1.1

1.5

4.40

8.31

u/l

1.77

Other postsurgical states

148

2.24

4.50

1.8

1.6

4.78

7.84

u/l

1.61

130

Palmar fascial fibromatosis [Dupuytren]

215

2.01

4.44

1.7

1.3

5.56

5.68

u/l

0.07

184

Diabetes mellitus

427

1976

1.25

4.44

1.6

1.4

8.20

5.54

u/l

0.99

367

1693

Substance abuse, excluding more controls

198

1204

1.38

4.42

1.3

1.4

7.33

6.56

u/l

0.24

168

1034

Insulin, fast-acting

143

987

1.45

4.42

1.4

1.5

12.73

5.77

u/l

0.80

119

855

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

131

552

1.50

4.41

1.4

5.32

5.04

u/l

0.38

110

472

False labour

129

534

1.50

4.40

1.2

1.5

4.66

5.31

u/l

1.64

117

453

Diseases of male genital organs

181

645

1.42

4.37

1.5

1.4

7.11

6.70

u/l

0.14

165

565

Peripheral artery disease

149

816

1.44

4.36

1.6

1.5

7.74

6.19

u/l

0.53

125

686

Viral and other specified intestinal infections, including avohilmo

111

702

1.52

4.36

1.5

1.6

4.79

5.94

u/l

2.56

604

Skin changes due to chronic exposure to nonionizing radiation

138

857

1.46

4.36

1.7

1.5

5.43

6.44

u/l

1.31

114

717

Pacemaker

123

767

1.49

4.35

1.4

1.6

7.69

6.06

u/l

0.49

100

640

Primary coxarthrosis, bilateral

107

699

1.53

4.35

1.2

1.6

5.13

6.40

u/l

2.27

586

Other and unspecified local infections of skin and subcutaneous tissue

245

1.93

4.34

1.3

1.5

4.93

6.96

u/l

1.80

217

Disorders of synovium and tendon in diseases classified elsewhere

4.29

4.33

1.6

1.4

3.99

5.67

u/l

1.69

Lyme disease, including avohilmo

142

984

1.45

4.33

1.5

5.60

6.01

u/l

0.49

120

854

Lyme disease

142

984

1.45

4.33

1.5

5.60

6.01

u/l

0.49

120

854

Injury of muscle and tendon at shoulder and upper arm level

146

1018

1.44

4.31

1.6

1.4

6.16

6.47

u/l

0.22

130

872

Anankastic personality disorder

101

2.50

4.30

1.2

1.4

4.64

6.47

u/l

1.55

Actinic keratosis

134

834

1.46

4.30

1.7

1.5

5.48

6.47

u/l

1.23

110

696

Problems related to lifestyle

239

1.93

4.28

1.3

1.5

21.13

6.32

u/l

0.54

197

Appendectomy

270

1974

1.30

4.28

1.3

1.5

5.51

6.10

u/l

0.62

230

1700

Obesity due to excess calories

199

1465

1.36

4.27

1.7

1.4

6.24

5.65

u/l

0.34

177

1261

Open wound of lower leg

362

1.75

4.27

1.7

1.5

4.87

6.57

u/l

2.07

316

Hypertensive Heart Disease

356

1.67

4.26

1.6

1.5

5.85

6.28

u/l

0.28

300

Endometriosis ASRM stages 1,2

507

1.62

4.23

1.3

1.5

4.44

5.22

u/l

2.11

446

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

124

842

1.48

4.21

1.3

1.5

6.29

5.59

u/l

0.36

740

Diabetes, varying definitions

423

1977

1.24

4.20

1.6

1.4

8.24

5.53

u/l

1.00

363

1694

Type 1 diabetes

104

680

1.53

4.20

1.4

11.89

5.68

u/l

0.48

595

Other pleural conditions

180

2.06

4.14

1.5

12.03

6.00

u/l

0.62

160

Type 2 diabetes

410

1910

1.24

4.14

1.6

1.4

8.38

5.55

u/l

1.02

351

1635

Unspecified kidney failure

194

2.02

4.12

1.8

1.4

7.26

5.90

u/l

0.42

169

Obesity, other/unspecified

146

1028

1.42

4.10

1.5

1.4

7.01

5.66

u/l

0.64

125

892

Vascular disorders of the intestines

122

2.31

4.10

2.1

1.5

7.57

7.56

u/l

0.00

103

Gout, idiopatic and unspecified

582

1.57

4.09

1.4

1.5

5.73

6.32

u/l

0.62

491

Superficial injury of thorax

397

1.69

4.09

1.6

1.5

16.00

6.21

u/l

0.54

341

412

1.66

4.07

1.4

1.5

4.98

6.33

u/l

1.82

335

Demyelinating diseases of the central nervous system

223

1.94

4.05

1.2

1.6

5.19

5.73

u/l

0.51

192

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

124

849

1.46

4.05

1.5

1.4

5.69

5.85

u/l

0.17

109

741

Injuries to the neck

100

655

1.53

4.05

1.5

5.61

5.94

u/l

0.30

564

Other obstetric conditions, not elsewhere classified

132

569

1.47

4.05

1.3

1.4

5.35

5.04

u/l

0.45

111

486

Degeneration of macula and posterior pole

171

951

1.39

4.05

1.5

5.69

6.33

u/l

0.66

141

793

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

2.77

4.02

1.1

1.5

5.70

5.83

u/l

0.07

Other diseases of intestine

355

1.72

3.98

1.8

1.5

5.56

6.55

u/l

0.89

309

Insulin, fast-acting or short human

144

1017

1.42

3.98

1.4

1.5

12.66

5.83

u/l

0.79

120

880

Excessive attrition of teeth

254

1939

1.30

3.96

1.4

1.5

5.43

6.29

u/l

1.00

230

1656

Superficial injury of abdomen, lower back and pelvis

416

1.66

3.96

1.6

1.5

5.35

6.21

u/l

0.67

361

Fissure and fistula of anal and rectal regions

595

1.55

3.95

1.5

5.20

6.36

u/l

1.00

520

Benign thyroid growths and nodules

123

784

1.46

3.95

1.2

1.5

7.11

5.39

u/l

0.60

100

675

Psychotic depression

118

2.30

3.94

1.6

4.83

6.66

u/l

1.43

102

Secondary parkinsonism

3.15

3.94

1.0

1.8

5.09

5.75

u/l

—

Fracture of lower leg, including ankle

214

1584

1.33

3.93

1.7

1.4

6.61

6.28

u/l

0.11

185

1356

Gout, unspecified

463

1.62

3.92

1.2

1.5

5.66

6.45

u/l

0.77

398

Benign neoplasm: Caecum

240

1.88

3.91

1.5

9.18

5.97

u/l

0.39

206

Arthropod-borne viral fevers and viral haemorrhagic fevers

226

1.91

3.91

1.2

1.5

5.07

7.22

u/l

1.75

201

Fracture of skull and facial bones

597

1.55

3.90

1.6

1.5

7.10

6.02

u/l

0.39

531

Viral warts, including avohilmo

613

1.54

3.90

1.6

5.77

6.02

u/l

0.20

529

Cardiomyopathy

387

1.68

3.90

1.8

1.5

8.83

5.58

u/l

0.54

329

Other CVD (FINNGEN)

159

1.97

3.89

1.9

1.4

11.61

6.11

u/l

0.72

137

Other strabismus

595

1.54

3.89

1.3

1.5

4.96

5.85

u/l

1.45

525

Recurrent aphthous stomatitis , including avohilmo

365

1.70

3.89

1.5

5.33

6.45

u/l

1.01

321

AV-block

316

1.71

3.88

1.4

1.5

6.75

5.73

u/l

0.37

266

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

403

1.67

3.88

1.2

1.5

5.28

6.39

u/l

1.20

350

COPD-related respiratory insufficiency

241

1.87

3.87

1.2

1.5

8.88

6.11

u/l

0.39

214

Gonarthrosis, primary, with knee surgery

214

1254

1.33

3.86

1.4

1.5

4.94

6.10

u/l

4.04

188

1062

Fracture of foot, except ankle

105

703

1.50

3.86

1.7

1.5

6.25

5.90

u/l

0.15

604

Other noninflammatory disorders of vulva and perineum

213

1.93

3.86

1.3

1.5

4.84

6.52

u/l

1.33

185

Female infertility

110

438

1.51

3.85

1.3

1.5

4.66

5.72

u/l

1.67

367

Heterophoria

186

2.00

3.82

1.6

1.5

5.16

6.79

u/l

1.01

165

Striking against or struck by other objects

136

958

1.42

3.81

1.3

1.5

6.14

5.73

u/l

0.24

116

832

Sequelae of cerebrovascular disease

125

739

1.45

3.80

1.6

1.5

7.15

6.03

u/l

0.38

625

Other diseases of arteries and capillaries

194

1.97

3.76

1.4

1.7

5.88

6.49

u/l

0.35

173

Other complications of surgical and medical care, not elsewhere classified

237

1.86

3.73

1.3

1.7

7.13

6.31

u/l

0.15

209

Other inflammatory liver diseases

154

2.09

3.72

1.8

1.4

7.45

7.32

u/l

0.03

133

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

384

1969

1.23

3.70

1.6

1.4

5.51

6.35

u/l

0.90

340

1674

Care involving dialysis

168

2.03

3.69

1.7

1.5

5.16

6.31

u/l

0.91

149

Acute and subacute iridocyclitis

518

1.57

3.69

1.3

1.5

5.20

6.16

u/l

1.26

451

Other disorders of kidney and ureter

311

1.74

3.68

1.4

1.6

4.95

6.49

u/l

1.53

271

Disorders of psychological development

233

1.84

3.68

1.5

1.6

6.91

6.34

u/l

0.17

202

Endometriosis of ovary

385

1.64

3.66

1.4

1.5

4.67

5.99

u/l

1.85

325

IBD patients in KELA-register

639

1.51

3.65

1.5

1.4

5.37

5.86

u/l

0.58

552

Covid-19 suspected case

583

1.53

3.65

1.5

6.38

5.92

u/l

0.22

508

Follicular cysts of skin and subcutaneous tissue

512

1.57

3.64

1.3

1.5

7.26

5.77

u/l

0.36

449

Ulcerative colitis, NAS

366

1.67

3.60

1.2

1.4

5.34

6.18

u/l

0.71

323

Open wound of wrist and hand

175

1256

1.35

3.59

1.5

9.85

6.03

u/l

0.52

153

1095

Disorders of breast

201

1339

1.32

3.59

1.4

1.5

4.81

5.33

u/l

1.86

171

1128

Secondary parkinsonism+Parkinsonism in other disease

2.97

3.58

1.0

1.4

5.09

5.53

u/l

—

Paralytic ileus and intestinal obstruction

577

1.53

3.58

1.4

1.5

5.25

6.58

u/l

1.79

491

Liquid cancers, including Hilmo

136

854

1.41

3.57

1.5

1.4

7.74

6.00

u/l

0.69

110

736

Sequelae of other external causes

124

2.19

3.54

1.6

1.4

5.98

7.55

u/l

0.47

106

Other ulcerative colitis

144

2.10

3.53

1.0

1.4

4.88

6.09

u/l

1.27

122

Anterior Iridocyclitis

548

1.54

3.52

1.4

1.5

5.24

6.01

u/l

0.98

478

Unspecified misadventure during surgical and medical care

131

2.15

3.51

1.5

6.35

7.32

u/l

0.29

112

Primary biliary cholangitis, wide definition

3.91

3.50

2.3

1.2

4.38

6.69

u/l

0.55

Other medical care

170

1058

1.35

3.47

1.4

6.60

6.11

u/l

0.21

144

906

Allergic contact dermatitis

332

1.69

3.47

1.2

1.4

4.84

5.97

u/l

1.16

285

Injuries to the elbow and forearm

285

1943

1.26

3.47

1.5

8.71

5.58

u/l

0.69

238

1671

Osteomyelitis

132

2.13

3.45

1.5

5.19

8.30

u/l

1.36

113

Medicines for HER+ breast cancer

1026

0.64

3.45

1.6

1.5

6.54

5.38

u/l

0.51

874

Injury of muscle and tendon at hip and thigh level

273

1.77

3.44

1.7

1.5

5.87

6.71

u/l

0.46

238

Other disorders of skin and subcutaneous tissue, not elsewhere classified

333

1.69

3.43

2.1

1.5

5.46

5.82

u/l

0.32

296

Myocardial infarction, without ST-elevation

133

859

1.40

3.42

1.5

9.05

6.11

u/l

1.04

117

717

Diseases of appendix

298

2135

1.25

3.42

1.4

1.5

5.64

6.22

u/l

0.62

247

1837

Persons with potential health hazards related to communicable diseases

149

1080

1.37

3.41

1.5

9.58

5.76

u/l

0.39

123

938

Scleritis and episcleritis

160

2.01

3.39

1.6

4.76

6.25

u/l

1.85

137

Convalescence

120

2.18

3.38

1.3

1.5

4.42

6.20

u/l

1.55

105

Benign neoplasm: Adrenal gland

188

1.93

3.38

1.3

1.7

14.10

6.59

u/l

0.59

164

Phlebitis and thrombophlebitis (not including DVT)

618

1.49

3.38

2.0

1.5

4.91

6.27

u/l

2.44

534

Benign neoplasm: Transverse colon

254

1.78

3.32

2.2

1.5

5.59

6.54

u/l

0.61

220

Hypertrophy of breast in women and men

556

1.52

3.32

1.3

1.5

4.68

6.00

u/l

2.32

482

Vulvovaginal ulceration/inflammation in other diseases

176

1.94

3.28

1.5

5.37

5.50

u/l

0.08

153

Bell's palsy

255

1.77

3.28

2.0

1.5

5.12

6.55

u/l

1.21

220

Unstable angina pectoris

120

666

1.42

3.28

1.5

5.79

5.74

u/l

0.05

101

555

Inflammatory bowel disease, strict (require KELA)

655

1.47

3.28

1.5

5.37

6.02

u/l

0.81

567

Macular pucker

361

1.64

3.26

1.7

1.5

5.56

6.64

u/l

0.83

302

Other secondary gonarthrosis

109

2.22

3.25

1.4

5.09

7.19

u/l

0.76

Autoimmune hyperthyroidism

109

2.21

3.25

1.7

1.3

5.07

5.41

u/l

0.19

Stomatitis and related lesions

551

1.51

3.24

1.4

1.5

6.47

5.82

u/l

0.24

475

Other and unspecified mood [affective] disorders

163

1.97

3.23

1.2

1.3

7.83

6.09

u/l

0.23

137

Deficiency of other B group vitamins

3.37

3.23

1.2

1.4

4.03

6.85

u/l

1.39

Anomalies of dental arch relationship, including avohilmo

513

1.50

3.19

1.5

5.64

5.99

u/l

0.22

448

Appendicitis, broad definition

293

2121

1.24

3.19

1.4

1.5

5.60

6.21

u/l

0.65

243

1825

Chronic iridocyclitis

110

2.20

3.19

1.4

1.5

5.09

6.58

u/l

1.10

Injuries to unspecified part of trunk, limb or body region

243

1.78

3.18

1.4

1.5

5.28

7.08

u/l

1.32

215

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

506

1.53

3.16

1.2

1.6

4.94

5.35

u/l

0.54

434

Hypercalcemia

104

2.23

3.16

1.1

1.5

36.09

8.13

u/l

0.42

Injuries to the hip and thigh

177

1205

1.32

3.15

1.8

1.5

5.42

6.18

u/l

1.43

144

1027

Diseases of peritoneum

230

1.79

3.11

1.4

1.5

5.88

7.11

u/l

0.64

203

Parkinson's disease

320

1.66

3.10

1.2

1.5

5.61

6.46

u/l

0.36

270

Obsessive-compulsive disorder

145

2.01

3.09

1.5

1.3

7.98

6.35

u/l

0.32

117

Mucosal proctocolitis

336

1.64

3.08

1.3

1.4

5.93

6.51

u/l

0.35

296

Haemorrhage in early pregnancy

115

798

1.40

3.07

1.4

1.5

5.05

5.41

u/l

0.44

679

Disorders of optic nerve and visual pathways

231

1.78

3.07

1.3

1.6

6.60

6.37

u/l

0.05

202

Acute appendicitis

275

2058

1.24

3.05

1.4

5.62

6.24

u/l

0.62

229

1772

Supplementary factors related to causes of morbidity and mortality classified elsewhere

123

891

1.38

3.05

1.4

1.5

7.85

5.91

u/l

0.50

106

766

Disorders of refraction and accommodation

115

821

1.40

3.03

1.5

5.16

5.88

u/l

0.96

724

Conduction disorders

104

584

1.43

3.01

1.5

1.4

6.14

5.68

u/l

0.26

496

557

1.45

3.00

1.5

5.91

6.10

u/l

0.09

460

Acute appendicitis, no complications

219

1718

1.27

2.97

1.4

5.74

6.27

u/l

0.41

186

1491

Parkinson's disease, including avohilmo

340

1.62

2.96

1.2

1.6

5.71

6.42

u/l

0.30

288

Non-ischemic cardiomyopathy

105

587

1.42

2.95

1.7

1.5

6.06

5.63

u/l

0.31

487

Parkinson's disease, strict definition

302

1.66

2.94

1.2

1.5

5.55

6.55

u/l

0.41

255

Acne vulgaris

176

1.88

2.93

1.9

1.4

5.11

6.73

u/l

1.13

147

Cholelithiasis, broad definition with cholecystitis

336

1842

1.21

2.92

1.5

1.4

5.34

5.88

u/l

1.34

285

1577

Thyrotoxicosis with diffuse goitre

357

1.60

2.91

1.6

6.12

5.20

u/l

0.63

309

Sequelae of injuries, of poisoning and of other consequences of external causes

672

1.43

2.91

1.7

1.5

5.03

6.04

u/l

1.98

589

Suicide or other Intentional self-harm

697

1.42

2.91

1.3

1.5

6.42

5.80

u/l

0.24

613

Cholelithiasis

324

1817

1.22

2.90

1.5

1.4

5.29

5.89

u/l

1.54

277

1554

Crohn disease

335

1.62

2.87

1.4

6.76

6.21

u/l

0.12

293

Later onset COPD, excluding more controls

259

1.62

2.85

1.2

1.4

12.90

6.58

u/l

0.68

225

Other puerperal infections

200

1.81

2.85

1.2

1.4

4.97

5.17

u/l

0.18

173

Endometriosis of rectovaginal septum and vagina

157

1.92

2.84

1.2

1.6

4.33

5.99

u/l

1.71

137

Alzheimer disease

511

0.60

2.83

1.4

1.5

5.27

6.08

u/l

0.94

415

Viral and other specified intestinal infections

491

1.49

2.82

1.3

1.7

4.87

6.32

u/l

2.29

427

Primary biliary cholangitis (PBC)

3.36

2.82

2.5

1.2

4.52

6.44

u/l

0.48

Relapsing fevers, including avohilmo

8.70

2.78

1.0

1.8

6.90

11.78

u/l

—

Use of donepezil

380

0.48

2.78

1.2

1.4

5.09

6.11

u/l

0.90

309

Malignant neoplasm of breast, ER-positive, including Hilmo

737

0.66

2.78

1.5

1.4

6.71

5.18

u/l

0.67

628

Non-Hodgkin lymphoma, all, including Hilmo

300

1.64

2.76

1.3

1.4

7.44

6.36

u/l

0.30

261

Maltreatment syndromes

124

2.03

2.76

1.2

1.3

7.39

7.12

u/l

0.07

101

Cluster headache, strict, including avohilmo

131

2.00

2.75

1.1

1.3

4.38

6.26

u/l

2.13

111

Acne

238

1.72

2.75

2.0

1.5

4.99

6.14

u/l

1.00

201

Acute gastritis

152

1.92

2.75

1.2

1.4

4.94

6.42

u/l

1.36

135

Malignant neoplasm of breast, HER-positive

736

0.67

2.75

1.5

1.4

6.71

5.18

u/l

0.67

628

Pollen allergy

508

1.48

2.74

1.7

1.5

4.73

6.11

u/l

2.28

440

Caries of enamel

387

2128

1.19

2.73

1.4

1.5

7.14

5.94

u/l

0.32

340

1817

Melanocytic naevi

123

910

1.35

2.72

1.2

1.5

4.97

6.12

u/l

2.59

102

794

Lichen ruber planus, wide definition including periferal and oral lichen planus

632

1.43

2.71

1.4

1.5

5.04

6.26

u/l

2.04

544

Memory loss

196

1.79

2.71

1.3

1.5

6.20

7.05

u/l

0.33

169

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

180

1216

1.29

2.70

1.4

1.5

6.69

5.00

u/l

1.13

150

1035

Atrophic disorders of skin

428

1.52

2.70

1.1

1.5

5.14

6.19

u/l

1.21

367

Female infertility, cervical, vaginal, other or unspecified origin

426

1.43

2.69

1.3

1.5

4.78

5.62

u/l

1.10

358

Nasal polyp

461

1.50

2.68

1.5

1.4

5.33

6.31

u/l

1.21

405

Ulcerative proctitis

147

1.91

2.65

1.5

1.3

5.57

7.12

u/l

0.63

126

Type of accident

113

829

1.37

2.64

1.4

1.5

7.88

5.98

u/l

0.43

712

Poisoning by drugs, medicaments and biological substances

677

1.41

2.64

1.3

1.5

6.68

5.84

u/l

0.33

596

Poisoning by medicine

619

1.43

2.64

1.3

1.5

6.78

5.92

u/l

0.30

547

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

372

1853

1.19

2.63

1.5

1.4

8.46

5.59

u/l

0.91

320

1593

Postmenopausal bleeding

348

1.43

2.63

1.6

1.4

4.84

5.84

u/l

1.14

287

Superficial injury of forearm

243

1.69

2.62

1.3

1.4

5.50

6.29

u/l

0.44

209

Nontoxic goitre/thyroid nodule

110

805

1.37

2.62

1.2

1.6

6.99

5.77

u/l

0.34

687

Monoamine oxidase A inhibitors

266

1.66

2.62

2.1

1.6

4.57

6.52

u/l

2.01

229

Other congenital malformations of limb(s)

4.75

2.61

1.1

1.7

7.10

8.67

u/l

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

321

1.59

2.59

1.2

1.5

6.35

5.70

u/l

0.24

272

Other female pelvic inflammatory diseases

433

1.51

2.58

1.4

1.5

4.93

5.81

u/l

1.12

366

Other and/or unspecified nontoxic goitre

185

1.79

2.56

1.2

1.7

5.08

5.24

u/l

0.19

154

Disorders of parathyroid gland, other and/or unspecified

5.55

2.56

1.0

1.5

97.97

9.05

u/l

—

Malignant neoplasm of digestive organs

825

0.69

2.55

1.8

1.4

7.58

5.94

u/l

0.32

716

Transport accidents

171

1112

1.28

2.52

1.6

1.4

6.75

5.73

u/l

0.48

152

952

Gout, strict definition

403

1.52

2.52

1.3

1.5

5.94

6.35

u/l

0.28

345

Epilepsy

673

1.39

2.51

1.5

8.81

6.47

u/l

0.47

580

Cluster headache, wide,, including avohilmo

136

1.92

2.50

1.1

1.4

4.38

6.25

u/l

2.23

116

Iron deficiency anaemia secondary to blood loss (chronic)

380

1.53

2.49

1.4

1.5

7.14

6.35

u/l

0.13

329

Acute nasopharyngitis (common cold)

283

1.62

2.49

1.2

1.4

5.17

7.25

u/l

1.42

248

Other specified/unspecified deforming dorsopathies

3.49

2.48

2.3

1.6

5.62

7.01

u/l

—

Seropositive rheumatoid arthritis, strict definition

389

1.52

2.47

1.5

1.6

5.06

6.23

u/l

1.38

342

L02BG Aromatase inhibitors

866

0.67

2.45

1.7

1.5

6.64

5.48

u/l

0.41

738

Presence of cardiac and vascular implants and grafts

142

798

1.31

2.45

1.5

7.33

6.27

u/l

0.35

119

682

Hypertrophy of breast

496

1.46

2.44

1.3

1.5

4.77

5.61

u/l

1.37

433

Diabetic retinopathy, excluding more controls

332

1.43

2.44

1.4

1.6

13.44

6.26

u/l

0.44

281

Sub-endpoint used in defining T1D endpoints

104

752

1.36

2.43

1.4

1.5

11.96

6.00

u/l

0.45

657

Unspecified haematuria

144

901

1.30

2.42

1.6

1.5

5.71

6.24

u/l

0.43

121

783

Nontoxic multinodular goitre

464

1.47

2.42

1.3

1.6

8.52

5.42

u/l

0.62

395

Listeriosis

5.13

2.42

1.0

1.2

4.80

4.63

u/l

—

Astigmatism

145

1.87

2.40

1.5

1.6

6.55

7.33

u/l

0.16

127

Use of other anti-dementia drugs

439

0.59

2.40

1.9

1.4

5.53

6.04

u/l

0.40

357

Use of memantine

439

0.59

2.40

1.9

1.4

5.53

6.04

u/l

0.40

357

Hernia of abdominal wall

166

1307

1.27

2.39

1.3

1.5

8.89

6.22

u/l

0.31

147

1128

Benign neoplasm: Connective and other soft tissue of thorax

6.39

2.38

1.0

1.5

5.66

10.31

u/l

—

Pre-eclampsia or poor fetal growth

117

875

1.33

2.38

1.4

1.5

5.87

5.27

u/l

0.44

101

742

Maternal care related to the fetus and amniotic cavity and possible delivery problems

172

790

1.28

2.38

1.3

1.5

4.71

5.46

u/l

1.80

150

676

Other disorders of optic [2nd] nerve and visual pathways

146

1.86

2.37

1.3

1.4

6.85

7.23

u/l

0.06

127

Complications predominantly related to the puerperium

100

735

1.36

2.36

1.4

1.5

4.79

5.43

u/l

1.17

634

Glomerular diseases

451

1.47

2.34

1.4

1.5

5.55

6.41

u/l

0.85

391

Nonsuppurative otitis media, including avohilmo

119

776

1.33

2.32

1.5

5.23

5.83

u/l

0.55

672

Chronic periodontitis, complicated

215

1706

1.23

2.30

1.6

1.4

5.41

6.15

u/l

1.57

191

1475

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

628

0.63

2.30

1.5

1.4

13.39

6.06

u/l

0.98

538

Malignant neoplasm of digestive organs, including Hilmo

896

0.73

2.30

1.8

1.4

7.22

5.87

u/l

0.32

777

Other disorders of bladder

253

1.63

2.29

1.3

1.6

5.03

6.23

u/l

1.69

214

Emotional disorders starting during childhood or adolecense, excluding more controls

2.39

2.29

2.2

2.0

4.71

5.72

u/l

—

Listeriosis, including avohilmo

4.73

2.29

1.0

1.4

4.80

4.59

u/l

—

Acute suppurative otitis media

680

1.36

2.28

1.9

1.5

6.01

5.84

u/l

0.10

584

Herpesviral [herpes simplex] infections

301

1.57

2.26

1.7

1.5

5.05

6.32

u/l

1.20

265

Unspecific neurodegenerative disorder

698

0.70

2.26

1.6

1.5

5.21

6.17

u/l

1.66

572

Extracorporeal dialysis

134

1.87

2.26

1.8

1.5

5.57

8.33

u/l

1.10

116

Benign neoplasm of bone and articular cartilage

208

1.69

2.26

1.6

1.4

4.93

7.06

u/l

1.49

180

Ingrowing nail

127

1.90

2.26

1.1

1.5

5.76

6.45

u/l

0.39

108

Diabetes, insulin treatment (Kela reimbursement)

389

1982

1.17

2.25

1.5

1.4

8.33

5.72

u/l

0.84

334

1702

Lichen planus, including avohilmo

530

1.42

2.25

1.3

1.6

5.11

6.43

u/l

1.88

456

Malignant neoplasm of skin, including Hilmo

197

1062

1.24

2.24

1.8

1.4

5.44

5.69

u/l

0.25

164

923

Other condition

382

1.50

2.24

1.3

1.5

7.00

6.30

u/l

0.16

334

Stroke, including SAH

217

1268

1.23

2.24

1.5

6.63

6.14

u/l

0.18

183

1087

Suppurative and unspecified otitis media

134

916

1.30

2.24

1.8

1.5

5.84

5.71

u/l

0.11

112

790

Cardiomyopathies, Primary/intrinsic

255

1.61

2.23

1.5

1.4

10.61

5.60

u/l

0.46

218

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

410

1.47

2.23

1.6

5.26

6.44

u/l

0.97

362

Injury of urinary and pelvic organs

2.88

2.21

1.3

23.83

6.66

u/l

—

Anogenital herpesviral [herpes simplex] infection

172

1.75

2.20

1.1

1.3

7.43

5.63

u/l

0.43

148

L02BA Anti-estrogens

479

0.58

2.19

1.5

1.6

5.50

5.77

u/l

0.19

413

Glomerular disorders in diseases classified elsewhere

272

1.59

2.19

1.5

1.4

5.62

7.07

u/l

1.00

234

Malignant neoplasm of breast, including Hilmo

102

871

0.75

2.19

1.4

5.93

5.22

u/l

0.39

742

Malignant neoplasm of breast, HER2-negative, including Hilmo

102

871

0.75

2.19

1.4

5.93

5.22

u/l

0.39

742

Vestibular neuronitis

203

1.68

2.17

1.1

1.6

5.77

7.19

u/l

0.67

179

Anorexia (incl.atypical)

122

1.89

2.15

1.6

1.3

4.73

5.55

u/l

0.67

103

COPD

143

908

1.28

2.15

1.3

1.5

8.39

6.17

u/l

0.65

119

785

Carrier of infectious disease

2.31

2.15

1.2

1.3

9.20

7.58

u/l

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

460

1.44

2.15

1.3

1.5

7.04

5.90

u/l

0.30

404

Diabetes medication

409

2062

1.16

2.14

1.6

1.4

8.29

5.65

u/l

0.91

349

1771

Keratitis

133

1035

1.29

2.14

1.5

5.18

6.16

u/l

2.40

115

902

Early onset COPD

569

1.39

2.14

1.4

1.5

6.00

5.96

u/l

0.02

501

Pregnancy hypertension

159

1129

1.26

2.13

1.4

1.5

6.93

5.03

u/l

1.13

133

962

Conductive and sensorineural hearing loss

292

1632

1.19

2.13

1.4

5.93

5.95

u/l

0.01

246

1409

Problems related to social environment

2.38

2.12

2.5

1.2

5.21

7.27

u/l

0.64

Acute laryngitis and tracheitis

270

1.57

2.12

1.2

1.5

5.02

6.44

u/l

1.17

236

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

448

1.43

2.11

1.6

5.27

6.27

u/l

0.83

394

Ulcerative colitis (strict definition, all Crohn cases excluded)

388

1.47

2.10

1.5

1.4

5.71

6.53

u/l

0.64

339

Acute pharyngitis

360

1.49

2.09

2.0

1.5

5.02

6.39

u/l

1.54

318

Type 1 diabetes, wide definition, subgroup 1

571

1.38

2.09

1.3

1.4

5.75

5.71

u/l

0.03

499

Sequelae of injuries of neck and trunk

2.15

2.09

1.1

1.4

4.76

7.10

u/l

1.31

Congenital malformations of spine and bony thorax

5.09

2.08

3.0

1.4

4.70

6.21

u/l

—

Foreign body on external eye

389

1.47

2.08

1.4

5.57

6.74

u/l

0.84

344

Lung cancer and mesothelioma

287

1.51

2.07

1.1

1.4

9.80

6.80

u/l

0.42

251

Hypotension

365

1.48

2.06

1.7

1.5

9.81

6.73

u/l

0.47

306

Retinal detachments and breaks

123

954

1.29

2.05

1.7

1.5

6.72

6.28

u/l

0.11

106

814

Sudden idiopathic hearing loss

238

1.60

2.04

1.7

1.6

5.55

6.90

u/l

0.75

206

Necrosis of pulp, including avohilmo

227

1865

1.20

2.02

1.4

5.80

6.22

u/l

0.32

194

1603

Cyst of kidney

162

1.74

2.02

1.4

1.6

5.07

7.51

u/l

1.37

141

Malignant neoplasm of breast

101

857

0.76

2.01

1.4

5.96

5.24

u/l

0.39

730

Ovarian dysfunction

185

1.68

2.00

2.1

1.5

4.84

5.07

u/l

0.12

159

Gastric ulcer

368

1.47

1.99

1.1

1.6

8.37

6.31

u/l

0.27

317

Malignant neoplasm of breast, HER2-negative

101

856

0.76

1.99

1.4

5.96

5.25

u/l

0.38

729

Effects of foreign body entering through natural orifice

654

1.35

1.99

1.4

1.5

5.14

6.18

u/l

1.33

583

Other specified and unspecified personality disorders

240

1.59

1.98

1.1

1.5

9.48

7.09

u/l

0.25

207

Other chronic obstructive pulmonary disease

135

869

1.27

1.97

1.3

1.5

8.58

6.20

u/l

0.67

113

748

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

169

918

1.24

1.97

1.7

1.4

5.61

5.80

u/l

0.15

144

792

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

444

1.42

1.96

1.5

1.4

5.64

6.38

u/l

0.65

387

Preterm labour and delivery

751

1.32

1.95

1.3

1.5

5.12

5.27

u/l

0.19

645

Other CVD

436

1.42

1.95

1.7

1.5

9.55

6.53

u/l

0.50

368

Granuloma annulare

2.59

1.95

1.5

1.3

18.52

7.85

u/l

—

Other maternal disorders predominantly related to pregnancy

215

1111

1.21

1.95

1.5

4.96

5.27

u/l

0.54

188

935

Other articular cartilage disorders

2.58

1.94

1.2

1.3

4.21

7.59

u/l

—

Retinal detachment with retinal break

297

1.52

1.94

1.8

1.5

5.64

6.58

u/l

0.69

252

Postmenopausal atrophic vaginitis

362

1.36

1.94

1.5

1.4

5.09

6.01

u/l

1.03

301

Other disorders of glucose regulation and pancreatic internal secretion

187

1.66

1.93

1.2

1.4

7.60

7.69

u/l

0.02

161

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

218

1.61

1.93

1.2

1.6

5.34

6.65

u/l

0.68

188

Childhood allergy (age < 16)

237

1.53

1.93

1.5

1.7

4.89

6.30

u/l

1.47

202

Endometriosis ASRM stages 3,4

641

1.34

1.92

1.3

1.5

4.64

5.54

u/l

1.87

557

Peritonsillar abscess

530

1.38

1.92

1.3

1.4

6.03

6.01

u/l

0.01

469

Malignant neoplasm of skin

182

1004

1.23

1.91

1.7

1.4

5.56

5.72

u/l

0.13

149

869

Tonsillectomy and adenotomy

219

1266

1.20

1.90

1.4

1.5

5.35

6.30

u/l

0.87

184

1097

Postpartum haemorrhage due to anatomy

267

0.49

1.90

1.2

1.3

4.60

5.01

u/l

0.40

231

Other abnormal uterine and vaginal bleeding

391

1.38

1.89

1.5

4.89

6.06

u/l

1.46

328

Benign neoplasm: Sigmoid colon

481

1.40

1.89

1.5

1.6

4.94

6.12

u/l

1.92

416

Polypectomy (DHB20)

143

1.76

1.89

1.8

1.5

6.17

8.11

u/l

0.75

122

Bronchiectasis

151

1.73

1.86

1.2

1.5

9.48

6.03

u/l

0.44

129

MS-disease / Multiple Sclerosis

197

1.63

1.86

1.1

1.5

5.57

5.78

u/l

0.13

170

Use of anticholinesterases

612

0.70

1.85

1.4

1.5

5.26

6.33

u/l

1.58

501

N06DA Anticholinesterases

612

0.70

1.85

1.4

1.5

5.26

6.33

u/l

1.58

501

Non-follicular lymphoma

205

1.61

1.85

1.5

8.49

7.19

u/l

0.24

181

Crohn's disease NAS

159

1.70

1.85

1.1

1.4

8.25

6.92

u/l

0.14

137

Stroke, excluding SAH

198

1181

1.21

1.84

1.5

6.83

6.10

u/l

0.26

166

1011

Cholecystectomy

261

1882

1.18

1.83

1.5

1.4

5.33

5.83

u/l

1.02

226

1606

Thyrotoxicosis, other and/or unspecified

518

1.37

1.83

1.7

1.5

5.08

5.48

u/l

0.45

449

Crohn's disease of small intestine

175

1.66

1.82

1.5

1.4

5.06

5.90

u/l

0.65

151

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

238

1.56

1.81

1.6

1.5

6.11

6.89

u/l

0.36

213

Deep bite

236

1.53

1.81

1.2

1.8

4.76

6.18

u/l

1.41

204

Other superficial mycoses, including avohilmo

287

1.50

1.79

1.6

1.4

7.33

6.63

u/l

0.16

249

Primary gonarthrosis, bilateral

175

1203

1.22

1.78

1.4

1.5

4.92

6.08

u/l

3.85

154

1025

Alzheimer’s disease (Atypical or mixed)

164

0.42

1.78

1.9

1.3

5.54

7.42

u/l

—

135

Glaucoma

190

1337

1.21

1.77

1.5

5.47

6.17

u/l

1.07

158

1141

Puerperal sepsis

354

1.44

1.75

1.5

1.6

4.64

5.92

u/l

1.33

309

Type 1 diabetes, wide definition

599

1.34

1.75

1.3

1.4

5.75

5.69

u/l

0.05

524

Gastroduodenal ulcer

538

1.35

1.74

1.2

1.5

8.27

6.11

u/l

0.40

459

Peroneal tendinitis

2.52

1.74

2.4

1.6

4.88

6.56

u/l

—

Acute lymphadenitis

140

1.72

2.0

1.3

6.87

6.90

u/l

0.01

120

Supervision of high-risk pregnancy

337

1.36

1.71

1.2

1.6

5.16

5.19

u/l

0.03

291

Colorectal cancer

578

0.68

1.71

1.9

1.4

4.71

5.97

u/l

2.39

490

Schizoid personality disorder

0.00

1.71

0.0

1.3

—

6.70

—

Lung diseases due to external agents

282

1.49

1.71

2.1

1.5

6.01

6.75

u/l

0.28

245

Inguinal hernia, bilateral

218

1.56

1.70

1.7

1.5

6.58

7.15

u/l

0.12

187

Dipeptidyl peptidase 4 (DPP-4) inhibitors

195

1275

1.20

1.70

1.6

1.5

6.03

5.70

u/l

0.15

159

1096

Ulcerative colitis (strict definition, require KELA)

466

1.38

1.69

1.5

5.63

6.28

u/l

0.58

408

Carbimazole or st.post thyroidectomy, condition for graves disease

604

1.33

1.68

1.5

5.03

6.08

u/l

1.56

520

Basal cell carcinoma

154

855

1.23

1.67

1.7

1.4

5.70

5.85

u/l

0.10

129

734

Benign lipomatous neoplasm

106

832

1.28

1.67

1.5

5.37

6.25

u/l

1.46

720

Infections with a predominantly sexual mode of transmission, including avohilmo

147

1095

1.23

1.66

1.3

1.5

6.11

5.71

u/l

0.15

119

952

Umbilical hernia

736

1.29

1.66

1.3

1.5

5.19

6.31

u/l

1.81

645

Other or unspecified ileus, impaction or obstruction

383

1.41

1.66

1.4

1.5

5.19

6.62

u/l

1.42

322

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

502

1.36

1.66

1.4

1.5

5.59

6.18

u/l

0.56

440

Erosion of teeth , including avohilmo

101

789

1.28

1.66

1.5

5.88

5.83

u/l

0.03

689

Granulomatous disorders of skin and subcutaneous tissue

2.11

1.66

1.8

1.3

15.45

6.95

u/l

0.38

Lichen planus

317

1.45

1.66

1.4

1.6

4.99

6.46

u/l

1.51

270

Colonic or urogenital fistula

764

1.28

1.64

1.5

5.16

5.97

u/l

0.70

664

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

181

1.61

1.63

1.2

1.5

6.55

6.76

u/l

0.06

158

Embedded and impacted teeth

562

1.30

1.62

1.8

1.5

5.04

6.13

u/l

1.70

477

Sensorineural hearing loss

267

1529

1.16

1.62

1.4

5.91

6.02

u/l

0.07

224

1313

Lichen sclerosus et atrophicus

286

1.47

1.61

1.1

1.4

5.15

5.44

u/l

0.23

239

D07AA Corticosteroids, weak (group I)

402

1.39

1.61

1.8

1.5

5.65

6.23

u/l

0.44

353

Other malignant neoplasms of skin (=non-melanoma skin cancer)

159

886

1.22

1.61

1.7

1.4

5.67

5.82

u/l

0.10

134

762

Agranulocytosis

278

1.48

1.61

2.3

1.5

8.02

6.59

u/l

0.42

244

Cardiomyopathy (excluding other)

278

1.48

1.61

1.5

1.4

10.61

5.71

u/l

0.45

236

Emotional disorders and disorders of social functioning with onset specific to childhood

1.92

1.60

2.1

1.6

4.69

6.14

u/l

1.07

Other and unspecified injuries of wrist and hand

1.91

1.60

1.1

1.4

4.97

7.22

u/l

—

Basal cell carcinoma, including Hilmo

160

891

1.22

1.59

1.8

1.4

5.63

5.83

u/l

0.15

135

766

Iridocyclitis in diseases classified elsewhere

2.34

1.59

1.3

1.4

4.54

8.17

u/l

—

Type 2 diabetes, definitions combined

359

1833

1.14

1.59

1.6

1.4

6.95

5.58

u/l

1.31

304

1568

Type 2 diabetes, strict (exclude DM1)

361

1844

1.14

1.59

1.6

1.4

6.96

5.59

u/l

1.34

306

1578

Glomerulonephritis

222

1.54

1.59

1.2

1.4

5.56

7.13

u/l

0.93

194

Contraceptive management

153

877

1.22

1.58

1.5

1.4

5.91

6.67

u/l

0.36

136

765

Excessive earwax

226

1747

1.17

1.57

1.4

1.5

5.52

5.97

u/l

0.86

194

1498

Seborrhoeic keratosis

655

1.30

1.57

1.6

1.5

5.51

6.16

u/l

0.71

561

Malignant neoplasm of endocrine gland, including Hilmo

215

1.54

1.56

1.6

1.5

9.64

6.08

u/l

0.34

186

L01XX Other antineoplastic agents

114

1.76

1.56

1.3

1.6

6.10

7.65

u/l

0.43

Inguinal or femoral hernia, bilateral

223

1.53

1.56

1.7

1.5

6.58

7.11

u/l

0.11

191

Melanocytic naevi of trunk

313

1.44

1.56

1.3

1.5

5.49

6.66

u/l

0.82

279

Myocardial infarction, with ST-elevation

355

1.41

1.55

1.2

1.4

14.04

5.98

u/l

1.23

305

COPD related to multimorbidity

121

822

1.24

1.55

1.3

1.5

8.97

6.11

u/l

0.74

100

704

Optic neuritis

107

1.78

1.55

1.2

1.3

5.95

6.51

u/l

0.25

Dermatitis due to ingested food

2.20

1.54

1.1

1.7

5.15

6.80

u/l

0.56

Fracture at wrist and hand level

120

964

1.24

1.54

1.4

1.5

11.18

6.10

u/l

0.44

102

838

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

2.44

1.54

1.8

1.1

5.03

6.45

u/l

—

Poor fetal growth

314

1.44

1.54

1.4

5.17

5.13

u/l

0.04

276

Amiodarone users

208

1.54

1.53

1.7

1.6

6.91

6.78

u/l

0.04

183

Coxarthrosis, primary, with hip surgery

148

1131

1.21

1.52

1.3

1.5

5.02

6.35

u/l

2.85

130

950

Fall on and from stairs and steps

746

1.28

1.52

1.9

1.5

6.19

5.88

u/l

0.16

640

Other embolism and thrombosis

315

1.43

1.52

1.3

1.5

5.23

6.47

u/l

1.07

277

Peripheral artery operations in Hilmo

241

1.50

1.51

1.5

5.27

6.05

u/l

0.70

204

Diabetic nephropathy, excluding more controls

242

1.45

1.51

1.5

1.7

5.47

6.52

u/l

1.14

209

COPD, hospital admission 2, with asthma infections

651

1.27

1.48

1.3

1.6

9.44

6.14

u/l

0.67

554

Ischaemic Stroke, excluding all haemorrhages

181

1120

1.19

1.47

1.5

5.48

6.19

u/l

0.93

151

958

Colorectal cancer, including Hilmo

629

0.72

1.46

1.8

1.4

4.58

6.01

u/l

3.29

536

Panhypopituitarism

2.39

1.46

1.1

1.4

7.02

8.81

u/l

—

Congenital malformations of the circulatory system

358

1.39

1.44

1.6

5.00

6.62

u/l

1.38

315

Congenital malformations of spine and bony thorax, including avohilmo

3.16

1.44

3.0

1.6

4.70

5.87

u/l

—

Visual impairment including blindness (binocular or monocular)

125

1.68

1.43

1.4

5.00

7.47

u/l

0.97

104

Thyrotoxicosis

709

1.27

1.43

1.7

1.5

6.16

5.96

u/l

0.10

614

Glucosamine medication

145

958

1.21

1.42

1.3

1.6

5.45

6.08

u/l

1.01

114

814

Other disorders of veins

150

1230

1.20

1.41

1.3

1.4

6.35

5.61

u/l

0.34

135

1049

Ventral hernia

614

1.29

1.40

1.2

1.5

13.09

6.34

u/l

0.40

527

Other disorders of breast

380

1.37

1.40

1.5

4.53

5.19

u/l

1.11

329

Other hearing loss

663

1.27

1.39

1.6

1.5

5.34

6.09

u/l

0.90

555

Presence of other devices

544

1.30

1.39

1.4

1.6

5.03

6.02

u/l

1.35

460

Periapical abscess

170

1437

1.18

1.38

1.4

1.5

6.15

6.10

u/l

0.02

149

1250

Mixed and other personality disorders

222

1.49

1.38

1.3

1.4

5.46

6.18

u/l

0.46

188

Benign neoplasm: Rectum, anus and anal canal

519

1.31

1.38

1.5

1.6

7.14

6.03

u/l

0.19

442

Aortic aneurysm

466

1.33

1.38

1.2

1.4

5.31

6.02

u/l

1.15

394

Degenerative diseases of the nervous system

612

0.76

1.36

1.3

1.5

5.38

6.11

u/l

0.98

504

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

179

1.54

1.36

1.6

1.4

5.24

6.27

u/l

0.63

154

Otitis media, unspecified

235

1.45

1.36

1.9

1.5

6.43

6.74

u/l

0.08

197

Fracture of forearm

199

1532

1.17

1.35

1.5

9.47

5.67

u/l

0.58

169

1315

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

237

1.46

1.35

1.6

1.3

6.34

6.27

u/l

0.02

199

Other diseases of the digestive system

787

1.25

1.34

1.5

6.61

5.98

u/l

0.14

676

Traumatic subarachnoid haemorrhage

2.15

1.33

1.0

1.4

17.40

6.57

u/l

—

Chalazion

282

1.42

1.33

1.2

1.5

5.30

6.99

u/l

1.26

251

Open wound of forearm

224

1.48

1.33

1.2

1.3

6.57

6.10

u/l

0.16

194

Viral conjunctivitis

2.05

1.33

1.5

1.4

5.09

7.36

u/l

0.93

Leisure time condition

470

1.32

1.33

1.5

8.51

6.18

u/l

0.27

408

Diabetic retinopathy

105

524

1.24

1.33

1.4

1.5

14.26

6.68

u/l

0.60

444

Social phobias

184

1.52

1.31

1.6

1.4

13.18

6.12

u/l

0.37

152

Polycystic ovarian syndrome

129

1.63

1.30

2.0

1.4

4.49

5.19

u/l

0.31

109

Other complications of labour and delivery, not elsewhere classified

281

1.39

1.28

1.2

1.5

4.88

5.11

u/l

0.24

237

Other noninflammatory disorders of uterus, except cervix

348

1.31

1.28

1.6

1.4

5.07

6.07

u/l

1.15

291

Endometriosis diagnosis and infertility diagnosis occurring together

293

1.40

1.28

1.4

4.28

5.08

u/l

1.71

259

Benign neoplasm: Ascending colon

344

1.37

1.27

1.5

5.94

6.21

u/l

0.08

301

Retinoschisis and retinal cysts

2.06

1.27

1.4

5.40

6.59

u/l

—

Diseases of middle ear and mastoid

205

1446

1.16

1.26

1.7

1.5

5.65

6.26

u/l

0.54

174

1251

Fitting and adjustment of other devices

108

777

1.22

1.26

1.3

1.5

5.29

6.29

u/l

1.41

657

Aneurysms, operations, SAH

405

1.34

1.26

1.5

5.49

6.20

u/l

0.31

351

Osteonecrosis

154

1.56

1.25

1.6

1.5

4.47

7.05

u/l

1.48

132

Benign mammary dysplasia

363

1.35

1.24

1.5

1.6

5.19

5.93

u/l

0.68

314

Substance use, excluding alcohol

555

1.28

1.24

1.3

1.5

6.50

6.10

u/l

0.11

486

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

163

1.54

1.23

1.2

1.4

9.41

6.21

u/l

0.30

143

Thoracic aortic aneurysm

330

1.37

1.22

1.3

1.5

5.48

6.22

u/l

0.81

287

Inflammatory diseases of the central nervous system

196

1.48

1.21

1.3

7.73

7.64

u/l

0.01

168

Type 2 diabetes, definitions combined, including avohilmo

356

1844

1.12

1.21

1.6

1.4

6.96

5.58

u/l

1.33

303

1578

Fall on same level involving ice and snow

208

1809

1.15

1.20

1.5

5.40

5.84

u/l

1.03

182

1549

Colorectal adenocarcinoma

472

0.71

1.20

2.1

1.4

4.80

5.74

u/l

1.54

400

Chondropathies

409

1.32

1.19

1.4

1.5

4.76

6.31

u/l

2.08

361

Other (not insulin) diabetes medications

366

1930

1.11

1.18

1.6

1.4

6.86

5.69

u/l

1.07

310

1656

Deep endometriosis

247

1.42

1.18

1.3

1.5

4.47

5.23

u/l

0.96

212

Acne, including avohilmo

458

1.27

1.18

1.6

4.74

5.77

u/l

2.03

389

Abrasion of teeth

134

1129

1.19

1.18

1.4

1.5

9.78

5.85

u/l

0.37

113

981

Diabetic maculopathy, excluding more controls

256

1.41

1.17

1.4

1.3

5.57

6.08

u/l

0.39

219

Glaucoma suspect

119

992

1.20

1.17

1.4

1.5

5.67

6.07

u/l

0.34

846

Ethmoidectomy

350

1.35

1.17

2.0

1.5

4.70

6.58

u/l

2.35

308

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

0.00

1.16

0.0

1.3

—

9.07

—

Family history of other specific disorders

0.00

1.16

0.0

1.4

—

7.79

—

Open wound of head

184

1495

1.16

1.7

1.4

6.39

6.48

u/l

0.05

163

1276

Alcohol use disorder, Swedish definition

185

1455

1.16

1.15

1.3

1.5

11.52

6.02

u/l

0.85

161

1259

Cellulitis of external ear

0.00

1.15

0.0

1.3

—

8.95

—

Cardiodefibrillation

107

883

1.21

1.14

1.8

1.5

5.66

6.31

u/l

0.72

752

COPD, hospital admissions 3, with asthma pneumonia sepsis

526

1.26

1.14

1.4

1.5

10.70

6.03

u/l

0.79

449

Diseases of external ear

121

1014

1.19

1.14

1.4

1.5

5.18

6.15

u/l

2.35

104

882

Intestinal stricture

100

823

1.22

1.13

1.5

5.23

6.38

u/l

1.85

699

Sequelae of injuries of upper limb

258

1.40

1.13

2.3

1.5

5.43

7.26

u/l

1.30

223

Abnormal findings in secretions and smears from cervix uteri vagina vulva

183

1166

1.16

1.12

1.6

1.4

4.74

5.39

u/l

2.39

151

993

Sulfonylureas

627

0.78

1.11

1.5

8.43

5.89

u/l

0.44

524

FESS (DNB20)

336

1.34

1.11

2.1

1.5

4.78

6.64

u/l

2.18

296

Impacted teeth

423

1.28

1.10

1.7

1.6

5.00

6.04

u/l

1.42

356

GI-bleeding

781

1.22

1.09

1.5

6.64

5.99

u/l

0.14

670

Inguinal hernia

190

1097

1.15

1.09

1.4

1.5

5.86

6.44

u/l

0.61

168

947

Sequelae of tuberculosis, including avohilmo

2.39

1.09

2.4

1.0

6.54

6.87

u/l

—

Maternal care for known or suspected malpresentation of fetus

351

1.28

1.08

1.3

1.5

5.14

5.33

u/l

0.13

300

Morphin

2.20

1.08

1.9

1.2

4.61

6.82

u/l

—

Toxic effects of substances chiefly nonmedicinal as to source

278

1.37

1.07

1.3

1.4

5.51

7.12

u/l

1.19

242

Asthma and opportunity respiratory infection

1.66

1.06

1.3

1.4

5.39

5.91

u/l

0.34

Mental and behavioural disorders due to psychoactive substance use

205

1649

1.14

1.06

1.3

1.5

7.35

6.39

u/l

0.35

173

1424

Injury of eye and orbit

391

1.31

1.06

1.5

5.13

6.42

u/l

1.40

348

Impacted cerumen

253

1.39

1.06

1.3

1.5

5.55

6.85

u/l

0.87

221

Chronic hepatitis NAS

2.14

1.06

2.3

1.4

8.81

6.71

u/l

—

Benign neoplasm of brain and other parts of central nervous system

145

1.52

1.06

1.3

1.6

5.02

7.08

u/l

1.06

125

Disorders resulting from impaired renal tubular function

1.71

1.05

1.1

1.6

4.34

8.11

u/l

—

Other congenital malformations of skin

1.71

1.05

1.2

1.4

4.97

6.80

u/l

0.95

Carcinoma in situ of skin of other and unspecified parts of face

162

1.48

1.04

1.8

1.5

6.88

6.74

u/l

0.03

140

Pre-eclampsia or eclampsia

616

1.24

1.02

1.4

1.5

6.39

5.04

u/l

0.82

536

Substance abuse

198

1618

1.14

1.02

1.3

1.5

7.33

6.43

u/l

0.31

168

1397

Gestational [pregnancy-induced] hypertension

751

1.21

1.01

1.3

1.5

7.49

5.02

u/l

0.81

642

Infliximab

1.84

0.98

1.2

1.5

3.98

5.75

u/l

—

Campylobacter enteritis

1.81

0.98

1.2

1.4

7.14

7.30

u/l

0.03

Other disorders of the genitourinary system

318

1.32

0.97

1.8

1.6

5.15

5.92

u/l

0.62

269

Polycystic ovarian syndrome, broad definition

275

1.35

0.97

1.2

1.5

4.56

5.29

u/l

0.78

234

Excessive vomiting in pregnancy

224

1.39

0.96

1.2

1.5

4.43

5.30

u/l

1.29

194

Benign neoplasm: Rectum

451

1.27

0.96

1.5

1.6

7.62

5.65

u/l

0.33

384

Retinal vascular disorders

250

1.36

0.95

1.6

1.5

11.22

7.27

u/l

0.28

209

Mental disorders, not otherwise specified

216

1.39

0.95

1.2

1.4

4.95

6.09

u/l

0.98

184

Nonsuppurative otitis media

508

1.23

0.94

1.6

5.48

6.23

u/l

0.44

434

Alzheimer’s disease, strict definition

414

0.76

0.94

1.3

1.5

5.18

6.08

u/l

0.98

337

Right bundle-branch block

1.72

0.92

2.7

1.5

4.86

5.56

u/l

0.41

Malignant melanoma of skin, including Hilmo

357

1.29

0.91

1.9

1.4

6.22

6.15

u/l

0.02

309

Squamous cell neoplasms and carcinomas of the skin

184

1.41

0.91

1.7

1.3

6.44

6.33

u/l

0.03

152

Peripheral arterial reconstruction

296

1.32

0.90

2.1

1.4

5.56

6.07

u/l

0.47

252

Glucagon-like peptide-1 (GLP-1) analogues

113

966

1.17

0.90

1.6

1.4

6.87

5.67

u/l

0.51

103

846

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

113

966

1.17

0.90

1.6

1.4

6.87

5.67

u/l

0.51

103

846

Dementia

748

0.84

0.90

1.4

1.5

5.13

6.54

u/l

2.37

618

Infections with a predominantly sexual mode of transmission

108

918

1.17

0.90

1.3

1.5

6.72

5.72

u/l

0.31

798

Bacterial, viral and other infectious agents, including avohilmo

236

1.36

0.89

1.3

1.4

4.91

6.50

u/l

1.70

207

Calculus of lower urinary tract

102

0.49

0.89

1.6

6.08

7.63

u/l

—

Maternal care for known or suspected fetal abnormality and damage

348

1.27

0.88

1.2

1.5

5.34

5.36

u/l

0.02

298

192

1523

1.13

0.88

1.2

1.5

11.34

6.03

u/l

0.86

168

1317

Pregnancy examination and test

248

1.28

0.87

1.3

1.6

4.35

5.15

u/l

1.79

212

Helminthiases, including avohilmo

1.61

0.87

1.3

4.91

6.70

u/l

—

In situ neoplasms

128

1109

1.16

0.87

1.4

1.5

5.15

5.95

u/l

1.28

108

942

Leiomyoma of uterus

227

1140

1.12

0.86

1.3

1.5

5.78

5.19

u/l

0.64

195

964

Combinations of oral blood glucose lowering drugs

792

0.82

0.86

1.4

1.5

8.73

5.92

u/l

0.64

687

Benign leiomyoma with endometriosis

423

1.25

0.85

1.2

1.6

4.86

5.94

u/l

1.57

362

Meningitis

120

1.50

0.85

1.2

1.5

8.55

6.38

u/l

0.26

Other disorders of cornea

247

1.34

0.85

1.1

1.6

5.64

6.79

u/l

0.73

212

Ulcerative rectosigmoiditis

204

1.38

0.85

1.9

1.4

5.92

6.95

u/l

0.46

178

Calculus of kidney and ureter

806

1.18

0.84

1.5

5.51

6.12

u/l

0.76

697

Postpartum hemorraghe, parous women as controls

643

0.82

0.84

1.3

1.4

4.50

5.29

u/l

1.61

553

Insulin, fast-acting (human)

362

1.27

0.83

1.3

1.4

5.46

6.06

u/l

0.55

315

Any dementia

652

0.84

0.82

1.5

5.12

6.29

u/l

2.17

534

Malignant neoplasm of ovary

115

0.52

0.82

2.0

1.4

4.85

5.91

u/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

209

1455

1.12

0.82

1.6

1.4

4.76

5.72

u/l

4.23

175

1240

Perineal laceration during delivery

396

0.77

0.82

1.2

1.6

5.09

5.16

u/l

0.06

340

Retinal vascular occlusion

249

1.33

0.81

1.6

1.5

11.22

7.29

u/l

0.28

208

conjunctival degenerations and deposits

1.71

0.81

1.6

1.3

6.39

6.29

u/l

—

Postpartum haemorrhage

631

0.82

0.80

1.3

1.4

4.50

5.12

u/l

1.20

545

Malignant melanoma, including Hilmo

436

1.24

0.80

1.8

1.4

10.40

5.88

u/l

0.60

373

Duodenal ulcer

212

0.66

0.79

1.2

1.5

8.04

6.22

u/l

—

181

Dementia due to Parkinson's disease

1.82

0.79

1.0

1.6

4.45

5.55

u/l

—

Long labour

609

0.82

0.79

1.4

1.5

5.51

5.12

u/l

0.39

522

Inguinal hernia, unilateral

1.67

0.79

1.6

1.3

5.00

10.10

u/l

—

Femoral hernia, unilateral

1.67

0.79

1.6

1.3

5.00

10.10

u/l

—

Inguinal of femoral hernia, unilateral

1.67

0.79

1.6

1.3

5.00

10.10

u/l

—

Emotional disorders starting during childhood or adolescence

1.56

0.78

2.2

1.5

4.71

5.97

u/l

—

Dislocation, sprain and strain of joints and ligaments of thorax

1.59

0.78

1.8

1.6

5.24

6.84

u/l

0.84

201

1573

1.11

0.77

1.3

1.5

11.04

5.98

u/l

0.85

176

1359

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.76

0.0

1.3

—

9.42

—

Prolapse and hernia of ovary and fallopian tube

1.72

0.75

1.4

5.40

6.64

u/l

—

Uterine polyps

420

1.18

0.75

1.3

1.4

4.83

5.84

u/l

1.46

351

Unspecified lump in breast

422

1.23

0.75

1.2

1.5

5.27

5.81

u/l

0.53

363

Malignant neoplasm of colon, including Hilmo

435

0.78

0.74

1.9

1.4

4.79

5.78

u/l

1.68

370

Pilonidal cyst

227

1.32

0.74

2.1

1.4

6.00

7.14

u/l

0.57

197

COPD, early/later onset

135

1000

1.13

0.72

1.3

1.5

8.58

6.22

u/l

0.67

113

851

Dysplasia of cervi uteri

412

1.20

0.72

1.4

1.5

4.44

5.79

u/l

2.27

347

Contact with and exposure to communicable diseases

101

872

1.15

0.71

1.5

11.11

5.78

u/l

0.37

761

Other benign neoplasms of skin

120

1054

1.14

0.71

1.6

1.5

5.55

6.07

u/l

0.60

102

905

Myopia

353

1.25

0.71

1.8

1.5

4.51

6.58

u/l

2.64

308

Dilated cardiomyopathy

273

1.28

0.71

1.6

1.4

11.56

6.84

u/l

0.36

236

Salpingitis and oophoritis

462

1.21

0.70

1.3

1.5

4.93

5.75

u/l

1.14

393

Urolithiasis

859

1.15

0.70

1.5

1.4

5.54

6.10

u/l

0.72

742

Scar conditions and fibrosis of skin

101

1.49

0.70

1.3

1.4

5.26

6.38

u/l

0.67

Corneal degeneration

1.71

0.70

1.0

1.3

5.31

6.19

u/l

—

COPD, hospital admissions

133

991

1.13

0.70

1.3

1.5

8.68

6.23

u/l

0.68

111

842

Malignant neoplasm of urinary organs, including Hilmo

256

1.29

0.70

1.4

6.12

6.29

u/l

0.09

219

Superficial injury of hip and thigh

346

1.24

0.68

1.9

1.5

5.40

6.66

u/l

0.90

303

Infectious mononucleosis

213

1.32

0.68

1.5

1.4

5.71

6.12

u/l

0.16

179

Infectious mononucleosis, including avohilmo

213

1.32

0.68

1.5

1.4

5.71

6.12

u/l

0.16

179

Ectopic pregnancy

501

1.20

0.68

1.3

1.5

4.49

5.57

u/l

1.95

431

Benign neoplasm: Skin of eyelid, including canthus

401

1.22

0.67

1.3

1.6

5.31

6.18

u/l

0.68

346

Otitis externa

658

1.17

0.67

1.4

1.5

4.91

5.94

u/l

2.11

569

Use of biperiden

121

0.58

0.67

1.0

1.5

6.29

8.39

u/l

—

102

Human immunodeficiency virus [HIV] disease resulting in other conditions

1.63

0.67

1.0

1.6

5.13

8.34

u/l

—

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

1.63

0.67

1.0

1.6

5.13

8.34

u/l

—

Hydronephrosis

258

1.28

0.66

1.5

4.74

6.02

u/l

1.85

218

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

214

1.31

0.66

1.3

1.4

5.78

6.43

u/l

0.47

185

Other keratitis

285

1.26

0.66

1.1

1.5

4.94

6.81

u/l

1.66

249

Colon adenocarcinoma, helper endpoint

283

0.74

0.66

2.3

1.5

5.24

6.42

u/l

0.90

244

Unspecified urinary incontinence

206

1.31

0.65

1.1

1.4

4.26

6.66

u/l

1.79

175

Erythema intertrigo

1.59

0.65

1.1

1.5

4.27

6.51

u/l

—

Obstructed labour due to malposition and malpresentation of fetus

639

0.84

0.65

1.6

1.5

6.31

5.12

u/l

0.47

550

Schizophrenia or delusion, excluding more controls

708

1.16

0.64

1.3

1.5

8.82

6.70

u/l

0.41

612

Vertigo of central origin

1.73

0.64

1.0

1.2

4.54

7.24

u/l

—

Malignant neoplasm of stomach, including Hilmo

104

1.44

0.62

1.3

1.6

4.61

6.91

u/l

—

Diabetic maculopathy

263

1.26

0.62

1.5

1.7

5.64

7.50

u/l

1.31

227

Benign lipomatous neoplasm of other sites/unspecified

199

1.31

0.62

1.7

1.5

5.61

6.86

u/l

0.69

173

Postpartum hemorraghe, all women as controls

722

0.85

0.62

1.3

1.4

4.50

5.25

u/l

1.56

621

Other, unspecified and serous retinal detachments

1.59

0.62

3.6

1.3

5.64

6.96

u/l

—

Diabetic nephropathy

347

1.22

0.61

1.5

1.6

5.47

7.81

u/l

1.84

298

Hydrocele

217

1.29

0.61

1.1

1.3

34.11

6.04

u/l

0.55

184

Car occupant injured in other and unspecified transport accidents

517

1.18

0.60

1.5

5.21

6.20

u/l

1.14

455

Hypermetropia

156

1.35

0.60

1.3

1.5

5.16

7.22

u/l

1.12

137

Other fall from one level to another

601

1.16

0.59

1.4

1.5

7.81

6.03

u/l

0.26

525

Cholecystitis

299

1.24

0.59

1.3

1.6

5.88

6.75

u/l

0.47

255

Glaucoma, exfoliation

192

1.30

0.59

1.3

1.5

4.52

6.88

u/l

1.56

159

Other and unspecified injuries of head

166

1.33

0.58

1.5

1.3

5.38

7.70

u/l

1.21

144

Alzheimer’s disease (Late onset)

365

0.81

0.58

1.3

1.4

5.33

6.27

u/l

0.90

294

COPD, hospital admissions 1, only main diagnosis

702

1.14

0.58

1.4

1.5

9.72

6.10

u/l

0.76

595

Polyp of the female genital tract

429

1.15

0.58

1.5

1.4

5.19

5.91

u/l

0.65

359

Hypertrophic cardiomyopathy

1.46

0.58

1.5

6.70

7.65

u/l

—

Antenatal screening

351

1.16

0.58

1.5

1.6

6.28

5.19

u/l

0.67

304

Asymmetry of jaw

1.72

0.58

1.2

1.4

4.22

7.57

u/l

—

Malignant melanoma

382

1.21

0.57

1.8

1.4

10.08

6.06

u/l

0.42

327

Supervision of normal pregnancy

337

1.17

0.57

1.3

1.6

4.68

5.18

u/l

0.96

291

Schizophrenia, schizotypal and delusional disorders

926

0.87

0.57

1.3

1.5

8.99

5.72

u/l

0.79

805

Other disorders of optic disc

1.67

0.57

1.2

1.3

4.13

8.44

u/l

—

Pre-eclampsia

577

1.16

0.56

1.4

1.5

6.45

5.05

u/l

0.72

501

Infections of breast associated with childbirth

0.58

0.56

1.0

1.3

5.06

5.82

u/l

—

Intentional self-harm by sharp object

1.46

0.56

1.4

1.3

4.36

7.70

u/l

—

Other and unspecified nonorganic psychotic disorders

549

0.84

0.56

1.3

1.6

11.59

5.68

u/l

0.91

481

Malignant neoplasm of testis, including Hilmo

1.63

0.55

1.0

1.4

5.60

6.82

u/l

—

Burns and corrosions of external body surface, specified by site

274

0.77

0.55

1.7

1.5

4.79

6.98

u/l

1.81

240

All dysplastic lesions of the vulva

116

1.38

0.54

1.5

5.13

5.67

u/l

—

105

Injuries involving multiple body regions

1.47

0.54

2.1

1.4

6.24

6.74

u/l

0.15

Assault

367

1.20

0.54

1.4

1.5

8.09

6.37

u/l

0.34

322

severe traumatic brain injury, does not include concussion

524

1.16

0.53

1.6

1.5

11.33

6.47

u/l

0.58

445

Post-traumatic wound infection, not elsewhere classified

1.48

0.53

1.8

1.4

4.81

7.47

u/l

—

Bacterial, viral and other infectious agents

222

1.26

0.53

1.3

1.4

4.87

6.56

u/l

1.75

194

Degenerative macular diseases

249

1.25

0.53

1.4

1.5

6.03

7.24

u/l

0.53

211

Amputation of ankle bones

1.54

0.53

1.2

1.3

4.25

6.87

u/l

—

Calcific aortic valvular stenosis, including rheumatic fever

621

1.15

0.53

1.8

1.5

6.17

6.21

u/l

0.02

515

Aortic valve malfunction, age under 60 years

250

1.24

0.52

1.1

1.6

5.54

6.98

u/l

0.96

217

Smoking dependency

223

1.26

0.52

1.3

1.6

6.06

7.17

u/l

0.60

196

241

1.25

0.52

1.2

1.4

4.52

5.28

u/l

0.95

210

Malignant neoplasm of stomach

1.41

0.50

1.2

1.6

4.72

7.15

u/l

—

Malignant neoplasm of colon

346

0.81

0.49

2.0

1.4

4.99

6.01

u/l

1.50

294

Other chronic obstructive pulmonary disease, including avohilmo

164

1236

1.09

0.49

1.3

1.5

8.48

5.95

u/l

0.94

138

1066

Mental and behavioural disorders due to alcohol

163

1426

1.09

0.49

1.2

1.5

7.89

6.59

u/l

0.39

140

1232

Left ventricular outflow tract obstruction (LVOTO), broad definition

271

1.22

0.48

1.2

1.6

5.63

6.82

u/l

0.80

235

Human immunodeficiency virus [HIV] disease

1.53

0.48

1.0

1.6

5.13

8.16

u/l

—

Calcific aortic valvular stenosis, diagnosis (helper)

618

1.14

0.48

1.8

1.5

6.16

6.12

u/l

0.02

512

Operations 2 for CAVS

618

1.14

0.48

1.8

1.5

6.16

6.12

u/l

0.02

512

Mental and behavioural disorders due to tobacco

226

1.24

0.48

1.3

1.6

6.06

7.14

u/l

0.58

198

Other and unspecified vascular occlusions

190

1.26

0.47

1.6

1.4

13.32

7.45

u/l

0.31

159

Human immunodeficiency virus [HIV] disease, including avohilmo

1.49

0.47

1.0

1.6

5.13

8.08

u/l

—

Other congenital malformations

217

1.24

0.47

1.3

1.6

4.54

6.21

u/l

1.66

190

Calcific aortic valvular stenosis, operated

619

1.14

0.47

1.8

1.5

6.16

6.11

u/l

0.02

513

Calcific aortic valvular stenosis

619

1.14

0.47

1.8

1.5

6.16

6.11

u/l

0.02

513

Nontraumatic intracranial haemmorrhage

438

1.16

0.47

1.5

10.24

6.38

u/l

0.40

371

Pregnancy, childbirth and the puerperium

399

0.88

0.46

1.4

1.6

6.13

5.13

u/l

0.53

326

Otitis externa, unspecified

301

1.20

0.45

1.2

1.6

4.97

6.82

u/l

1.82

262

Malignant neoplasm of other connective and soft tissue

1.40

0.45

1.0

1.2

4.69

6.49

u/l

—

Biguanides

340

1941

1.06

0.44

1.6

1.4

6.95

6.00

u/l

0.63

287

1664

Dementia, including avohilmo

108

812

0.91

0.44

1.4

1.5

5.24

6.63

u/l

2.52

670

Diabetes mellitus in pregnancy

630

0.90

0.44

1.3

1.4

5.04

5.14

u/l

0.11

529

Schizophrenia or delusion

925

0.90

0.43

1.3

1.5

8.82

5.73

u/l

0.76

804

Acquired absence of organs, not elsewhere classified

1.62

0.43

1.0

1.3

4.24

7.01

u/l

—

Superficial injuries involving multiple body regions

1.43

0.42

2.6

1.3

6.63

7.66

u/l

—

Fall on and from ladder

167

1.26

0.41

2.2

1.5

5.62

7.73

u/l

0.74

145

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

369

1.17

0.41

1.4

1.5

27.57

6.36

u/l

0.75

324

Congenital aortic valve stenosis

0.00

0.41

0.0

1.5

—

11.71

—

Drug-induced hypoglycaemia without coma

1.52

0.41

1.0

1.3

5.08

9.01

u/l

—

Moderate mental retardation

0.00

0.41

0.0

1.4

—

11.56

—

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

0.00

0.41

0.0

1.4

—

8.71

—

Status post-ami

403

0.86

0.41

1.2

1.5

12.57

5.96

u/l

0.70

334

Any event in cancer register

329

1821

1.05

0.41

1.4

6.13

6.17

u/l

0.02

284

1569

Malignant neoplasm of urinary organs

204

1.23

0.40

1.2

1.4

5.43

6.49

u/l

0.93

176

Malignant neoplasm of bone and articular cartilage, including Hilmo

1.47

0.40

1.0

1.3

4.40

6.72

u/l

—

Mumps

1.34

0.40

1.5

1.4

5.18

6.06

u/l

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

139

1273

1.08

0.40

1.2

1.5

8.34

6.62

u/l

0.46

118

1106

Vitiligo

1.43

0.39

1.0

1.3

6.46

7.11

u/l

—

Malignant neoplasm of testis

1.43

0.39

1.0

1.4

5.72

6.99

u/l

—

Charcot foot

1.43

0.39

1.2

1.9

6.04

6.47

u/l

—

Single delivery by forceps and vacuum extractor

252

0.85

0.38

1.3

1.6

5.25

5.51

u/l

0.23

210

Drug-induced neutropenia

169

1.24

0.38

2.1

1.5

7.39

6.46

u/l

0.18

148

Single delivery by caesarean section

308

0.87

0.38

1.4

1.5

5.43

5.62

u/l

0.10

261

Donors of organs and tissues

1.39

0.38

2.2

1.4

4.70

8.85

u/l

—

Embolic stroke with flimmer

1.39

0.38

1.4

1.6

8.80

6.21

u/l

—

Single spontaneous delivery

105

607

0.91

0.38

1.6

1.5

5.68

5.54

u/l

0.07

509

Colon adenocarcinoma

258

0.81

0.38

2.3

1.4

5.24

6.29

u/l

1.08

219

Scabies

107

1.31

0.37

3.0

1.3

11.25

7.35

u/l

0.30

Malignant melanoma of skin

290

1.17

0.36

2.0

1.5

5.04

6.32

u/l

1.23

253

Certain conditions originating in the perinatal period

159

1.23

0.36

1.7

1.6

4.81

5.86

u/l

0.94

137

Retained placenta and membranes, without haemorrhage

343

0.84

0.36

1.4

1.5

4.21

5.64

u/l

2.23

299

Other disorders of amniotic fluid and membranes

343

1.15

0.36

1.2

1.5

4.33

5.31

u/l

1.91

295

Alcohol use disorder, ICD-based

129

1195

1.08

0.36

1.2

1.5

8.48

6.66

u/l

0.46

110

1041

Oral lichen planus

1.27

0.36

1.1

1.4

5.54

5.93

u/l

—

Disorders of eyelid in diseases classified elsewhere

1.27

0.36

1.4

1.3

5.01

6.92

u/l

—

Retinal breaks without detachment

431

1.14

0.36

1.4

1.5

4.98

6.21

u/l

1.67

373

Congenital malformations of heart and great arteries

309

1.16

0.36

1.9

1.6

5.41

6.60

u/l

0.72

271

Cyst of Bartholin Gland

1.34

0.35

1.5

1.3

4.43

5.93

u/l

0.97

Unspecified nephritic syndrome

1.43

0.35

1.0

1.3

5.93

6.74

u/l

—

Gestational diabetes (for exclusion)

105

785

0.92

0.35

1.4

4.88

5.25

u/l

0.60

667

Wet age-related macular degeneration

317

1.16

0.34

1.7

1.4

7.24

6.28

u/l

0.23

259

Unspecified mental disorder

127

1179

1.08

0.34

1.2

1.5

5.22

6.51

u/l

1.38

103

1029

Melanocytic naevi of other and unspecified parts of face

145

1.24

0.33

1.2

1.4

4.69

6.12

u/l

1.35

124

LSIL lesion of the cervix uteri

318

0.85

0.33

1.3

1.4

4.69

5.06

u/l

0.28

280

Primary open-angle glaucoma

720

1.10

0.33

1.7

1.5

5.85

6.16

u/l

0.17

606

Malignant neoplasm of prostate

414

0.90

0.32

1.7

1.3

8.11

6.23

u/l

0.34

364

Hyperprolactinaemia

1.33

0.32

1.4

1.3

5.75

6.72

u/l

0.37

Burns and corrosions

359

0.86

0.31

1.6

1.5

4.63

6.59

u/l

2.31

318

Fracture of femur

547

1.10

0.31

1.9

1.5

5.29

6.30

u/l

1.24

456

Benign neoplasm: Skin of scalp and neck

1.35

0.31

1.9

1.3

6.30

7.79

u/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.32

0.31

1.6

1.3

5.59

7.67

u/l

—

Maternal care for other known or suspected fetal problems

405

1.10

0.30

1.4

1.5

5.35

5.31

u/l

0.03

340

Medical abortion

210

1079

1.05

0.29

1.3

1.5

5.47

5.32

u/l

0.16

180

905

Unspecified event, undetermined intent

1.23

0.29

1.0

1.3

5.19

7.62

u/l

—

Pediculosis, acariasis and other infestations

139

1.22

0.29

2.8

1.5

11.22

6.86

u/l

0.45

118

Malignant neoplasm of kidney, except renal pelvis

195

1.18

0.28

1.3

1.4

5.31

6.35

u/l

0.92

167

Scissor bite

1.28

0.28

1.4

1.5

4.46

6.50

u/l

—

Mumps, including avohilmo

1.27

0.27

1.5

1.4

5.17

6.06

u/l

—

Diabetic retinopathy, strict definition

349

1.12

0.27

1.3

1.6

21.59

7.17

u/l

0.43

302

Endocarditis

1.23

0.27

1.4

1.5

6.92

6.47

u/l

—

Corneal ulcer

519

1.10

0.26

1.6

1.5

4.82

6.20

u/l

2.35

452

Benign neoplasm: Tongue

1.20

0.26

1.4

4.46

5.99

u/l

—

Labour and delivery complicated by fetal stress [distress]

449

1.09

0.26

1.2

1.5

5.12

5.15

u/l

0.03

385

Entropion and trichiasis of eyelid

150

1.20

0.26

1.1

1.5

5.10

6.79

u/l

0.75

128

Anisometropia and aniseikonia

0.67

0.26

1.4

4.06

6.73

u/l

—

Acute appendicitis, with complications

511

1.10

0.25

1.3

1.5

5.12

6.05

u/l

1.07

450

Delivery, wide proxy

480

0.93

0.25

1.3

1.6

6.54

5.09

u/l

0.77

394

Bronchitis, not specified as acute or chronic

179

1.17

0.25

1.2

1.4

5.53

6.90

u/l

1.05

154

Psoriasis (vulgaris), strict definition

1.27

0.24

1.4

1.6

4.99

7.06

u/l

1.31

Maternal care for known or suspected abnormality of pelvic organs

475

1.08

0.24

1.3

1.5

5.12

5.37

u/l

0.26

407

Serous carcinoma of ovary, including Hilmo

0.73

0.24

1.8

1.3

4.30

5.25

u/l

—

Perforation of tympanic membrane

237

1.14

0.23

1.7

1.5

4.89

7.03

u/l

1.50

207

Graves disease, strict definition

294

1.12

0.23

1.6

1.5

4.83

5.51

u/l

1.03

259

Non-small cell lung cancer, adenocarcinoma, helper endpoint

134

1.20

0.23

1.1

1.4

21.22

5.90

u/l

0.62

117

Non-small cell lung cancer, adenocarcinoma

134

1.20

0.23

1.1

1.4

21.22

5.94

u/l

0.62

117

Use of glatiramer acetate

1.25

0.22

1.2

1.5

7.18

6.76

u/l

—

Melanocytic naevi, other sites/unspecified

210

1.14

0.21

1.1

1.5

4.96

6.94

u/l

1.22

183

Crushing injury of lower leg

0.00

0.21

0.0

1.4

—

5.87

—

Lichenoid drug reaction

0.00

0.21

0.0

1.2

—

8.05

—

Sickle-cell disorders

0.00

0.21

0.0

1.6

—

9.02

—

Shigellosis

0.00

0.21

0.0

1.8

—

4.92

—

Hypospadias

0.00

0.21

0.0

1.0

—

10.63

—

Atrioventricular septal defect

0.00

0.21

0.0

1.8

—

8.58

—

Apocrine sweat disorders, other sweat gland disorders

0.00

0.21

0.0

1.5

—

9.49

—

Open wounds involving multiple body regions

0.00

0.21

0.0

1.2

—

8.85

—

Pneumonia due to Haemophilus influenzae

0.00

0.21

0.0

1.5

—

4.30

—

Medical treatment for female infertility

611

0.92

0.21

1.5

1.4

5.57

5.09

u/l

0.35

521

Supernumerary teeth EXCLUDE clefts and syndromes

0.00

0.21

0.0

1.4

—

6.24

—

Vitamin A deficiency

0.00

0.21

0.0

1.7

—

9.16

—

Mucinous and mucinous cystic tumor

0.00

0.21

0.0

1.5

—

4.75

—

Cleft hard palate NOS

0.00

0.21

0.0

1.5

—

10.12

—

Paget disease

0.00

0.21

0.0

1.1

—

8.83

—

Sequelae of transport accidents

0.00

0.21

0.0

1.1

—

8.87

—

Pectus excavatum

0.00

0.21

0.0

1.5

—

10.94

—

Neurofibromatosis, type 1

0.00

0.21

0.0

1.8

—

8.65

—

Isolated growth hormone deficiency

0.00

0.21

0.0

2.1

—

5.99

—

Foreign object accidentally left in body during surgical and medical care

0.00

0.21

0.0

1.8

—

4.48

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

0.21

0.0

1.5

—

5.46

—

Later onset COPD

487

0.92

0.21

1.2

1.5

12.79

6.19

u/l

0.75

407

Slow fetal growth and fetal malnutrition

0.00

0.21

0.0

1.9

—

5.44

—

Other and specified injuries of hip and thigh

1.16

0.21

2.0

1.3

3.42

6.77

u/l

—

Perforation of oesophagus

0.00

0.21

0.0

1.2

—

9.89

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

0.00

0.21

0.0

1.5

—

9.41

—

Malignant neoplasm, including Hilmo

304

1713

1.03

0.21

1.5

1.4

6.08

6.14

u/l

0.03

264

1481

All dysplastic lesions of the cervix uteri

758

0.93

0.20

1.4

4.37

5.23

u/l

2.54

660

Alcohol dependence

721

1.07

0.20

1.2

1.5

10.15

6.09

u/l

0.75

640

Hereditary corneal dystrophies

1.25

0.20

1.0

1.3

6.52

5.88

u/l

—

Brain astrocytoma, helper endpoint

0.00

0.20

0.0

1.6

—

8.14

—

Rheumatic fever with heart involvement

0.00

0.20

0.0

1.3

—

8.21

—

Accidental poisoning by and exposure to other gases and vapours

0.00

0.20

0.0

1.5

—

8.73

—

Pectus excavatum, including avohilmo

0.00

0.20

0.0

1.4

—

9.43

—

Unequal limb length (acquired)

0.00

0.20

0.0

1.0

—

8.39

—

Premature rupture of membranes

423

0.92

0.20

1.2

1.5

4.56

5.36

u/l

1.84

365

Exposure to smoke, fire and flames

1.23

0.20

1.0

1.4

5.70

6.60

u/l

—

Other arterial embolism and thrombosis

1.20

0.19

1.5

1.2

5.75

6.36

u/l

—

Malignant neoplasm, wide definition

304

1716

1.03

0.19

1.5

1.4

6.07

6.13

u/l

0.03

265

1483

Pterygium

1.13

0.18

3.3

1.7

5.35

8.88

u/l

—

malignant neoplasm of male genital organs

437

0.94

0.18

1.6

1.3

7.91

6.21

u/l

0.34

384

Fracture of neck

132

0.83

0.18

1.5

5.55

7.88

u/l

0.75

112

All dysplastic lesions of the cervix uteri, vagina or vulva

860

1.05

0.18

1.5

1.4

4.66

5.20

u/l

1.29

740

Secondary uncertain malignant neoplasm

300

1.10

0.17

1.2

1.4

12.61

6.34

u/l

0.67

262

Abscess of anal and rectal regions

195

0.87

0.17

1.1

1.4

4.62

7.54

u/l

2.19

173

Extreme obesity with alveolar hypoventilation

1.21

0.17

1.4

1.3

17.69

6.57

u/l

0.43

Carcinoma in situ, bladder

1.13

0.17

1.3

1.5

6.03

9.35

u/l

—

Delivery

110

608

0.95

0.17

1.3

1.5

5.73

5.54

u/l

0.11

510

Carcinoma in situ of other and unspecified sites

1.11

0.17

1.3

1.5

6.03

9.35

u/l

—

Other abnormal products of conception

655

0.95

0.16

1.4

1.5

4.98

5.23

u/l

0.35

566

Non-small cell lung cancer, including Hilmo

328

1.09

0.16

1.1

1.4

10.98

6.15

u/l

0.56

273

Simple and mucopurulent chronic bronchitis

1.14

0.16

2.5

1.5

5.09

6.15

u/l

—

Pregnancy with abortive outcome

215

1085

1.03

0.15

1.4

1.5

5.39

5.31

u/l

0.08

189

911

Follicular lymphoma, hilmo

1.21

0.15

1.2

1.4

4.86

7.69

u/l

—

Malignant neoplasm of mesothelium and soft tissue

1.15

0.15

1.0

1.3

5.30

6.53

u/l

—

Traumatic amputation of wrist and hand

1.15

0.15

1.4

5.02

8.35

u/l

—

Myocardial infarction, unclassifiable

376

0.93

0.15

2.0

1.5

6.65

6.47

u/l

0.10

312

Focal epilepsy

565

1.06

0.15

1.5

10.80

6.11

u/l

0.66

492

Other symptoms and signs involving general sensations and perceptions

1.11

0.15

2.1

1.4

5.52

7.10

u/l

—

Unspecified jaundice

1.08

0.14

1.2

1.4

6.66

8.49

u/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

498

1.06

0.14

1.4

1.5

4.48

5.66

u/l

2.77

437

Fracture of shoulder and upper arm

105

1006

1.04

0.14

1.8

1.5

4.93

6.13

u/l

2.75

857

Valvular operations

285

1.09

0.14

1.2

1.4

6.54

5.68

u/l

0.72

241

Malignant neoplasm of other connective and soft tissue, including Hilmo

1.19

0.14

1.0

1.3

4.62

6.03

u/l

—

Congenital malformations of genital organs

262

0.91

0.13

2.2

1.5

4.69

5.88

u/l

1.18

233

Ulcerative ileocolitis

0.82

0.13

1.1

1.5

5.18

6.47

u/l

—

Solid cancers

275

1650

0.98

0.13

1.5

1.4

6.05

6.10

u/l

0.03

236

1428

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

588

1.05

0.13

1.3

1.5

4.55

5.78

u/l

3.12

512

Any death

189

1359

0.97

0.13

1.6

1.5

9.22

5.82

u/l

1.61

159

1175

Unspecified abortion

159

0.88

0.13

1.1

1.6

4.44

5.57

u/l

1.13

142

Malignant neoplasm of breast, HER-negative

500

1.06

0.12

1.3

1.4

4.52

5.51

u/l

1.77

427

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

104

1.16

0.12

1.2

1.5

5.58

5.27

u/l

0.23

Coronary artery bypass grafting

386

1.06

0.12

1.4

10.78

5.98

u/l

0.69

318

Other diseases of biliary tract

181

1.11

0.12

1.3

1.6

4.45

7.70

u/l

2.31

154

Focal epilepsy, mode (most common among epilepsy diagnosis)

493

1.05

0.11

1.3

1.5

10.91

6.12

u/l

0.57

428

Malignant neoplasm

293

1682

1.02

0.11

1.5

1.4

6.12

6.15

u/l

0.01

250

1453

Malignant neoplasm

292

1677

1.02

0.10

1.5

1.4

6.12

6.15

u/l

0.02

249

1448

Benign neoplasm of major salivary glands

231

1.08

0.10

1.9

1.6

5.49

6.95

u/l

0.95

204

Focal epilepsy, strict definition

515

1.05

0.10

1.3

1.6

10.92

6.15

u/l

0.58

447

Dislocation, sprain and strain of joints and ligaments of elbow

154

1.10

0.10

1.4

5.56

6.80

u/l

0.64

132

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.14

0.10

1.0

1.4

5.36

6.21

u/l

—

Malignant neoplasm, without specification of site

1.09

0.09

1.4

1.2

5.76

6.39

u/l

—

Any dementia, excluding more controls

548

0.96

0.09

1.5

5.12

6.08

u/l

1.87

448

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

145

1.10

0.09

1.0

1.5

5.42

6.58

u/l

0.75

127

Maternal care for other conditions predominantly related to pregnancy

590

1.04

0.09

1.3

1.5

5.58

5.27

u/l

0.21

508

Other sexually transmitted chlamydial diseases, including avohilmo

243

1.07

0.08

1.5

1.4

4.21

6.13

u/l

2.25

206

Colectomy operation

410

1.05

0.08

1.7

1.5

22.35

6.30

u/l

0.46

349

Non-small cell lung cancer, squamous, helper endpoint

0.84

0.07

1.0

1.4

5.63

8.38

u/l

—

Bacterial meningitis

1.08

0.07

1.3

1.7

10.72

7.09

u/l

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

486

0.96

0.07

1.2

1.4

9.21

6.03

u/l

0.55

414

Disorder of external ear, unspecified

1.05

0.07

1.4

1.6

4.81

6.22

u/l

—

Crowding of teeth, including avohilmo

170

1.07

0.07

1.1

1.7

4.39

6.46

u/l

2.24

150

Alzheimer’s disease (Atypical or mixed), excluding more controls

0.83

0.07

1.9

1.5

5.54

6.33

u/l

—

Car occupant injured in noncollision transport accident

0.85

0.07

1.0

1.4

5.60

6.93

u/l

—

Benign neoplasm of breast

315

0.95

0.06

1.6

4.24

5.17

u/l

2.01

273

Acute alcohol intoxication

671

1.03

0.06

1.1

1.5

7.49

5.99

u/l

0.51

592

HSIL lesion of the cervix uteri, vagina or vulva

582

1.03

0.06

1.4

4.40

5.09

u/l

1.81

514

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

131

0.92

0.05

1.8

1.6

5.07

5.49

u/l

0.27

117

HSIL lesion of the cervix uteri

535

0.97

0.05

1.5

1.4

4.35

5.14

u/l

1.96

473

Complications of labour and delivery

197

1107

0.99

0.04

1.4

1.5

5.30

5.32

u/l

0.02

173

934

Malignant neoplasm of bronchus and lung

357

1.03

0.04

1.1

1.4

10.43

6.10

u/l

0.57

296

Acute alcohol intoxication, ICD10

537

1.02

0.04

1.2

1.5

8.12

6.02

u/l

0.58

476

Acute and transient psychotic disorders

321

0.97

0.03

1.6

1.5

5.64

5.79

u/l

0.10

279

Malignant neoplasm of respiratory system and intrathoracic organs

413

1.02

0.03

1.2

1.4

9.67

5.98

u/l

0.58

347

Spontaneous abortion

148

980

1.01

0.03

1.3

1.5

5.01

5.35

u/l

0.62

131

829

Malignant neoplasm of prostate, including Hilmo

420

0.98

0.02

1.6

1.3

7.91

6.20

u/l

0.34

370

Other blood glucose lowering drugs, excl. Insulins

379

0.98

0.02

1.3

1.5

13.23

5.68

u/l

0.77

324

Varicose veins

184

1380

1.01

0.01

1.7

1.4

5.85

5.74

u/l

0.05

162

1160

Malignant neoplasm of bronchus and lung, including Hilmo

410

1.02

0.01

1.1

1.4

9.91

5.97

u/l

0.60

346

Kela-code for severe mental illness

104

1049

0.99

0.01

1.2

1.5

5.28

5.99

u/l

1.30

919

LSIL lesion of the cervix uteri, vagina or vulva

407

0.98

0.01

1.7

1.4

5.16

5.05

u/l

0.07

360

Non-small cell lung cancer

221

1.03

0.01

1.0

1.4

15.72

6.33

u/l

0.58

188

malignant neoplasm of male genital organs, including Hilmo

446

1.01

0.01

1.6

1.3

7.69

6.18

u/l

0.32

392

Benign neoplasm of ovary

464

1.01

0.00

1.9

1.6

4.70

5.86

u/l

1.69

401

Solid cancers, including Hilmo

290

1688

1.00

0.00

1.5

1.4

6.00

6.13

u/l

0.06

253

1460

Malignant neoplasm of breast, ER-negative, including Hilmo

535

1.00

0.00

1.3

1.4

4.49

5.44

u/l

1.77

456

Other benign neoplasms of uterus

111

0.99

0.00

1.3

1.4

5.67

5.44

u/l

—

Thiazolidinediones

266

1.02

0.00

1.1

1.4

12.30

5.65

u/l

0.55

227

Intracerebral haemorrhage

255

0.98

0.00

1.4

1.5

16.41

7.00

u/l

0.49

215

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

107

1.03

0.00

1.5

1.4

4.91

7.86

u/l

1.02

Primary open-angle glaucoma, strict

608

1.00

0.00

1.9

1.5

6.19

6.29

u/l

0.04

505

Polyhydramnios

117

1.03

0.00

1.3

1.4

5.17

5.26

u/l

0.03

Organic, including symptomatic, mental disorders

139

977

1.00

0.00

1.5

5.11

6.50

u/l

3.31

119

819

Osteochondrodysplasia with defects of growth of tubular bones and spine

0.00

0.0

1.2

—

5.02

—

Abnormal pulmonary venous return

0.00

0.0

1.8

—

6.02

—

Factitial dermatitis

0.00

0.0

1.6

—

11.19

—

Victim of lightning

0.00

0.0

2.2

—

4.98

—

Type 1 diabetes, strict definition, subgroup 2

0.00

0.0

1.4

—

6.44

—

Acne varioliformis

0.00

0.0

1.7

—

6.53

—

Congenital malformations of lung, including avohilmo

0.00

0.0

1.8

—

7.86

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

0.0

1.7

—

12.77

—

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

0.00

0.0

1.6

—

11.80

—

Localized hypertrichosis

0.00

0.0

2.0

—

3.84

—

Eccrine sweat disorders

0.00

0.0

1.3

—

5.03

—

Embolism and thrombosis of abdominal aorta

0.00

0.0

1.2

—

13.52

—

Other and unspecified postprocedural disorders of eye and adnexa

0.00

0.0

1.8

—

5.72

—

Other endophthalmitis

0.00

0.0

1.1

—

9.78

—

Femoral hernia, bilateral

0.00

0.0

1.6

—

10.95

—

Constitutional tall stature

0.00

0.0

1.6

—

13.67

—

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

0.00

0.0

1.0

—

10.10

—

Carcinoma in situ, other/unspecified

0.00

0.0

1.2

—

11.94

—

Benign neoplasm: Larynx

0.92

0.00

1.2

1.6

4.12

7.41

u/l

—

Malignant neoplasm of uterus, part unspecified, including Hilmo

0.00

0.0

1.1

—

4.05

—

Malignant neoplasm, without specification of site, including Hilmo

1.00

0.00

1.3

5.45

6.42

u/l

—

Plasmodium falciparum malaria, including avohilmo

0.00

0.0

1.8

—

4.40

—

Melanocytic naevi of upper limb, including shoulder

0.98

-0.00

1.0

1.3

4.32

7.23

u/l

—

Malaria

0.00

-0.00

0.0

1.7

—

9.89

—

Congenital ptosis, including avohilmo

0.00

-0.00

0.0

1.8

—

6.75

—

Generalized epilepsy

0.96

-0.00

2.8

1.4

8.67

6.98

u/l

—

Secondary sideroblastic anaemia

0.00

-0.00

0.0

1.3

—

9.76

—

Hereditary sideroblastic anaemia

0.00

-0.00

0.0

1.2

—

10.82

—

Hyperchylomicronaemia

0.00

-0.00

0.0

1.1

—

5.26

—

Malignant neoplasm of vagina, including Hilmo

0.00

-0.00

0.0

1.1

—

4.05

—

Other combined immunodeficiencies

0.00

-0.00

0.0

1.2

—

11.94

—

Drug-induced aplastic anaemia

0.00

-0.00

0.0

1.8

—

14.00

—

Nondiabetic hypoglycaemic coma

0.00

-0.00

0.0

1.2

—

5.07

—

Neurofibromatosis, type 2

0.00

-0.00

0.0

2.8

—

5.02

—

Central nervous system disorder causing precocious puberty

0.00

-0.00

0.0

1.8

—

6.82

—

Erectile dysfunction, exclusion

0.00

-0.00

0.0

1.1

—

10.66

—

Benign neoplasm: Mediastinum

0.00

-0.00

0.0

1.1

—

5.11

—

Diseases of thymus

0.00

-0.00

0.0

2.0

—

11.12

—

Epileptic seizures related to drugs

0.00

-0.00

0.0

1.7

—

6.04

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

-0.00

0.0

1.2

—

4.94

—

Hereditary spastic paraplegia

0.00

-0.00

0.0

1.8

—

11.75

—

Multiple system atrophy (rare forms of Parkinsonism)

0.00

-0.00

0.0

1.0

—

13.68

—

Internuclear ophthalmoplegia

0.00

-0.00

0.0

1.8

—

10.50

—

Chorioretinal scars

0.00

-0.00

0.0

1.2

—

12.05

—

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

-0.00

0.0

1.1

—

11.53

—

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

0.00

-0.00

0.0

1.0

—

14.60

—

Oesophageal varices

1.00

-0.00

1.8

1.4

19.76

8.60

u/l

—

Venous complications and haemorrhoids in pregnancy

1.00

-0.00

1.6

1.4

4.60

6.46

u/l

—

Monocytic leukaemia

0.00

-0.00

0.0

1.9

—

10.61

—

Mechanical strabismus

0.00

-0.00

0.0

1.2

—

5.45

—

Labyrinthine fistula

0.00

-0.00

0.0

1.7

—

10.43

—

Degenerative conditions of globe

0.00

-0.00

0.0

1.2

—

12.60

—

Malignant neoplasm of vagina

0.00

-0.00

0.0

1.1

—

4.16

—

Other and unspecified disease of Bartholin gland

0.94

-0.00

2.2

1.4

3.82

6.36

u/l

—

Crohn's disease (strict) with PSC

0.00

-0.00

0.0

1.4

—

4.90

—

Pemphigus vulgaris

0.00

-0.00

0.0

1.8

—

13.26

—

Acné excoriée

0.00

-0.00

0.0

2.6

—

5.00

—

Periodontal disease, other/unspecified

0.89

-0.00

1.5

1.2

6.17

7.43

u/l

—

Secondary systemic amyloidosis

0.00

-0.00

0.0

1.9

—

4.47

—

Benign neoplasm: Pineal gland

0.00

-0.00

0.0

1.2

—

5.00

—

Benign neoplasm: Extrahepatic bile ducts

0.00

-0.00

0.0

1.1

—

10.31

—

Medullary carcinoma of thyroid gland, including Hilmo

0.00

-0.00

0.0

1.1

—

5.43

—

Postinflammatory hyperpigmentation

0.00

-0.00

0.0

1.4

—

4.10

—

Hypoplasia of dental enamel, prenatal , including avohilmo

0.00

-0.00

0.0

2.8

—

7.08

—

Non-small cell lung cancer, squamous

0.94

-0.00

1.0

1.3

5.63

6.58

u/l

—

Maxillary hypoplasia

0.00

-0.00

0.0

1.7

—

13.16

—

Calcium deposit in bursa

0.00

-0.00

0.0

2.4

—

5.50

—

Sunburn

0.00

-0.00

0.0

1.7

—

5.56

—

Myositis ossificans

0.00

-0.00

0.0

2.2

—

7.22

—

Progressive osseous muscle inflammation

0.00

-0.00

0.0

1.4

—

5.44

—

Adenocarcinoma of small intestine

0.00

-0.00

0.0

1.0

—

11.12

—

Chronic tubulo-interstitial nephritis

0.96

-0.00

1.4

1.3

5.63

5.38

u/l

—

Use of interferon beta-1a

0.88

-0.00

1.0

1.4

7.20

6.41

u/l

—

Mental and behavioural disorders due to use of volatile solvents

0.00

-0.00

0.0

1.5

—

6.30

—

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

0.00

-0.00

0.0

1.1

—

4.46

—

Rapidly progressive nephritic syndrome

0.00

-0.00

0.0

1.1

—

4.59

—

Congenital malformations of ear causing impairment of hearing

0.00

-0.00

0.0

2.0

—

6.14

—

Microtia (small ears)

0.00

-0.00

0.0

2.0

—

6.30

—

Cleft lip

0.00

-0.00

0.0

1.0

—

5.48

—

Congenital ptosis

0.00

-0.00

0.0

1.8

—

6.75

—

Congenital malformations of lung

0.00

-0.00

0.0

1.8

—

7.86

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

0.00

-0.00

0.0

1.2

—

3.96

—

Yaws

0.00

-0.00

0.0

1.0

—

12.70

—

Metabolic disorder, other/unspecified

0.00

-0.00

0.0

1.7

—

5.70

—

Other congenital malformations of face and neck

0.91

-0.00

1.3

5.70

7.36

u/l

—

Spina bifida

0.00

-0.00

0.0

2.3

—

4.89

—

Malignant neoplasm of cervix uteri, including Hilmo

0.86

-0.00

4.0

1.4

5.10

6.31

u/l

—

Other congenital musculoskeletal deformities

0.00

-0.00

0.0

1.8

—

6.08

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

-0.00

0.0

1.8

—

7.07

—

Other congenital malformations of spinal cord

0.00

-0.00

0.0

2.0

—

6.92

—

Burn and corrosion of other internal organs

0.00

-0.00

0.0

2.1

—

11.07

—

Fracture of spine, level unspecified

0.00

-0.00

0.0

1.6

—

10.21

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.00

-0.00

0.0

1.2

—

11.15

—

Crushing injury of head

0.00

-0.00

0.0

1.1

—

4.59

—

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

0.00

-0.00

0.0

2.0

—

5.38

—

Frostbite with tissue necrosis

0.00

-0.00

0.0

1.7

—

10.01

—

Alzheimer’s disease (undefined)

0.00

-0.00

0.0

1.0

—

10.01

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

-0.00

0.0

1.7

—

4.57

—

Upper arm

0.00

-0.00

0.0

1.8

—

4.68

—

Other helminthiases, including avohilmo

0.00

-0.00

0.0

1.1

—

10.21

—

Diphtheria

0.00

-0.00

0.0

1.6

—

5.39

—

Discharge from other and unspecified firearms

0.00

-0.00

0.0

1.3

—

9.90

—

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

0.00

-0.00

0.0

1.2

—

11.25

—

Inhalation of gastric contents

0.00

-0.00

0.0

1.2

—

12.34

—

Other cestode infections, including avohilmo

0.00

-0.00

0.0

1.0

—

10.84

—

Other zoonotic bacterial diseases, not elsewhere classified

0.00

-0.00

0.0

1.8

—

4.12

—

Intentional self-harm by other and unspecified firearm discharge

0.00

-0.00

0.0

1.2

—

6.04

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

-0.00

0.0

1.3

—

11.38

—

Other cestode infections

0.00

-0.00

0.0

1.0

—

11.78

—

Plasmodium falciparum malaria

0.00

-0.00

0.0

1.8

—

4.40

—

Pedestrian injured in collision with car, pick-up truck or van

1.00

-0.00

1.4

1.3

5.32

7.79

u/l

—

0.00

-0.00

0.0

1.2

—

13.34

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

-0.00

0.0

1.0

—

4.63

—

Vitreous prolapse

0.00

-0.00

0.0

1.3

—

5.73

—

Diphtheria, including avohilmo

0.00

-0.00

0.0

1.6

—

5.39

—

Cholera, including avohilmo

0.00

-0.00

0.0

2.8

—

5.70

—

Otorrhoea

0.00

-0.00

0.0

1.8

—

10.53

—

Alpha thalassaemia

0.00

-0.00

0.0

1.2

—

5.42

—

Severe bullous disorders, KELA reimbursement

0.00

-0.00

0.0

1.1

—

10.69

—

Other disorders following mastoidectomy

0.00

-0.00

0.0

1.1

—

10.71

—

Obstetric embolism

0.00

-0.00

0.0

1.8

—

3.98

—

Other helminthiases

0.00

-0.00

0.0

1.2

—

12.48

—

Marasmic kwashiorkor

0.00

-0.00

0.0

1.2

—

10.98

—

Noninfective disorders of pinna

0.00

-0.00

0.0

1.8

—

12.66

—

Hereditary nephropathy, not elsewhere classified

0.00

-0.00

0.0

1.1

—

9.64

—

Toxic erythema

0.00

-0.00

0.0

2.0

—

3.84

—

Supernumerary ureter

0.00

-0.00

0.0

1.8

—

6.08

—

Sequelae of malnutrition and other nutritional deficiencies

0.00

-0.00

0.0

1.9

—

10.63

—

Glycosuria

0.00

-0.00

0.0

1.8

—

13.48

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Aldolase [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS